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Abstract
ABSTRACT OF THE DISSERTATION

Contributions to the Methodology of Electrocardiographic Imaging (ECGI) and
Application of ECGI to Study Mechanisms of Atrial Arrhythmia, Post Myocardial
Infarction Electrophysiological Substrate, and Ventricular Tachycardia in Patients

by
Yong Wang
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2009
Professor Yoram Rudy, Chair

Electrocardiographic Imaging (ECGI) is a noninvasive imaging modality for cardiac
electrophysiology and arrhythmia. ECGI reconstructs epicardial potentials, electrograms
and isochrones from body-surface electrocardiograms combined with heart-torso
geometry from computed tomography (CT). The application of a new meshless method,
the Method of Fundamental Solutions (MFS) is introduced to ECGI with the following
major advantages: 1. Elimination of meshing and manual mesh optimization processes,
thereby enhancing automation and speeding the ECGI procedure. 2. Elimination of
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mesh-induced artifacts. 3. Simpler implementation. These properties of MFS enhance the
practical application of ECGI as a clinical diagnostic tool.

The current ECGI mode of operation is offline with generation of epicardial potential
maps delayed to data acquisition. A real time ECGI procedure is proposed, by which the
epicardial potentials can be reconstructed while the body surface potential data are
acquired (< 1msec/frame) during a clinical procedure. This development enables
real-time monitoring, diagnosis, and interactive guidance of intervention for arrhythmia
therapy.

ECGI is applied to map noninvasively the electrophysiological substrate in eight post-MI
patients during sinus rhythm (SR). Contrast-enhanced MRI (ceMRI) is conducted to
determine anatomical scar. ECGI imaged regions of electrical scar corresponded closely
in location, extent, and morphology to the anatomical scars. In three patients, late
diastolic potentials are imaged in the scar epicardial border zone during SR. Scar-related
ventricular tachycardia (VT) in two patients are imaged, showing the VT activation
sequence in relation to the abnormal electrophysiological substrate. ECGI imaging the
substrate in a beat-by-beat fashion could potentially help in noninvasive risk stratification
for post-MI arrhythmias and facilitate substrate-based catheter ablation of these
arrhythmias.
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ECGI is applied to eleven consecutive patients referred for VT catheter ablation
procedure. ECGI is performed either before (8 patients) or during (3 patients) the ablation
procedure. Blinded ECGI and invasive electrophysiology (EP) study results are compared.
Over a wide range of VT types and locations, ECGI results are consistent with EP data
regarding localization of the arrhythmia origin (including myocardial depth) and
mechanism

(focal,

reentrant,

fascicular).

ECGI

also

provides

mechanistic

electrophysiological insights, relating arrhythmia patterns to the myocardial substrate.
The study shows ECGI has unique potential clinical advantages, especially for
hemodynamically intolerant VT or VT that is difficult to induce. Because it provides
local cardiac information, ECGI may aid in better understanding of mechanisms of
ventricular arrhythmia. Further prospective trials of ECGI with clinical endpoints are
warranted.

Many mechanisms for the initiation and perpetuation of atrial fibrillation (AF) have been
demonstrated over the last several decades. The tools to study these mechanisms in
humans have limitations, the most common being invasiveness of a mapping procedure.
In this paper, we present simultaneous noninvasive biatrial epicardial activation
sequences of AF in humans, obtained using the Electrocardiographic Imaging (ECGI)
system, and analyzed in terms of mechanisms and complexity of activation patterns.
We performed ECGI in 36 patients with a diagnosis of AF. To determine ECGI atrial
accuracy, atrial pacing from different sites was performed in six patients (37 pacing
iv

events), and ECGI was compared to registered CARTO images. Then, ECGI was
performed on all 36 patients during AF and ECGI epicardial maps were analyzed for
mechanisms and complexity. ECGI noninvasively imaged the low-amplitude signals of
AF in a wide range of patients (97% procedural success).

The spatial accuracy in

determining initiation sites as simulated by atrial pacing was ~ 6mm. ECGI imaged many
activation patterns of AF, most commonly multiple wavelets (92%), with pulmonary vein
(69%) and non-pulmonary vein (62%) trigger sites. Rotor activity was seen rarely (15%).
AF complexity increased with longer clinical history of AF, though the degree of
complexity of nonparoxysmal AF varied and overlapped. ECGI offers a way to identify
unique epicardial activation patterns of AF in a patient-specific manner. The results are
consistent with contemporary animal models of AF mechanisms and highlight the
coexistence of a variety of mechanisms among patients.
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为学日益 为道日损
损之又损 以至于无为
无为而无不为
取天下常以无事
及其有事 不足以取天下
《道德经》

In the pursuit of knowledge, every day something is learned.
In the practice of the Tao*, every day some desire is dropped.
Drop and again drop until non-action is achieved.
When nothing is done on purpose, nothing is left undone.
The world is possessed by letting things take their natural courses.
It cannot be mastered by interfering or manipulating.
《Tao De Jing》
* Tao is the essential nature of human being.
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Chapter 1 Introduction

Cardiac electrical activity is a complex process that is both time dependent and spatially
distributed throughout the heart. Conventional ECG and multi-electrode body-surface
potential mapping (BSPM) only record a very low resolution projection of this activity on
the torso surface. Therefore, locations of cardiac events (e.g. activation initiation sites)
and spatial details (e.g. number and locations of activation fronts) cannot be determined
from such measurements. As a result, invasive electrophysiological mapping from the
epicardial and endocardial surfaces of the heart has become an important experimental
tool in the study of cardiac excitation. It has also become an essential clinical tool for
diagnosis of arrhythmias, guidance of intervention (e.g., ablation) and evaluation of
treatment outcome.

Electrocardiographic imaging (ECGI)1,2 is a novel, noninvasive tool for imaging cardiac
arrhythmia and defining electrophysiologic properties. ECGI combines multi-electrode
body surface ECG recordings with three-dimensional anatomical heart-torso imaging to
reconstruct an epicardial electroanatomical map. ECGI images can be presented as
epicardial potential maps, electrograms, isochrones (activation sequences), or
repolarization patterns during activation and repolarization of the heart. Unlike invasive
electrophysiological mapping, the ECGI technique is completely noninvasive and only
requires a single beat to reconstruct the entire epicardial electrical activity. This makes
-1-

ECGI a potentially useful tool for noninvasive evaluation of cardiac electrophysiology in
patients.

Prior to the recent development of noninvasive ECGI in our laboratory, studies involved
invasive cardiac mapping and were, consequently, very limited. With the successful and
extensive application and validation of ECGI in animal modes3-9 and humans studies2,11-19,
we can now begin to study noninvasively the electrophysiology of the human heart in
different clinical settings.

1.1 ECGI Theory
The torso volume conductor between the surface of the heart and torso can be treated as a
homogenous, passive volume, which greatly simplifies the complex electrocardiography
problem into an electrostatic field problem. Because there is no primary electrical source
in the volume conductor enclosed by torso surface and epicardial surface, the Laplace
equation holds in the volume domain.

The distribution of potentials on the torso can be known through the body surface
mapping procedure. The derivative of torso potentials in the normal direction is zero
since the normal component of current at the torso surface is zero (the torso is in air-an
insulating medium that does not support current flow). However we do not know
anything on the epicardial surface, which is the goal of the whole inverse computation in
-2-

electrocardiography. This constitutes the following Cauchy problem for Laplace’s
equation:
∇ 2u ( x ) = 0, x ∈ Ω

(1-1)

with the following boundary conditions:
(i)

Dirichlet condition: u ( x ) = uT ( x ),

(ii)

Neumann condition:

∂u( x )
= cT ( x ),
∂n

x ∈ Γ T on the torso surface

x ∈ Γ T on the torso surface

where Ω is the 3D volume domain between the heart’s epicardial surface, ΓE , and the
torso surface, ΓT , The potential distribution on epicardial surface ΓE is sought. The
above system of partial differential equations fully describes the electrostatic field in the
electrocardiography inverse problem. There is a unique solution to this Cauchy problem,
however the problem is ill-posed.

1.2 Computational Implementation
In the inverse problem of electrocardiography, the goal is to compute the electric
potential distribution on the surface of the heart (epicardium) from potential data
measured on the torso. The relationship between the potential distributions on the surface
of the body and the surface of the heart is mathematically described by the Cauchy
problem. The numerical solution for the ECGI inverse computation requires two steps.
The first step is the construction of a mathematical expression describing the potential
field throughout the torso volume conductor, particularly on the body surface, as a
function of epicardial potential data (the forward problem). The second step is the
-3-

inversion of that expression to enable the reconstruction of epicardial potentials from the
measured torso potential data (the inverse problem).

1.2.1 The Forward Model

To solve the Cauchy problem for Laplace operator in an irregular geometry such as the
human heart-torso configuration, it is necessary to utilize numerical methods. There are
many kinds of popular numerical methods available: Finite Element Method (FEM),
Boundary Element Method (BEM) and so on. Each of these methods has its own
advantages and suitable for different kinds of problems.

In the case of computing epicardial surface potential in ECGI, BEM is an excellent
choice because only the boundary is discretized into elements (mesh) instead of the
whole 3D volume domain, as in FEM (see the following figure for torso mesh and heart
surface mesh). Therefore, it involves fewer nodes and mesh connections than does FEM
requiring less overhead computationto assemble the mesh, and the mesh can be adapted
more easily to different geometries. After applying BEM, the Laplace Equation is
discretized into the following form:
Vt = A *Ve

(1-2)

where Vt is the vector of the torso potential, Ve is the vector of the heart surface
potential, and A matrix is the transfer matrix between heart and torso that depends only
on the geometry.

-4-

1.2.2 The Inverse Solution

Although the solution to the Cauchy problem is unique, because the inverse problem is
ill-posed, one cannot simply invert the A matrix to compute Ve from Vt .

Even

low-level noise in the measured data can cause unbounded error in the solution. That is to
say, the solution does not depend continuously on the data. Techniques of regularization
must therefore be used to minimize the effects of such error by imposing constraints on
the solution. Several classes of techniques are available to regularize ill-posed problems.
The Tikhonov regularization scheme, which is a type of single parameter minimization
method, is used to find the Ve in ECGI.
2

2

min{ Vt -AVe +t Ve }
Ve

(1-3)

The composite residual and smoothing operator technique (CRESO)24 is used in the
Tikhonov scheme to automatically select the regularization parameter “ t ”. Temporal and
spatial information known a priori can also be added into Tikhonov regularization
scheme to improve solution accuracy. General Minimal Residual Method (GMRES)25 is
also adopted in our ECGI computation packages as an extension of the minimal residual
method (MINRES) from symmetric systems to asymmetric systems.

1.3 Experimental Validation
In the work of previous generations of students in our laboratory, ECGI method was
extensively validated using “torso tank” experiment setup3-9. The torso-tank experimental
setup, developed by Taccardi and co-workers, was used for detailed and rigorous
evaluation of our ECGI methodology. This experimental setup consists of a tank in the

-5-

shape of a 10-year-old boy's torso filled with an electrolytic solution, with a perfused dog
heart (connect to the circulation of a support dog) suspended in the correct anatomical
position within the torso volume. The torso tank system consisted of 384 torso surface
electrodes and 384 rods projecting radially from the torso surface toward the center of the
tank. Each radially projecting rod had an electrode at its tip and multiple electrodes along
its length within the torso volume, for a total of 918 rod electrodes. The rods at the level
of the heart were pushed in so the tips created an epicardial envelope about 1cm from the
epicardial surface.

Based on the torso tank experimental setup, ECGI has been demonstrated to have the
capability of reconstructing epicardial potentials, electrograms and isochrones during
pacing and determining pacing site locations with better than 10mm accuracy26,27. ECGI
could reconstruct potential and electrogram characteristics associated with abnormal EP
substrates28. The pathway and features of reentrant ventricular tachycardia (VT) were
faithfully reconstructed using ECGI8,29. Repolarization abnormalities were also detected9.

1.4 ECGI Applications in Human
1.4.1 Body Surface Potential Mapping System

We recently established a new active-electrode mapping system (Active Two System,
Biosemi, Netherland), which is a highly integrated system, designed to be a stand-alone
and portable unit with data acquisition and data processing capabilities. Noise levels as

-6-

low as the thermal noise of the electrode impedance (which is the theoretical minimum)
can be achieved by the active design. The electrodes are made from conductive carbon to
prevent interference with X-ray fluoroscopy when the system is used in the catheterizaion
laboratory during an EP study. These flat electrodes are encapsulated in strips to facilitate
application. The Active Two System is fully portable (total weight about 5kg) and
operable by a single person. It contains the following components: 1) carbon electrodes
in strips 2) A/D converter for 256 channels 3) USB2 receiver 4) high performance laptop
with 256 parallel channel data acquisition Labview software 5) battery box with chargers.

1.4.2 Computerized Tomography Imaging

The CT scan is ECG gated at 20% (on) and 70% (off) of the RR intervals. Since the
active electrodes are made from X-ray transparent carbon material, CT markers are
attached onto each electrode to mark the electrodes location in the CT images. We scan
caudal to cranial (foot to head). Most respiratory motion occurs in the lower chest, so
patients can hold their breath as long as they can, and then do a slow release. The
radiation dose is about 1.8 rad. The slice thickness is 3mm.

1.4.3 Procedure for ECGI Reconstruction

By combining a multi-electrode body surface ECG mapping data with a CT scan of the
heart-torso geometry, CADIS (the core ECGI software) can reconstructs an epicardial
electro-anatomical map noninvasively. The ECGI images can be presented as epicardial
potential maps, electrograms, isochrones or repolarization maps during activation and
-7-

repolarization. The complete ECGI procedure is shown in the Figure 1-1. Elastic belts are
used to hold the electrodes to the subjects’ torso surface. The subject holds breath or
keeps shallow breath during the procedure to minimize the affect of respiration.

Figure 1 (Figure 1-1): ECGI Procedure.

1.5 Dissertation Objectives and Organization
In this thesis, there are two major objectives related to further development and
improvement of the ECGI system: 1)development of a new forward computing model
based on meshless numerical method to avoid the limitations of mesh based numerical
method (such as BEM, FEM;), 2) design and implement a new ECGI scheme to achieve
real time ECGI computation, which can enhance ECGI system’s clinical applications.
There are three other major objectives related to the clinical evaluation and applications
of ECGI to different groups of adult patients: 1) patients with Post-MI, 2) patients with
ventricular arrhythmias, and 3) patients with atrial arrhythmias.
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The dissertation is organized into following 8 Chapters
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Isolation, and Scar-Related Atypical Atrial Flutter.
Chapter 8: Conclusions and Future Work.
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Chapter 2 Application of Method of Fundamental Solutions to
Potential-based Inverse Electrocardiography

Abstract
Electrocardiographic Imaging (ECGI) is a noninvasive imaging modality for cardiac
electrophysiology and arrhythmia. ECGI reconstructs epicardial potentials, electrograms
and isochrones from body-surface electrocardiograms combined with heart-torso
geometry from computed tomography (CT). The method of choice for computing
epicardial potentials has been the boundary element method (BEM) which requires
meshing the heart and torso surfaces and optimizing the mesh, a very time-consuming
operation that requires manual editing. Moreover, it can introduce mesh-related artifacts
in the reconstructed epicardial images. Here we introduce the application of a meshless
method, the Method of Fundamental Solutions (MFS) to ECGI. This new approach that
does not require meshing is evaluated on data from animal experiments and human
studies, and compared to BEM. Results demonstrate similar accuracy, with the following
advantages: 1. Elimination of meshing and manual mesh optimization processes, thereby
enhancing automation and speeding the ECGI procedure. 2. Elimination of mesh-induced
artifacts. 3. Elimination of complex singular integrals that must be carefully computed in
BEM. 4. Simpler implementation. These properties of MFS enhance the practical
application of ECGI as a clinical diagnostic tool.
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2.1 Introduction
Computation of potentials on the surface of the heart from potentials measured on the
body surface involves solving Laplace’s equation in the source-free volume between the
torso and heart surfaces. Several mathematical and computational approaches were
introduced to solve this problem, known as the inverse problem of electrocardiography in
terms of potentials.25-28 Other approaches used a bi-domain model-based method to
compute activation times (isochrones) on the heart surface.29-32 Recently, both the
potential-based approach (for computing epicardial potentials, electrograms, and
isochrones) and the activation-time approach were applied and evaluated in human
subjects.1,10,30-40 Both methods require discretizing the heart and torso surfaces into
continuous non-overlapping mesh elements, a procedure called meshing. Meshing is
difficult to apply to irregular surfaces41 and can introduce mesh-related artifacts,
especially in the computation of solutions to the ill-posed42 electrocardiographic problem,
if mesh optimization is not carefully done. In our application of inverse
electrocardiography, the Boundary Element Method (BEM)43,44 was used to solve
Laplace’s equation.45,46,10,47 In this approach, mesh optimization is the most
time-consuming step and requires manual intervention and editing. Importantly, this
formulation requires computation of complicated singular integrals that require careful
handling. 48,49,50 In addition, BEM often suffers from slow convergence due to the use of
low order polynomial approximations.48,51 These difficulties with the efficient
implementation of BEM led us to explore the possibility of applying a meshless method
- 11 -

to inverse electrocardiography, in the hope of overcoming such mesh-related problems.

Meshless methods have been applied successfully in a wide array of engineering and
industrial application.52,53 Inverse electrocardiography is a 3D Cauchy problem for the
Laplace operator which has a very well behaved, analytic fundamental solution.54 This
property suggests the Method of Fundamental Solutions (MFS)55 as the method of choice
for this problem among the family of meshless methods.56

In this study, we formulate the use of MFS in inverse electrocardiography and evaluate its
performance. We test this new method using data from animal experiments21 and human
studies,10,35 and compare its performance to the BEM-based approach that requires
meshing. Human data were processed using the potential-based method with geometrical
information (heart-torso geometry) obtained noninvasively using CT imaging. All
approaches to the noninvasive reconstruction of cardiac electrical activity can be referred
to as cardiac electrophysiological imaging modalities. For clarity, we refer in the paper to
the potential-based method employed here as electrocardiographic imaging (ECGI), its
MFS version MFS ECGI, and its BEM version BEM ECGI.
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2.2 Methods
2.2.1 Formulating the Method of Fundamental Solutions for ECGI

The method of fundamental solutions (MFS) has been used in various mathematical and
engineering applications to compute solutions of partial differential equations (PDE). 52,53
MFS approximates the solution of a PDE by a linear combination of fundamental
solutions of the governing partial differential operator,55 which for ECGI is the Laplacian
operator ∇ 2 . The formulation of MFS for a ∇ 2 boundary value problem and Cauchy
problem is described in the Appendix of this chapter; its implementation in ECGI is
described below.

The objective of ECGI is to determine the electric potential on the epicardial surface of
the heart noninvasively, from measurements of the electric potential on the torso surface.
This constitutes a Cauchy problem for Laplace’s equation:54
∇ 2u( x ) = 0, x ∈ Ω

(2-1)

with the following boundary conditions:
(iii)

Dirichlet condition: u ( x ) = uT ( x ),

(iv)

Neumann condition:

∂u( x )
= cT ( x ),
∂n

x ∈ Γ T on the torso surface
x ∈ Γ T on the torso surface

where Ω is the 3D volume domain between the heart’s epicardial surface ΓE and the
torso surface ΓT as shown in Figure 2-1. u(x ) is the potential at location x;
uT ( x ) and cT ( x ) are the potential and its normal derivative on the torso surface,
respectively. The goal of ECGI is to obtain the electric potential on the heart
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surface uE ( x ), x ∈ Γ E

Figure 2 (Figure 2-1): A schematic showing the configuration of fictitious points for a
multi-connected domain.
The dashed lines are the auxiliary surfaces that contain the fictitious points (virtual sources) marked
by black circles. The filled square is the geometrical center of the “heart”, the empty triangle is located
on the “heart surface” and the empty square on the “torso surface”, the two black circles on their
connecting line at the auxiliary surfaces are the corresponding virtual source points.

MFS is an approach for solving numerically Laplace’s equation. In MFS, an approximate
solution is represented in the form of a linear superposition of source functions
(fundamental solutions) located on a set of points (fictitious points, virtual sources) over
an auxiliary surface Γ̂ ( Γ̂ encloses the auxiliary domain Ω̂ , which contains the actual
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domain Ω as shown in Figure 2-1). As the fundamental solutions satisfy Laplace’s
equation everywhere except at source points, this representation satisfies Laplace’s
equation in the domain Ω . In addition, the specified boundary conditions are imposed at a
set of boundary points (collocation points) on the domain boundary Γ . Since the
fundamental solutions do not have singularities at points on the boundary Γ , standard
quadrature rules can be used to approximate the surface potential and its normal gradient
when computed on the boundary.41

As shown in the Appendix (equations (a21) and (a22)), MFS can be applied to discretize
the Dirichlet and Neumann boundary conditions in equation (2-1) as:
Dirichlet condition:
M

a0 + ∑ a j f ( xk − y j ) = uT ( xk ), 1 ≤ k ≤ N , xk ∈ ΓT , y j ∈ Γˆ

(2-2)

j =1

Neumann condition:
∂f ( xk − y j )

M

∑a
j =1

j

where f ( r ) =

∂n

= cT ( xk ) = 0, 1 ≤ k ≤ N , xk ∈ ΓT , y j ∈ Γˆ

(2-3)

1
is the fundamental solution of Laplace’s equation in 3D, r = x − y
4πr

is the 3D Euclidean distance between point x and point y ,

n̂ is normal to the torso

surface, a0 is the constant component of uT ( x ) and a j is the coefficient of a virtual
source at location y j . Note that a0 and a j have different units in this formulation.
The conductivity of the volume is reflected in the coefficient a j ; it does not appear
explicitly in the ECGI formulation when the volume of interest is homogenous. M is the
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number of fictitious points. N is the number of torso surface points. Γ is the boundary
of domain Ω , and Γ̂ is the auxiliary boundary of the auxiliary domain Ω̂ , which
contains the domain Ω as shown in Figure 2-1.

Boundary conditions are satisfied on N torso surface points xk . In equation (2-2)

uT ( xk ) is the measured body surface potential at electrode position xk . In equation (2-3),
cT ( xk ) = 0 because the torso is in air, an insulating medium that does not support current
flow. The locations of the fictitious points y j are configured based on the particular
domain geometry, which in ECGI is a multi-connected surface in 3D, composed of the
body surface and heart surface ( Γ = ΓT ∪ ΓE ). Using a static configuration scheme (see
Appendix), the fictitious sources are placed on two auxiliary surfaces ( Γˆ = Γˆ T ∪ Γˆ E )

which are determined by inflation/deflation of the true surfaces (torso surface and heart
surface). Figure 2-1 shows the configuration of the fictitious points in a 2D representation.
The fictitious boundary corresponding to the heart surface Γ̂E is obtained by deflating
the heart surface by a factor of 0.8 relative to the geometrical center of the heart. The
geometrical center of the heart can be found by computing the average coordinate value
of all the heart surface nodes. For the torso surface, the fictitious boundary Γ̂T is
obtained by inflating the torso surface by a factor of 1.2 relative to the geometrical center
of the heart.

Expressing equations (2-2) and (2-3) in matrix form gives:
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G G
Aˆ a = b
⎛ 1 f ( x1 − y1 )
⎜
#
⎜#
⎜1 f ( x − y )
N
1
where, ˆ ⎜
∂f ( x1 − y1 )
A=⎜
⎜0
∂n
⎜#
#
⎜
∂f ( x N − y1 )
⎜0
∂n
⎝

f ( x1 − y M ) ⎞
⎟
#
⎟
f ( xN − yM ) ⎟
⎟,
∂f ( x1 − y M ) ⎟
⎟
∂n
⎟
#
∂f ( x N − y M ) ⎟
⎟
∂n
⎠

"
"
#
"
"
"

(2-4)

⎛ a0 ⎞
⎜ ⎟
G ⎜ a1 ⎟
a=
,
⎜ # ⎟
⎜a ⎟
⎝ M⎠

⎛ uT ( x1 ) ⎞
⎜ # ⎟
⎜
⎟
G ⎜ uT ( xN ) ⎟
b =⎜
⎟
⎜ 0 ⎟
⎜ # ⎟
⎜
⎟
⎝ 0 ⎠

G
G
Matrix Â is of dimension 2 N × ( M + 1) ; a and b are vectors of dimensions M + 1 and
2 N respectively.

G
This matrix equation can not be solved for a without regularizaiton42, because the matrix

Â is ill-conditioned and the measured body surface potential contains measurement error.
The Tikhonov regularization method42 with CRESO-determined regularization
G
parameter46 is used to stabilize the inverse procedure and obtain a , similar to our previous

ECGI inverse computations using mesh-based BEM.4,8,9,21,24,33,57, 1, 47

G
Once the coefficient vector a is obtained, u(x ) can be computed at any location in the

domain using:
M

u( x ) = a 0 + ∑ a j f ( x − y j ), x ∈ Ω, y j ∈ Γˆ

(2-5)

j =1

The epicardial potential can then be calculated using:
M

uE ( x ) = a0 + ∑ a j f ( x − y j ), x ∈ Γ E , y j ∈ Γˆ

(2-6)

j =1

Epicardial potentials are calculated using (2-6) on many epicardial nodes; numbers are
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provided for each dataset in the Results section. An epicardial potential map, reflecting
the spatial distribution of potentials on the epicardial surface, is computed every
millisecond during the cardiac circle.

The time series of reconstructed epicardial

potential maps are then organized by location to provide temporal electrograms for any
given point on the epicardium. A reconstructed epicardial electrogram provides the
potential variation with time at a given point on the epicardium during the cardiac cycle.
Epicardial isochrone maps (a map of the epicardial activation sequence) are computed by
taking the time of maximum negative

duE
of the temporal electrogram (“intrinsic
dt

deflection”) at a given location as the time of epicardial activation at that location.

2.2.2 Experimental Methods and Protocols

MFS ECGI reconstructions were performed on data from four studies: (i) Single-site
pacing in an isolated canine heart suspended in a human torso-shaped tank; data were
obtained during pacing from a right ventricular (RV) anterior epicardial location;21 (ii)
RV endocardial pacing in a patient undergoing bi-ventricular pacing for cardiac
resynchronization therapy (CRT); (iii) Simultaneous RV endocardial pacing and left
ventricular (LV) epicardial pacing in a patient undergoing bi-ventricular pacing for CRT;
(iv) Normal atrial activation in a healthy human subject.1

Isolated Canine Hearts Suspended in a Human Torso-Shaped Tank 21
The performance of MFS in ECGI was evaluated using data from a human torso-shaped
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tank.21 The setup consisted of an isolated canine heart suspended in a homogenous
electrolytic medium in the correct anatomical position inside a tank molded in the shape
of a ten-year old boy. The tank had 384 surface electrodes recording torso potentials and
242 rods with electrodes at their tips that formed an epicardial recording envelope around
the heart. The torso-surface potentials and epicardial potentials were recorded
simultaneously. The directly measured epicardial potentials by the rod-tip electrodes
served as a “gold standard” for MFS ECGI validation. The torso-surface potentials
provided the input data for MFS ECGI noninvasive reconstruction of epicardial potentials,
electrograms and isochrones, which were then evaluated by comparison with the directly
measured “gold standard”. Details were provided in previous ECGI publications. 4,21,24,47
To simulate focal arrhythmogenic activity, the heart was paced from an anterior epicardial
location. The same datasets were used in BEM ECGI and reported in previous
publications.21 Here, these datasets are used to evaluate MFS ECGI and compare its
performance to that of BEM ECGI. The pacing protocol also provided a measure of MFS
ECGI spatial accuracy (its accuracy in locating the known pacing site). After pacing, a
quasi-elliptical region of intense epicardial negativity forms around the pacing site.
4,21,47,58

Bi-Ventricular Pacing In Human Subjects 1
We also applied MFS ECGI to clinical data from patients with an implanted
bi-ventricular pacing device. For the bi-ventricular pacing data, MFS ECGI accuracy in
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locating the pacing sites was evaluated by comparison with the pacing electrodes’
positions as determined from CT images. The reconstructed activation pattern was
evaluated based on the known patterns of activation generated by pacing.

Data from two heart failure patients undergoing cardiac resynchronization pacing
therapy1 are presented. Subject 1 was paced from a right ventricular (RV) endocardial site,
close to the RV apex. Subject 2 was paced simultaneously from an RV endocardial site
and from a left ventricular (LV) epicardial site. Body surface potentials were recorded
with a 224-channel mapping system using an electrode-vest as previously described.1
Epicardial geometry and location of the torso electrodes were obtained from CT images
of the thorax. The locations of the cardiac pacing leads were also determined from these
CT images.1

Normal Atrial Activation in a Healthy Human Subject 1
MFS ECGI was applied to reconstruct atrial activation in a healthy young adult. The
same data were used in BEM ECGI and reported in a previous study.1 The atrial
activation pattern was reconstructed from recorded P-wave body surface potential maps
with 224 channels, together with a subject-specific torso and atrial geometry obtained
using CT. The directly measured normal atrial activation pattern in isolated human hearts
(Durrer et. al59), was used for qualitative evaluation of the MFS ECGI reconstruction.

- 20 -

Informed consent was obtained according to Institutional Review Board guidelines at
University Hospitals of Cleveland, which approved all human studies protocols.

2.2.3 Evaluation Procedures

For the tank-torso protocols, measures in terms of relative error (RE) and correlation
coefficients (CC) were computed with respect to the measured data to quantitatively
evaluate the accuracy of ECGI; RE and CC were defined previously.27 RE gives an
estimate of the amplitude difference and CC gives an estimate of the similarity of
potential patterns or electrogram morphologies between the measured and computed data:
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For potential maps, L is the number of epicardial points at which potentials are measured
and computed. Vi C is the computed potential at epicardial point i , at a given instant of
time, and Vi M is the corresponding measured potential. V M and V C are the spatial
average of measured and computed potentials respectively, averaged over all L points.
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For electrograms, L is the number of time frames for which potential is measured and
computed. Vi C is the computed potential at time i , at a given epicardial location, and
Vi M is the corresponding measured potential. V M and V C are the temporal average of
measured and computed potentials respectively, averaged over all L times.

In addition to CC and RE, pacing site localization errors (distance between reconstructed
and measured locations) were also computed for both torso-tank and human
reconstructions. The reconstructed pacing site location was estimated by the center of an
ellipse that best fits the quasi-elliptical negative potential region that develops around the
pacing site.4,21,47 The earliest time frame after pacing, for which such pattern was present,
was used for this purpose. Pacing sites could also be determined from isochrone maps as
the sites of earliest activation.

Qualitative evaluations of ECGI reconstructions are conducted by visual comparison to
measured data (torso-tank experiments) and to well established potential, electrogram and
isochrone patterns associated with pacing and normal atrial activation (human subjects).

2.3 Results
2.3.1 Single Site Pacing in a Torso-Shaped Tank

Figure 2-2 shows epicardial potential maps for anterior RV pacing, at a time 25 ms after
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pacing. There are 240 epicardial nodes, 386 torso nodes and 626 (240+386) virtual source
points in this dataset. The top row shows the directly measured epicardial potential maps
in four views. The middle and bottom rows show MFS-reconstructed and
BEM-reconstructed epicardial potential maps, respectively. The white asterisk in the
anterior view marks the pacing site location (top row) and its estimation from the
reconstructed epicardial potential maps in the middle and bottom rows. The measured
potentials display a central quasi-elliptical negative region (blue) flanked by two positive
regions (red, maxima locations are marked by the white plus signs) as expected in the
anisotropic myocardium.21,58 This pattern is captured by both BEM ECGI and MFS ECGI.
However, MFS ECGI provides a more accurate potential map pattern than BEM ECGI.
MFS ECGI locates the pacing site with an error of 3 mm as compared to a 5 mm error for
BEM ECGI. CC (a measure of pattern similarity to the measured potentials) is improved
from 0.85 (BEM ECGI) to 0.92 (MFS ECGI); RE (indicative of amplitude accuracy) is
improved from 0.97 (BEM ECGI) to 0.47 (MFS ECGI).
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Figure 3 (Figure 2-2): Canine epicardial potential maps 25ms after pacing from a single anterior
site (indicated by the asterisk *).
Top row shows the directly measured epicardial potentials (four views) displaying the negative region

(dark blue) around the pacing site, and two flanking positive maxima (red). Middle row shows the
noninvasively reconstructed potentials computed using MFS ECGI; note close similarity of
noninvasive and invasive data. Bottom row shows the reconstruction using BEM ECGI.

Figure 2-3 shows noninvasively reconstructed epicardial electrograms (format described
in figure legend) using MFS ECGI. Figure 2-3A shows four views of the heart surface.
Electrograms reconstructed at epicardial sites close to pacing site (sites 1, 2, 3), at
intermediate distance from the pacing site (sites 4, 5, 6), and far way from the pacing site
- 24 -

(sites 7, 8, 9) are displayed. In panels B, C, and D, both measured and noninvasively
computed electrograms using MFS are displayed. Three main types of waveforms:
monophasic negative (B), biphasic (C), and monophasic positive (D), are reconstructed.
Notice the close resemblance (high Correlation Coefficient, CC) of the noninvasively
reconstructed MFS ECGI electrograms to the measured electrograms. Compared with
reconstructed electrograms using BEM ECGI22, MFS ECGI achieves better accuracy
with greatly reduced computation time.
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Figure 4 (Figure 2-3): Canine epicardial electrograms (measured and computed using MFS
ECGI) from selected locations.

Canine epicardial electrograms (measured and computed using MFS ECGI) from selected locations on
the heart surface for pacing from the same single site as in Figure 2 (indicated by the asterisk). (A)
Four views of epicardial surface. Numbers in boxes identify locations of the electrograms in the other
panels. Measured (left column) and computed (right column) electrograms are compared in B, C and
D. Number on the bottom left of each panel identifies the electrogram location (corresponding to
numbers in A). (B) Monophasic (Q wave) electrograms from sites 1, 2 and 3. (C) Biphasic

- 26 -

electrograms from sites 4, 5 and 6. (D) Monophasic (R wave) electrograms from sites 7, 8 and 9. CC
is the Correlation Coefficient between invasive and noninvasive electrograms, indicating high level of
similarity.

Figure 2-4 shows noninvasively reconstructed epicardial isochrones using MFS ECGI
and BEM ECGI. Notice that the region of earliest activation (red) is reproduced
accurately in the computed isochrones, as is the entire sequence of epicardial activation
(CC = 0.78). A similar epicardial isochrone map is reconstructed by BEM ECGI (CC =
0.74). Based on Figure 2-4, it appears that MFS reconstructs smoother isochrones than
BEM. A comparison of patterns shows closer similarity of the MFS reconstruction to the
measured data, suggesting that the BEM reconstruction is somewhat under-regularized
with the chosen CRESO regularization parameter. Similar observations apply to the
ECGI reconstructed potential maps in Figure 2-2.
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Figure 5 (Figure 2-4): Canine epicardial isochrone map for pacing from the same single site.

Canine epicardial isochrone map for pacing from the same single site as in Figure 2 (indicated by the
asterisk). Top row shows the directly measured isochrones (four views) displaying the anterior pacing
site. Middle row shows the noninvasively reconstructed isochrone map computed using MFS ECGI.
Bottom row shows the noninvasively reconstructed isochrone map computed using BEM ECGI.

2.3.2 RV Endocardial Pacing in a Human Subject

Figure 2-5 compares epicardial potential maps computed with BEM ECGI and MFS
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ECGI in a human subject during RV pacing (anterior view). There are 447 epicardial
nodes, 115 torso nodes and 562 (447+115) virtual source points in this dataset. The
pacing site as determined from CT images is marked by the white asterisk. Three
reconstructions are compared: Left, BEM ECGI with an automatically generated mesh;
Middle, MFS ECGI; Right, BEM ECGI with a manually optimized mesh. Panel A shows
epicardial potential maps during activation, 62 ms after pacing. The negative region (dark
blue) generated by BEM ECGI is fragmented, due to meshing artifacts. The three
negative regions could be interpreted erroneously as reflecting three pacing sites. MFS
ECGI effectively avoids such fragmentation and reconstructs a quasi-elliptical negative
region, reflecting the single pacing site. After manual mesh editing, fragmentation of the
negative region is eliminated, demonstrating that the fragmentation is mesh related. Panel
B of Figure 2-5 shows a reconstructed epicardial potential map for the same protocol
during repolarization (205 ms after pacing). As expected during pacing, the negative
region of activation in panel A is replaced by a positive region (red). 1,20 Similar to Panel
A, fragmentation of the positive region is observed for BEM ECGI, but not for MFS
ECGI; it is eliminated from the BEM ECGI reconstruction after manual mesh editing.
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Figure 6 (Figure 2-5): MFS ECGI is free of mesh artifacts
Panel A: Human epicardial potential map (anterior view) 62 ms after pacing from a single RV

endocardial site (marked by the asterisk).

Left: BEM ECGI reconstruction with initial mesh

(non-optimized), showing fragmentation of the negative region (blue) caused by meshing artifact.
Middle: MFS ECGI reconstructs a single continuous minimum (blue) associated with single-site

pacing. Right: BEM ECGI reconstruction with manually-edited mesh, showing that fragmentation is
mesh related. Panel B: Human epicardial potential map (anterior view) during repolarization for
pacing from the same site (205 ms after pacing).

The error in locating the pacing site is 14mm using BEM ECGI (by fitting an ellipse over
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the three negative regions in the automated mesh reconstruction), 8mm using BEM ECGI
with the manually optimized mesh, and 5mm using MFS ECGI. In order to improve the
BEM ECGI reconstruction result, several manual iterations of mesh editing and
optimization were required.

2.3.3 Simultaneous RV Endocardial and LV Epicardial Pacing

Figure 2-6 shows MFS ECGI reconstructions during simultaneous RV endocardial and
LV epicardial pacing in a patient undergoing bi-ventricular pacing for CRT. There are 437
epicardial nodes, 189 torso nodes and 626 (437+189) virtual source points in this dataset.
Panel A is an epicardial potential map 40 ms after pacing, displayed in three partially
overlapping views. The asterisks mark the pacing sites locations determined from CT
images. Panel B shows an epicardial isochrone map on the same views. From the
isochrone map, it is determined that epicardial activation above the endocardial RV
pacing site occurred 25ms later than epicardial activation around the epicardial LV pacing
site. Given that pacing from both leads was simultaneous, the delay probably reflects, at
least in part, endocardial to epicardial wave front propagation in the RV ventricular wall.
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Figure 7 (Figure 2-6): Human epicardial potential map and isochrone map for simultaneous RV
and LV pacing

Human epicardial potential map and isochrone map for simultaneous RV and LV pacing (pacing sites
marked by the asterisks *; note that the left and back views show the same pacing site). Panel A
shows the MFS ECGI reconstructed potential map 40ms after pacing (three partially overlapping
views).Typical quasi-elliptic negative region (blue) surrounds each pacing site. Panel B shows the
corresponding MFS ECGI reconstructed isochrone map in the same format.

From both isochrone maps and potential maps the RV pacing site and LV pacing site are
located within 5.2mm and 7.4mm, respectively, of their locations as determined from CT.
This accuracy is similar to the results of BEM ECGI after several iterations of mesh
optimization.
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2.3.4 Normal Human Atrial Activation

Figure 2-7 shows normal atrial activation isochrones reconstructed by MFS ECGI for a
healthy volunteer. There are 322 atrial epicardial nodes, 228 torso nodes and 550
(322+228) virtual source points in this dataset. Earliest activation starts in the right
atrium (RA) between the aorta and superior vena cava (SVC), near the anatomical
location of the sinoatrial node (SA node). From the SA node, the impulse propagates
radialy to the left atrium (LA) and the rest of the RA (the black arrows show the
propagation pathway). The LA appendage (LAA) activates last. The atrial isochrones by
MFS ECGI are practically identical to those reconstructed using BEM ECGI45. Both
reconstructions provide activation patterns that are very consistent with directly measured
atrial isochrones in normal isolated human hearts.59
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Figure 8 (Figure 2-7) Normal human atrial activation isochrones reconstructed with MFS ECGI.

RA: Right Atrium; LA: Left Atrium; LAA: Left Atrial Appendage; PV: Pulmonary Vein; SVC:
Superior Vena Cava. Black arrows indicate direction of activation spread.

2.4 Discussion
In this paper we implement a meshless method, MFS, for noninvasive ECGI and evaluate
its accuracy and performance. ECGI is formulated in terms of potentials, computing
potentials on the epicardial surface of the heart from electrocardiographic potentials
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measured on the body surface.25-28 The existence of a well-behaved, analytic fundamental
solution for the Laplace operator in 3D54 makes MFS highly suitable for the ECGI
application.
Being a potential-based scheme, ECGI reconstructs epicardial potentials, from which
electrograms and activation sequences (isochrones) can also be computed. This approach
is applicable not only during cardiac activation, but provides images of repolarization as
well. 9 A different approach to inverse electrocardiography has been to compute directly
the activation sequences on both epicardial and endocardial surfaces of the heart.29,30,60
The potential-based approach has also been used to reconstruct potentials on the
endocardial surface from a non-contact intracavitary catheter.61-65 It should be noted that
while for the potential-based approach optimizing the mesh (a procedure requiring
manual editing) is the time-limiting step, for the activation-based approach30 it is the
inverse computation which utilizes a nonlinear-optimization iterative scheme, a complex
time consuming process. Mesh related artifacts mainly affect patterns of epicardial
potential maps and magnitudes of electrograms in the potential-based ECGI
reconstruction. The morphology of electrograms (from which activation times are
determined) and activation patterns (isochrones) are minimally affected by mesh structure.
This suggests that the activation-time approach that only computes isochrones is less
sensitive to mesh properties.
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2.4.1 Geometry and Torso Inhomogeneitie

The importance to inverse electrocardiography of geometry accuracy and of conductivity
inhomogeneities in the torso volume conductor (due to the lungs and other torso
compartments) has been evaluated extensively. 66, 57,67,68 Huiskamp and van Oosterom66
concluded that a tailored accurate geometry is required for accurate ECGI inverse
computation. Other studies57,67 showed that although the accuracy of reconstruction
depends on accurate knowledge of the geometry, small errors in geometry determination
(e.g. 1-cm shift error in heart position) can be tolerated by ECGI without major
deterioration of reconstruction quality. A study using realistic human anatomy69
demonstrated that a homogeneous model of the torso produced less accurate epicardial
potential magnitudes than an inhomogeneous model, but epicardial potential patterns,
electrogram morphologies, isochrones, and locations of pacing sites were reconstructed
with comparable accuracy when the torso was assumed homogenous. Independence of
epicardial patterns from torso volume-conductor properties was demonstrated
experimentally as well.70 Based on results of these inhomogeneity studies, MFS ECGI is
applied and tested here in a homogeneous torso volume-conductor. However, if needed
the internal inhomogeneities can be included in BEM ECGI by extending the transfer
matrix A to include the boundaries of internal torso compartments.71 Similar to BEM, the
MFS approach can also be extended to a multi-compartment volume-conductor. Malik72
has shown how MFS can be applied to a multi-dielectric media problem. For such
multi-compartment problem additional boundary conditions must be satisfied, namely
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continuity of potential and normal component of current at each inter-compartmental
interface.73 Regional formulation of MFS for computation of electric fields was
developed in the early 90’s 74,75. Recently a domain decomposition method was combined
with MFS for solving the inhomogeneous multi-compartment problems.76 This approach
can be applied to MFS ECGI in cases where the effect of torso inhomogeneities is of
interest.
2.4.2 Mesh-Related Considerations

MFS application in ECGI has several advantages over boundary element (BEM) and
finite element (FEM) methods

55,77

that require meshing the heart and torso. These

advantages result from bypassing the meshing operation in BEM/FEM ECGI. Mesh
quality is well known to affect both the time and accuracy of numerical solutions to
PDE-based applications. 78 A “bad” mesh structure that contains elements of non-uniform
area, non-uniform angle or non-uniform aspect ratio, can introduce serious artifacts in the
numerical computation. This is especially true for the ECGI application, because the
ill-posed inverse computation42 that is involved tends to amplify such mesh related
numerical errors (Figure 2-5). Non-uniform mesh elements are difficult to avoid in
meshing complex surfaces including the heart, especially in the presence of structural
disease. Efficient methods for mesh optimization are the topic of ongoing research.78-80
For ECGI applications, it is difficult to define general criteria for automated optimal
mesh generation because the mesh related artifacts are influenced by the ill-posed inverse
computation. BEM ECGI usually requires several time-consuming manual iterations for
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mesh optimization (we use a constant potential field as a calibration dataset for this
purpose). Even after an optimized mesh is constructed, BEM requires manipulation of the
3D surface mesh and computation of a complicated singular surface integral over each
mesh element. Being a meshless method, MFS ECGI bypasses these procedures. The
reduced complexity of MFS ECGI, its independence of meshing and manual editing (and
therefore enhanced suitability for automation) makes this approach particularly suitable
for clinical application.

Figure 2-5 demonstrates that fragmentation of reconstructed epicardial potentials is mesh
dependent. Several iterations of manual editing improved the mesh and removed
fragmentation, resulting in a less fragmented and smoother reconstruction. However,
mesh-related artifacts were still present after editing (Figure 2-5, right panel), indicating
that even several iterations did not result in an optimal mesh. Based on our experience,
obtaining a fully optimized mesh that eliminates all artifacts is a very difficult and time
consuming process. MFS ECGI does not require meshing and mesh optimization, avoiding
this time consuming manual step that can introduce artifacts in the reconstructed images. It
is possible that different regularization schemes65,81-83 than the ones employed here could
provide better accuracy with an unedited mesh, or that better mesh generation algorithms
optimized for ECGI could be developed. These possibilities remain to be investigated in
future studies. Here, we focus on the possibility of eliminating the meshing step altogether,
thereby avoiding mesh related artifacts and the need to compute complex singular integrals
- 38 -

that require special care in BEM.

As shown in equation (2-3), normal vectors are required for the MFS computation. In the
results shown here, normal vectors are constructed using the initial unedited mesh, which is
generated very quickly by Amira (TGS Template Graphics Software, Inc.) without mesh
editing. This may create the impression that MFS is not completely meshfree. The field of
meshless approaches is progressing rapidly, including meshless methods for determining
normal directions for given surfaces. For example, the Radial Basis Functions (RBF)
method84,85 obtains the 3D surface representation and computes analytically the surface
normal/tangent vectors without forming a mesh. Figure 2-8 compares MFS ECGI
reconstructions (potential maps and electrograms) with mesh-generated normal vectors and
with meshless normal vectors obtained using RBF. Panels A and B show the reconstructed
potential maps during depolarization and repolarization, respectivcely. Panel C shows
reconstructed electrograms from selected epicardial locations. Both methods produce very
similar results. In addition, point-based rendering methods are also emerging very quickly,
86

allowing for direct rendering of the surface without the creation of a polygonal mesh

representation.
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Figure 9 (Figure 2-8): Comparison of MFS ECGI reconstructions with mesh-based and meshless
normal vectors.
Panel A: Human epicardial potential map (anterior view) 62 ms after pacing from a single RV

endocardial site (marked by the asterisk). Left: MFS ECGI reconstruction with normal vectors
computed using a mesh. Right: MFS ECGI reconstruction with normal vectors computed without a
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mesh, using Radial Basis Function (RBF). Panel B: Human epicardial potential map (anterior view)
during repolarization for pacing from the same site (205 ms after pacing). Same format as Panel A.
Panel C: Human epicardial electrograms from selected locations on the heart surface for the same

pacing dataset. Red traces show the MFS ECGI reconstruction with mesh-based normal vectors. Blue
traces show the MFS ECGI reconstruction with meshless normal vectors computed using RBF.

Morphing a template mesh of a stylized heart could be an effective approach for creating
a patient-specific mesh in BEM ECGI. However, it requires evaluation in this context.
One of the major concerns regarding application of morphing is that many hearts that can
benefit from clinical ECGI have pathologies that modify greatly the heart geometry (e.g.
dilation, presence of diverticuli or anneurisms). Such localized structural deformations
cause large deviations from the anatomy of a template heart. Our laboratory uses Amira
to obtain the initial surface mesh for such diseased hearts. The initial mesh requires
manual editing to obtain an improved mesh structure for reduction of mesh-related
artifacts.

For a given problem, the condition number of the Â matrix in MFS is usually larger than
that of the forward matrix in BEM. For the torso-tank data in this study, the condition
number is 2.3516e+014 for BEM, and 9.1934e+016 for MFS; however better accuracy is
obtained with MFS. Several studies by others41,51,87,88 have suggested that the numerical
accuracy of MFS is only minimally affected by the condition properties of the matrix.
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Recent work by Christiansen and Saranen89 and Christiansen and Hansen90 also suggests
that the condition number as commonly defined is not an appropriate measure of numerical
stability. Better accuracy with a larger condition number was also obtained when a second
order BEM scheme was applied in ECGI reconstruction.91

A possible advantage of BEM ECGI is that the torso geometry can be constructed with
greater precision than that delineated by the electrodes. Consequently, the transfer matrix
can be computed with greater accuracy. Such augmentation can not be implemented in
MFS ECGI. However, since the zero Neumann condition (no current flow across the
torso-air boundary) is valid on the entire torso surface, Neumann conditions at more torso
locations (Equation 2-3) can be added in the MFS ECGI formulation (Equation 2-4). We
examined the benefit of doing so and results (not shown) show similar or only slightly
improved electrograms and potential maps as judged by CC and RE values.

2.4.3 Placement of Virtual Source Points

Implementation of MFS requires choosing a fictitious boundary for placing the virtual
source points. There are two widely used approaches for doing so, the dynamic and static
methods.41 In the dynamic configuration, the fictitious boundary is determined together
with the solution92 via a complex, time-consuming nonlinear optimization procedure which
does not always guarantee global convergence. In the static configuration, the fictitious
boundary is pre-selected corresponding to the real boundary based on some fixed (static)
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rules (criteria), for example the inflation-deflation rule used here. For different patients’
geometries, the corresponding fictitious boundaries that are generated by the static rule are
different. The static method is not the optimal implementation of MFS, but it is very easy to
implement and highly suitable for practical engineering applications. Very good accuracy
has been obtained using the static method in engineering and industrial applications of
MFS,53 including the application presented here. Although optimal placement of the virtual
source points poses a difficulty for MFS implementation at present, much faster and more
efficient nonlinear optimization schemes32 are under development, which will facilitate use
of the dynamic method in MFS ECGI.

The “inflation-deflation” procedure used in our reconstructions was designed and tested
using data from the human-shaped torso-tank experiments,21 where directly measured
epicardial potentials provided a gold standard for evaluation. Because the heart surface is
globally convex, the “inflation-deflation” procedure works well for most heart geometries.
In the presence of structural heart disease, the heart surface could contain concave regions.
For such geometry, static inflation or deflation relative to a fixed point may place some
fictitious points in the domain of interest. In these cases, special care is needed to insure
that all fictitious points lie outside the domain of interest. An alternative approach is to
employ a more general “inflation-deflation” procedure, which does not inflate or deflate the
boundary relative to a fixed point and insures that the virtual source points are placed
outside the domain of interest. For example, in the FastRBF toolbox
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84,85

, inflation and

deflation are achieved by computing isosurfaces based on the distance from the actual
boundary, which insures that the fictitious nodes are placed outside the domain for all types
of heart geometry. This method is demonstrated in panel A of Figure 2-9 for the complex
geometry of the atria in Figure 2-7. A 3D Radial Basis Function (RBF)

84,85

computes a

signed distance from the actual object’s surface. If the normal direction is inward, points
inside the object have positive distances (red) while points outside have negative distances
(green-blue). The object’s surface is defined as the zero set of the function (yellow). In
Panel A, the RBF function grid values are shown on three orthogonal planes: x = 60 (mm),
y = 90 (mm), and z = 30 (mm). By setting different RBF values, different inflated (or
deflated) surfaces of the atria can be obtained. Panel B of Figure 9 shows an inflated atria
surface obtained by selecting RBF = 5(mm). This figure demonstrates that this more
general procedure can be used for complex heart geometry such as the atria in this example,
or ventricles with irregular geometry due to disease (e.g. diverticuli or aneurisms).
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Figure 10 (Figure 2-9): General method to place virtual source points
Panel A: Radial Basis Function (RBF) representation of the atrial surface in Fig. 7 and corresponding
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inflated/deflated surfaces. The RBF function grid values are shown on three orthogonal planes: x = 60
(mm), y = 90 (mm), and z = 30 (mm). The original boundary is represented by the isosurface with RBF =
0(mm). Since the positive normal direction is chosen inward, deflated surfaces are represented by
isosurfaces with RBF > 0 and inflated surfaces by the isosurfaces with RBF < 0. Panel B: A deflated
atrial surface obtained by selecting RBF = 5 (mm). Blue circles represent the original boundary points,
and red circles represent the deflated surface points; all red circles are enclosed by the 3D surface
defined by the blue circles.

Determination of the optimal position of the fictitious nodes relative to the actual boundary
is a difficult problem that is the subject of ongoing research41. For noise-free boundary
conditions, Golberg and Chen41 have shown that the accuracy of MFS improves when the
fictitious nodes are moved far away from the actual boundary. However, for noisy boundary
conditions that always exist in actual engineering applications, Mera93 has found that
accuracy deteriorates when the fictitious points are placed too close or too far from the
actual boundary. If the fictitious points (singularities) are placed too close to the actual
boundary, MFS will have to evaluate nearly-singular matrix elements ( f ( r ) =
∂f ( r )
) during formation of the matrix Â (equation (4)).
∂n

1
4π r

and

If the fictitious points are

placed too far from the actual boundary, the rows in the top half of matrix Â become very
similar to each other, as do the rows in the bottom half; this increases the singularity of the
matrix. We used several datasets from the human-shaped torso-tank experiments,21 to
evaluate the dependence of accuracy on the positions of fictitious nodes. The most accurate
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reconstructions were obtained for deflating by a factor in the range 0.6 to 0.9 and inflating
by a factor in the range 1.1 to 1.5 (within these ranges, accuracy did not depend
significantly on the exact parameter value). Based on this empirical observation in a
realistic human-shaped heart-torso geometry, we chose 0.8 as the deflating parameter and
1.2 as the inflating parameter for all studies presented here.

With this simple “inflation-deflation” scheme, the number of fictitious points is chosen
based on practical considerations to be equal to the number of actual boundary nodes.
This is a simple choice employed in this paper, and is not a requirement of the MFS
method. Mera93 has shown that the accuracy of inverse computation using MFS for a
backward heat conduction problem improved with increasing number of fictitious nodes.
He also found that the accuracy did not improve once the number of fictitious nodes
exceeded a certain limit. Since very good reconstruction accuracy was obtained here with
the number of fictitious nodes set equal to the number of boundary nodes, we did not
attempt to increase this number. It is possible that the number of fictitious nodes could be
reduced without significant loss of accuracy

as suggested by Mera.93

Systematic

evaluation is needed to determine the optimal number of fictitious points in the context of
ECGI.
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2.5 Appendix: Formulation of MFS for Laplacian Operator
MFS has evolved from traditional boundary integral methods. Without forming a mesh,
MFS uses a set of points to solve numerically partial differential equations. Details of this
method can be found in the review article41. The following Dirichlet boundary value
problem is used to describe the theoretical formulation of MFS for the Laplacian
operator:

∇ 2 u( x ) = 0, x ∈ Ω

(a1)

u ( x ) = b( x ), x ∈ Γ, Γ = ∂Ω

(a2)

where ∇ 2 is the Laplace differential operator with a known fundamental solution f (r )
in 3D space. u(x ) is a potential function in a source-free domain Ω and b(x ) is the
Dirichlet boundary condition. According to the definition of fundamental solution,55 the
fundamental solution of the Laplace operator can be obtained by solving the following
equation for f (r ) :
∇2 f (r ) = δ (r )

(a3)

Where δ (r ) is the delta function, r = x − y is the 3D Euclidean distance between
point x and point y , x, y ∈ Ω . f (r ) in two dimensions (2D) and three dimensions
(3D) is: 94
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⎧ 1
ln r , 2 D
⎪−
f ( r ) = ⎨ 2π
1
⎪
, 3D
⎩ 4πr

Both BEM and MFS use the same Green’s function f ( r ) =

(a4)
1
in 3D space. However
4πr

BEM integrates this function locally over elements of the real surface and requires
computation of complex singular integrals. By placing the fictitious source points outside
the domain of interest, MFS employs global integration and avoids the need to compute
complex singular integrals.

The traditional boundary integral approach is to represent the solution u(x ) in term of a
double layer potential:48,51
u( x ) = ∫

∂f ( x − y )
e( y )dy , x ∈ Ω, y ∈ Γ
Γ
∂n

(a5)

where, n is the outward pointing normal at point y , e( y ) is an unknown density function.
Equivalently a single layer potential representation of u(x ) can be used 48,95
u ( x ) = ∫ f ( x − y )e( y )dy , x ∈ Ω, y ∈ Γ
Γ

(a6)

The source density distribution e( y ) can be determined by solving the following equation
under the assumption of a double layer:

∫

∂f ( x − y )
e( y )dy = b( x ), x ∈ Γ, y ∈ Γ
Γ
∂n

(a7)

or under the assumption of a single layer:

∫

Γ

f ( x − y )e( y )dy = b( x ), x ∈ Γ, y ∈ Γ

(a8)

However, singular integrals are involved in both cases. To alleviate this difficulty, the
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following formulation, similar to the single layer potential in (a6), has been used: 92
u ( x ) = ∫ ˆ f ( x − y )e( y )dy , x ∈ Ω, y ∈ Γˆ
Γ

(a9)

where the auxiliary boundary Γ̂ is the surface of the auxiliary domain Ω̂ containing the
domain Ω (Figure 2-1).
Two different approaches for selecting Γ̂ and its fictitious source points y are described
in the literature: 48 static configuration and dynamic configuration. In static configuration,
the fictitious boundaries are fixed and pre-selected. The method is easy to implement and
use in practical applications. For dynamic configuration, the location of fictitious
boundaries is determined together with the solution92 by a complex, time-consuming
nonlinear optimization procedure, which greatly limits its practical application. Since the
geometry of the 3D domain between the torso surface and the heart surface is similar for
all humans, the static approach is the method of choice for ECGI application.

Because f ( x − y ) is the fundamental solution of the Laplace operator [equation (a3)],
(a9) satisfies the differential Equation (a1). Therefore we need only to apply the boundary
condition (a2):

∫

Γˆ

f ( x − y )e( y )dy = b( x ), x ∈ Γ, y ∈ Γˆ

(a10)

where the source density distribution e( y ) , y ∈ Γˆ , is to be determined. Once the source
density is determined, equation (a1) subject to (a2) is solved. The analytic integral
representation of (a10) implies that there is an infinite number of source density points
on Γ̂ .

In order to apply numerical methods to the solution, it is necessary to
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discretize e( y ) . Assume ψ i ( y ), i = 1,2, " ∞ is a complete set of functions on Γ̂ , e( y ) can
be approximated by:
∞

e( y ) = ∑ ciψ i ( y ), y ∈ Γˆ

(a11)

i =1

Substituting (a11) into (a10) and satisfying the boundary conditions at the n boundary
points xk ∈ Γ, k = 1,2," n; we have
∞

∑c ∫
i

i =1

Γˆ

f ( x k − y )ψ i ( y )dy = b( x k ), 1 ≤ k ≤ n, y ∈ Γˆ

(a12)

Since the fictitious boundary Γ̂ is located outside the physical domain (Figure 1), the
integrand f ( xk − y ) is nonsingular and standard quadrature rules can be applied giving

∫

M

Γˆ

f ( xk − y )ψ i ( y )dy ≈ ∑ w j f ( xk − y j )ψ i ( y j ), y j ∈ Γˆ , j = 1, 2,..., M
j =1

(a13)
where w j is a weight factor and M is the number of fictitious nodes on the fictitious
boundary Γ̂ . 41

From (a12) and (a13), we obtain:
M
M
⎤
⎡∞
c
w
f
(
x
y
)
ψ
(
y
)
w
−
=
∑
∑
i∑
j
k
j
i
j
j ⎢ ∑ ciψ i ( y j ) ⎥ f ( x k − y j ) = b( x k ), 1 ≤ k ≤ n.
i =1
j =1
j =1
⎦
⎣ i =1

∞

(a14)
Then:
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M

∑a
j =1

j

f ( x k − y j ) = b( x k ), 1 ≤ k ≤ n.

(a15)

where:
∞

a j = w j ∑ ciψ i ( y j )

(a16)

i =1

For completeness,87 a constant a0 is added to (a15):
M

a0 + ∑ a j f ( xk − y j ) = b( xk ), 1 ≤ k ≤ n.

(a17)

j =1

After Equation (a17) is solved for a0 and a j ( j = 1, 2,", M ) , the solution to (a1) can be
approximated by:
M

ua ( x ) = a0 + ∑ a j f ( x − y j ), x ∈ Ω, y j ∈ Γˆ

(a18)

j =1

The approximate solution ua to equation (a1) is represented by a linear combination of
fundamental solutions of the governing equation with the singularities y j , j = 1,2, " M
placed outside the domain of the problem.

MFS is applicable not only to the above boundary value problem, but also to the Cauchy
problem54 that underlies ECGI. In this problem, both Dirichlet and Neumann boundary
conditions are given only on portion of the boundary:54
∇ 2 u( x ) = 0, x ∈ Ω
Dirichlet conditions:
Neumann conditions:

u( x ) = b( x ), x ∈ Γ1 , Γ1 ⊂ Γ = ∂Ω
∂
u( x ) = i ( x ), x ∈ Γ1 , Γ1 ⊂ Γ = ∂Ω
∂n
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(a1)
(a19)
(a20)

For the Neumann condition (a20), the gradient at point x is along the outward normal to
the boundary at that point. Similar to equation (a17), MFS can be used to discretize the
Dirichlet and Neumann boundary conditions (equations (a19) and (a20)) as follows:
M

a0 + ∑ a j f ( xk − y j ) = b( xk ), xk ∈ Γ1 , k = 1, 2,..., n, y j ∈ Γˆ .

(a21)

j =1

M

∑a
j =1

j

∂
f ( xk − y j ) = i ( xk ), xk ∈ Γ1 , k = 1, 2,..., n, y j ∈ Γˆ .
∂n

(a22)

After solving for the coefficients ( a0 , a j , j = 1, 2," M ), subject to the boundary
conditions (a19) and (a20), the solution to (a1) can be approximated using Equation
(a18).

Convergence analysis of MFS for Laplace’s equation was conducted by Cheng.96 When
the problem boundary and boundary conditions are smooth functions, MFS converges
exponentially to the solution of the problem. This analysis was conducted for 2D;
Golberg and Chen48 provided arguments that similar convergence properties exist in 3D.
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Chapter 3 Real Time Electrocardiographic Imaging

Abstract
Electrocardiographic Imaging (ECGI) is a noninvasive modality for computation of
cardiac epicardial potentials from measured body surface electrocardiographic potential
data. ECGI was extensively validated in animal experiments and recently successfully
applied in patients. The current ECGI mode of operation is offline with generation of
epicardial potential maps delayed to data acquisition. Here we introduce a real time ECGI
procedure, by which the epicardial potentials can be reconstructed while the body surface
potential data are acquired (<1msec/frame) during a clinical procedure. This development
enables real-time monitoring, diagnosis, and interactive guidance of intervention for
arrhythmia therapy.

3.1 Introduction
Electrocardiographic Imaging (ECGI) is a noninvasive modality for imaging cardiac
electrophysiological function. The details of the technique were extensively discussed in
previous publications.1-3,8 ECGI has been validated extensively in animal experiments
under different physiological and pathological conditions.6,7,97 Recently, it was also
successfully validated and applied in patients.1,2,11,15,17 In patients, ECGI has
demonstrated its potential in the study of mechanisms of cardiac arrhythmias and in
providing important information for patient evaluation and guidance of therapy (e.g.,
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catheter ablation, pacing for resynchronization therapy in heart failure).

In the current ECGI procedure, a body surface potential map (BSPM) is recorded
simultaneously from 256 body surface electrodes and digitized with a sampling
frequency of 1kHz. The digitized BSPM data are saved on a hard drive of a computer for
later offline inverse computation of epicardial potentials. The ECGI reconstructed
epicardial potential data are typically available one day after the clinical procedure. We
refer to this procedure as Offline ECGI. If the ECGI inverse computation could be
executed as fast as the data acquisition speed (1kHz), which implies reconstruction time
for one frame of data < 1ms, the epicardial potential information could be obtained
during the BSPM recording, without any delay or data accumulation. We refer to this
procedure as Real Time ECGI.

Conducting ECGI in real time can provide the physician with epicardial
electrophysiological data during the clinical procedure, thus enabling real-time diagnosis
and interactive guidance of intervention. In real-time mode of operation, ECGI could
monitor cardiac electrophysiological function continuously, with higher sensitivity and
specificity than the body-surface ECG.

In this report, we introduce a new procedure and algorithm that achieve Real Time ECGI.
The procedure was tested and compared with Offline ECGI using data from animal
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models, from a patient with myocardial infarction, and from a patient with atrial
fibrillation.

3.2 Methods
3.2.1 Procedure for Offline ECGI

In offline ECGI, 256 ECG electrodes organized on strips are attached to the torso surface
of the patient to record electrocardiographic body surface potential maps (BSPM) during
as many cardiac cycles as desired. Following BSPM, a cardiac CT scan is conducted at
the same patient posture with the electrodes in place. The heart-torso geometry is labeled
and digitized from the CT images, and combined with the BSPM to compute epicardial
potentials, electrograms, activation patterns (isochrone maps) and repolarization patterns
on the heart surface off-line, following the procedure.

The body surface potential vector Vt can be related to the epicardial potential vector
Ve by the transfer matrix A , which encodes the torso-heart geometrical relationship:
Vt = A *Ve

(3-1)

Assume that there are N torso surface electrodes and M epicardial surface sites, then
Vt is a N *1 vector and Ve is a M *1 vector. The Singular Value Decomposition (SVD)

of matrix A ∈ R N *M can be written as98:
P

A = U * S *V ' = ∑ ui si vi' ,

P = min( N , M )

i =1

- 56 -

(3-2)

where U = (u1 ,..., uP ) and V = (v1 ,..., vP ) are unitary matrices with orthonormal columns

U '*U = V '*V = I P , and S = diag ( s1 ,..., sP ) is a diagonal matrix with positive diagonal
elements in a non-increasing order. The inversion of matrix A can be expressed as:

A−1 = V * S −1 *U '

(3-3)

Multiplying equation (3-1) by A−1 gives:

Ve = V * S −1 *U '*Vt

(3-4)

1
1
where S −1 = diag ( ,..., ) .
s1
sP
Since the A matrix is ill-conditioned (condition number s1 sP is very large), the

S −1 matrix can not be applied directly to compute A−1 and Ve . Instead, the Tikhonov
Regularization method99 is used to regularize the inverse procedure and obtain Ve :
minVe

{ AVe − Vt

2

+ t L *Ve

2

}

(3-5)

where t is a regularization parameter. Note that this operation depends on Vt , which is
different for each time frame during the cardiac cycle. Typically, Ve is computed for each
millisecond during the cardiac cycle, and for each time frame operation (3-5) must be
repeated. This operation is relatively slow in terms of computational time, precluding real
time application of ECGI.

3.2.2 Mathematical Derivation of the Inverse Matrix B

Based on SVD, Tikhonov solution to Equation (3-5) can be written as98:
P

Ve = V * ∑
i =1

fi
*U '*Vt
si
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(3-6)

where fi (i = 1, 2,..., P) are called filter factors98 and have the following form:

fi = si2 /( si2 + t 2 )

(i = 1, 2,..., P )

(3-7)

t is the regularization parameter, which depends on the signal quality (decreases with
increasing signal quality).

Equation (3-6) indicates that for a selected t value, fi

dampens the contribution from small singular values, which are usually associated with
measurement noise in the body surface potential Vt , stabilizing the epicardial potential
solution Ve . Based on Equation (3-6), we can define an inverse matrix B as:
P

fi
*U '
si

B = V *∑
i =1

(3-8)

and
Ve = B *Vt

(3-9)

This equation indicates that once the inverse matrix B has been computed, ECGI
computation of Ve involves only matrix multiplication, a fast operation that can be
achieved in real time.

3.2.3 Numerical Computation of Inverse Matrix B

Equations (3-8) and (3-9) imply that inverse matrix B is in fact the epicardial potential
solution for a body surface potential Vt given by the N * N identity matrix I .
Therefore, we define

Vt2 = [0,1,..., 0] ,

N torso potential basis elements as:

Vt N = [0, 0,...,1] ;

the

i _ th

torso

potential

Vt1 = [1, 0,..., 0] ,
basis

element

Vti = [0, 0,...,1(ith),..., 0] is the i _ th column of the identity matrix I . Each of the torso
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potential basis elements Vti , (i = 1, 2,..., N ) can be expressed on the epicardial surface
using Tikhonov regularization:

Vei = Tik ( A, t , Vti ) , (i = 1, 2,..., N )

(3-10)

where Vei are the corresponding epicardial potential basis elements. Obviously, the torso
surface potential map can be expressed in terms of the torso potentials basis elements as:
N

Vt = Vt (1) *Vt1 + Vt (2) *Vt2 + ... + Vt ( N ) *Vt N = ∑ Vt (i) *Vti

(3-11)

i =1

Since Vt = A *Ve and Tikhonov regularization are both linear operations, the
corresponding epicardial potential can be computed as:
N

Ve = Tik ( A, t ,Vt ) = Tik ( A, t , ∑ Vt (i ) *Vti )
i =1

N

N

i =1

i =1

= ∑ Vt (i ) * Tik ( A, t ,Vti ) = ∑ Vt (i ) *Vei = B *Vt

(3-12)

where B is a M * N matrix with the ith column equal to the Vei . Figure 3-1 is a
diagrammatic description of this ECGI computational procedure.
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Figure 11 (Figure 3-1): The computation procedure of inverse matrix B and Ve. Tik indicates
Tikhonov regularization.

3.2.4 Procedure for Real Time ECGI

Real Time ECGI requires a different protocol than offline ECGI (Figure 3-2). CT scan is
conducted before any BSPM data are collected. After the CT images are obtained, the
heart-torso geometry information is labeled and digitized while the patient with the
electrodes attached at the same positions as during CT is transported to the EP procedure
room. Scout BSPMs are recorded to evaluate the signal quality in the room based on
which electrodes with low Signal to Noise Ratio (SNR) are excluded and an appropriate
value for the regularization parameter t is obtained.

100

Based on the geometrical

information, transfer matrix A (Equation 1) is computed and saved. From A and t ,
matrix B is computed following the scheme in the previous section. Once B and t are
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available (before the start of the EP procedure), computing Ve involves only matrix
multiplication (Equations (9), (12)) and epicardial potentials are computed in real time
during the EP procedure. The key to Real Time ECGI is pre-computation of the inverse
matrix B , to avoid repetition of operation (5) for every time frame.

Figure 12 (Figure 3-2): Panel A: Offline ECGI procedure. Panel B: Real time ECGI procedure.
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3.2.5 Experimental Methods and Protocols

ECGI is performed on data from three studies: (i) Single-site pacing in an isolated canine
heart suspended in a human torso-shaped tank;4 Data were obtained during pacing from a
right ventricular (RV) anterior epicardial location.101 (ii) Sinus rhythm data from a patient
with healed myocardial infarction; (iii) Data from a patient with atrial fibrillation. Real
time ECGI is compared to offline ECGI for these representative datasets.

All protocols were approved by the Institutional Review Board at Washington University
in St. Louis, and informed consent was obtained from all patients. All the results were
generated on a laptop computer with dual core processor (2.33GHz) and 3GB RAM.

3.3 Results
3.3.1 Single Site Pacing in a Human Torso-Shaped Tank

Figure 3-3, panel A shows real time ECGI epicardial potential map at 17ms after the QRS
onset. The pacing site (white asterisk) is surrounded by negative potentials (blue). Real
time and offline ECGI reconstructed the same epicardial potential maps. However, real
time ECGI computes the map in 0.195 ms, about 30 times faster than offline ECGI.
Epicardial electrograms from sites b, c (indicated on the epicardial potential map) are
shown in Panel B and C respectively. The electrogram from site b, far away from the
pacing site, shows a positive R morphology (Panel B).The electrogram c at the pacing
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site (Panel C) is a pure negative Q waveform, reflecting an activation front propagating
away from the pacing site. Real time ECGI reconstructed the same EGMs as offline
ECGI.

Figure 13 (Figure 3-3): Pacing from anterior RV site (*).

Panel A: Anterior and left views of ECGI reconstructed epicardial potential maps by offline ECGI (left
panel) and real time ECGI (right panel). Panels B, C: Selected EGMs (from sites b and c)
reconstructed by offline ECGI (blue), real time ECGI (red), and directly measured from the
epicardium (black).

In this data set, there are 242 epicardial sites and 384 body surface electrodes, therefore
the transfer matrix A is a 384*242 matrix. Different segments (100 frames, 200 frames,
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400 frames, 800 frames, 1600 frames and 2000 frames) of body surface data were used to
compare the computational efficiency of offline ECGI and real time ECGI. The results
are summarized in Table 3-1. Total time refers to total computation time for all frames in
a given data segment.
Table 1 (Table 3-1) Computational efficiency comparison for torso-tank data
BSPM segment (ms)

100

200

400

800

1600

2000

Total Time, Offline

891

1437

2360

5359

13593

19515

32

47

78

157

313

422

8.91

7.185

5.90

6.6988

8.4956

9.7575

0.32

0.235

0.195

0.1963

0.1956

0.211

ECGI (ms)
Total Time, Real
time ECGI (ms)
Time per Frame,
Offline ECGI (ms)
Time per Frame,
Real time ECGI (ms)

The data in Table 3-1 are visualized in Figure 3-4. The top three panels show that the total
computation time of offline ECGI increases exponentially with the segment-length of
input data, while the total computation time of real time ECGI increases roughly linearly.
For data collected in 2 seconds, it only takes 0.422 seconds for real time ECGI to
compute the epicardial potentials, while offline ECGI requires19.515 seconds (a factor of
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46). The bottom 3 panels of figure 3-4 show that real time ECGI can execute inverse
computation for one frame (1ms data) well within 1ms. This means that following data
acquisition and digitization at 1kHz, real time ECGI can generate epicardial potentials for
the frame before the next frame is recorded.

Figure 14 (Figure 3-4): Comparison of computational efficiency of offline and real time ECGI.

Top left: Relationship between total offline ECGI computation time and length of data segment. Top
middle: Relationship between total real time ECGI computation time and length of data segment
(Note different scale from top left). Top right: comparison of offline and real time ECGI computation
times on the same scale. The bottom panels show computation times per single frame (same format as
top panels).

For Offline ECGI, matrix decomposition is always performed and is independent of the
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BSPM data segment. When the data segment is short (<400ms; <400 frames), most of the
computing time is spent on the matrix decomposition. In this situation, the total
computing time increases slowly with the segment length, but the computing time per
frame decreases. When the data segment is long (>800ms; >800 frames), data
manipulation becomes the major computational load. In this situation, the total
computing time increases dramatically with segment length.

Because the system

memory is limited, computing time per frame also increases. This explains the slower
initial increase and faster later increase in total time, and the non-monotonic dependence
(decrease then increase) of time per frame on the length of the data segment (gray
curves in Figure 3-4)

For real time ECGI, because the major computational load is matrix multiplication, total
computing time increases linearly with the length of the BSPM data segment before the
system memory becomes a “bottleneck” for computing. Computing time per frame
becomes essentially constant after initial oscillation, which is probably due to Matlab®
management of system memory. When the data segment becomes very long (>1600
ms;1600 frames) relative to available memory, total computing time increases nonlinearly,
and computing time per frame increases as well. This is demonstrated by the black curves
in the middle panels of Figure 3-4.
3.3.2 Sinus Rhythm Data from a Patient with Healed Myocardial Infarction (MI)

Figure 3-5, panel A shows real time ECGI computed epicardial potential map at 10ms
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after the QRS onset during sinus rhythm. Real time ECGI and offline ECGI reconstructed
the same epicardial potential maps. Epicardial EGMs from site b, c, d, labeled on the
epicardial potential maps, are shown in Panel B, C, and D, respectively. The EGM at site
b (Panel B) demonstrates an rS morphology. EGM from left ventricular (LV) site c
demonstrates R morphology (Panel C), and EGM from inferior site d demonstrates RS
morphology (Panel D). Offline ECGI and real time ECGI reconstructed the EGMs with
the same morphologies and magnitudes.

Figure 15 (Figure 3-5): Sinus Rhythm Post-MI.

Panel A: Two views (RV and LV) of ECGI reconstructed epicardial potential maps by offline ECGI
(left panel) and real time ECGI (right panel). Selected EGMs (from sites b, c and d) reconstructed by
offline ECGI (blue) and real time ECGI (red) are shown in Panel B, C and D.
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In this data set, there are 502 epicardial sites and 242 body surface electrodes, therefore
the transfer matrix A is a 242*502 matrix. This is a typical size of transfer matrix A
in ECGI application. Similar to the data from the Torso-Shaped Tank, different segments
(100 frames, 200 frames, 400 frames, 800 frames, 1600 frames and 2000 frames) of body
surface data were used to compare the computational efficiency of offline ECGI and real
time ECGI. The results are summarized in Table 3-2.

Table 2 (Table 3-2) Computational efficiency comparison for SR data in a healed MI patient
BSPM segment (ms)

100

200

400

800

1600

2000

Total Time, Offline

453

719

1563

4187

13906

20078

15

31

63

94

187

234

4.53

3.595

3.9075

5.2337

8.6913

10.039

0.15

0.1550

0.1575

0.1175

0.1167

0.1170

ECGI (ms)
Total Time, Real
time ECGI (ms)
Time per Frame,
Offline ECGI (ms)
Time per Frame,
Real time ECGI (ms)

The data in Table 3-2 are visualized in Figure 3-6. Similar observation can be made as in
the Torso-Shaped Tank data. Real time ECGI reconstructs one frame of epicardial
potential (1ms data) well within 1ms, which is far beyond the capability of offline ECGI.
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Figure 16 (Figure 3-6): Comparison of computational efficiency of offline and real time ECGI.

Same format as Figure 3-4.

3.3.3 Data from a patient with Atrial Fibrillation

Figure 3-7, Panel A shows real time ECGI computed epicardial potential map at 142 ms
from start of the recording. Both right atrium (RA) and left atrium (LA) are shown in the
map. Real time ECGI and offline ECGI reconstructed the same epicardial potential maps.
Epicardial electrograms from site b, c and d, labeled on the epicardial potential maps, are
shown in Panel B, C and D, respectively. EGM b close to the left superior pulmonary
vein (Panel B) is fragmented with high frequency components. EGM c from a right
superior pulmonary vein site is more regular with almost no high frequency fractionation
(Panel C).

EGM d from a RA free wall site is of regular morphology with no

fractionation (Panel D). This progression indicates a gradient in the degree of
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fractionation from LA to RA. Offline ECGI (blue) and real time ECGI (red) reconstructed
the same EGMs.

Figure 17 (Figure 3-7): Atrial fibrillation data

Panel A: Two views (LA and RA) of ECGI reconstructed epicardial potential maps by offline ECGI
(left panel) and real time ECGI (right panel). Selected EGMs (from sites b, c and d) reconstructed by
offline ECGI (blue) and real time ECGI (red) are shown in Panels B, C and D.

In this data set, there are 4004 epicardial sites and 217 body surface electrodes, therefore
the transfer matrix A is a 217*4004 matrix. This is a high resolution transfer matrix A
in ECGI application. Similar to the data from the Torso-Shaped Tank, different segments
(100 frames, 200 frames, 400 frames, 800 frames, 1600 frames and 2000 frames) of body
- 70 -

surface data were used to compare the computational efficiency of offline ECGI and real
time ECGI. The results are summarized in Table 3-3.

Table 3 (Table 3-3) Computational efficiency comparison for atrial fibrillation data
BSPM segment (ms)

100

200

400

800

1600

2000

Total Time, Offline

2234

3438

6234

13281

34078

46703

79

171

328

656

1312

1640

22.34

17.19

15.585

16.5225

21.2987

23.3515

0.79

0.855

0.820

0.820

0.820

0.820

ECGI (ms)
Total Time, Real
time ECGI (ms)
Time per Frame,
Offline ECGI (ms)
Time per Frame,
Real time ECGI (ms)

The data in Table 3-3 are visualized in Figure 3-8, showing similar behavior to the two
previous examples. Real time ECGI reconstructs one frame of epicardial potential (1ms
data) within 1ms (0.82ms) and therefore in real time. However, compared to the two
previous examples, the computation time per frame is increased. This is mainly due to the
high density of epicardial sites (4004 sites). This very high resolution was chosen to
challenge real time ECGI for evaluation purpose; it is more than needed in clinical
applications. For the same resolution, offline ECGI computed 1ms of data in 21.3 ms, far
beyond what is required for real time application.
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Figure 18 (Figure 3-8): Comparison of computational efficiency of offline and real time ECGI.

Same format as Figure 3-4.

3.4 Discussion
The Real Time ECGI introduced in this manuscript can reconstruct epicardial potentials
from BSPM recordings during data acquisition without delay. In addition to the obvious
importance of real-time performance during clinical intervention (catheter ablation,
application of pacing electrodes, drug delivery), it enables the use of ECGI in long-term
monitoring of cardiac patients. This is particularly useful in patients with dynamically
changing arrhythmias such as atrial fibrillation, unstable or polymorphic ventricular
tachycardia, etc.

The approach described in this paper is a computational framework that does not depend
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on the specific type of numerical methods used in ECGI. Boundary Element Method
(BEM) was used to construct the transfer matrix A for the data from the torso-tank
experiments and from the post-MI patient. The Method of Fundamental Solution (MFS)
102

, a mesh-free numerical method, was adapted for ECGI previously. Here, we applied

MFS instead of BEM in real time ECGI of the atrial fibrillation data. Similarly, other
types of numerical methods such as the Finite Element Method (FEM), or Radial Basis
Function (RBF) method85 can also be used in the Real Time ECGI framework as
proposed.

The key to Real Time ECGI is the pre-computation of inverse matrix B . The computation
of matrix B is conducted during the downtime before the start of the clinical procedure or
a research protocol. Once the B matrix is available, the ECGI inverse computation
becomes a process of matrix multiplication. Although all the examples described in this
manuscript use Matlab® to conduct the matrix multiplication, computation of matrix B
can be integrated into the data acquisition software or output to a custom designed
computation hardware to provide even faster matrix multiplication.

The real time ECGI procedure proposed in this paper requires that the regularization
method is a linear process and does not depend on the BSPM data recorded during the
procedure. Therefore, only direct regularization methods such as Tikhonov regularization
can be employed in the framework of real time ECGI. Non-stationary iterative
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regularization methods, such as GMRes

101

and other Krylov-Subspace based iteration

methods, depend on the BSPM data for convergence and are not suitable for real- time
ECGI.

The examples described in this manuscript employed the Tikhonov method with
pre-calculated CRESO103 regularization parameter t . The t value depends on the
BSPM signal quality. High quality signals (high signal/noise ratio) require only a small t ,
while lower quality signals require a larger t and greater regularization. The data
acquisition environment affects the signal quality during the study. We determine an
optimal t-value before the procedure by conducting pilot recordings in the same
environment where the procedure will be conducted.
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Abstract
Post-myocardial infarction (MI) scar-related arrhythmias are a life threatening rhythm
disorder. However, our ability to map and ablate these arrhythmias is limited by current
invasive mapping techniques. In this study, we applied a novel imaging modality for
cardiac electrophysiology and arrhythmia (Electrocardiographic Imaging, ECGI) to map
noninvasively the electrophysiological substrate in eight post-MI patients during sinus
rhythm (SR). Contrast-enhanced MRI (ceMRI) was conducted to determine anatomical
scar. ECGI imaged regions of low potentials with long duration, fractionated
electrograms that corresponded closely in location, extent, and morphology to the
anatomical scars. In three patients, late diastolic potentials were imaged in the scar
epicardial border zone during SR. We also imaged scar-related ventricular tachycardia
(VT) in two patients, showing the VT activation sequence in relation to the abnormal
electrophysiological

substrate.

ECGI

can

noninvasively

image

the

altered

electrophysiological substrate properties of a post-MI scar and map the activation
patterns during SR and VT in a beat-by-beat fashion. Imaging the substrate could
potentially help in noninvasive risk stratification for post-MI arrhythmias and facilitate
substrate-based catheter ablation of these arrhythmias.
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4.1 Introduction
Scar-related arrhythmias are the most common cause of sudden cardiac death.
Intraoperative mapping techniques have identified the border zone between scarred and
normal myocardium as the predominant substrate for development of ventricular
tachycardia (VT) in post-MI patients.104,105 In patchy and nonuniform border zone,
electrically active myocardial tissue is interspersed within fibrous scar tissue. This creates
local mismatches of electrical properties that lower the safety factor for conduction and
result in substrate for reentrant VT.106-108 Identification and characterization of such
arrhythmogenic substrates before an arrhythmia occurs could reduce the risk of sudden
death by indicating the need for device, drug, or ablation therapy.

Current noninvasive methods for characterizing abnormal substrates rely on the 12-lead
ECG109-112 in combination with other imaging modalities such as computed tomography
(CT), magnetic resonance imaging (MRI), nuclear imaging, and positron emission
tomography

(PET)

113-116

However,

these

methods

cannot

provide

detailed

electrophysiologic (EP) information about the cardiac substrate. Body surface potential
mapping has been used to estimate the location of abnormal EP substrate.109-111,117
However, this approach is limited by low specificity and challenges with interpretation of
low amplitude signals measured far from the heart.112 Invasive EP mapping techniques
have become an important tool for characterizing the scar substrate and for guiding
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catheter ablation of VT.118-122 So far, invasive substrate mapping during sinus rhythm is
mostly conducted on the endocardial surface using intracardiac catheters. Because not all
VTs originate from the endocardium and may involve epicardial components of the
reentry circuit,123,124 a percutaneous subxyphoid puncture technique has been developed,
permitting mapping and ablation on the epicardial surface.125

This technique is invasive

and carries risk.125 An accurate, noninvasive EP imaging tool would be helpful to
delineate the location and extent of the scar substrate during sinus rhythm and
characterize its electrophysiologic properties.

Experimental and clinical studies have shown that abnormal electrical properties
associated with a scar substrate are reflected in specific characteristics of cardiac
potential distributions and electrograms.

126-129

Canine studies in a 5-day old infarct

showed low-level fractionated electrograms in the infarct substrate, which correlated with
slow, discontinuous conduction; a property that supports arrhythmogenicity

130

.

Low-amplitude potentials, broad fractionated electrograms, and delayed activation were
recorded from a human infarcted papillary muscle107 and during invasive mapping in
post-MI patients with history of VT.131-134 Our laboratory has demonstrated the ability of
a new noninvasive EP imaging modality (Electrocardiographic Imaging, ECGI) to
reconstruct, from body surface potentials, such characteristics of epicardial potentials and
electrograms over the scar region in animal (canine) experiments8,23,24,97 In this study, we
use ECGI to reconstruct such electrical properties and to characterize the
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electrophysiological substrates in patients with structurally abnormal myocardium
(healed

MI).

Through

image-fusion

techniques,

we

combine

the

ECGI

electrophysiological images with delayed-contrast MRI anatomic images and correlate
electrophysiological properties with structural scar information.

4.2 Methods
Eight patients included in this study had histories of myocardial infarction (>=3 months).
All protocols were approved by the Human Research Protection Office at Washington
University in St. Louis, and informed consent was obtained.

ECGI methodology was described previously 1. 256 carbon electrodes were applied to the
patient’s torso and connected to a portable mapping system (BioSemi, Netherlands). After
CT markers were attached to each electrode, the patients underwent thoracic non-contrast
gated CT imaging (70% of R-R interval) with an axial resolution of 1mm. The 256
electrodes were kept in the same position during ECGI data acquisition as in the CT
scanner. Ventricular epicardial surface geometry and body surface electrode positions
were labeled and digitized from the CT images. 256 channels of body surface potentials
(BSP) were sampled at 1-ms intervals during the cardiac cycle, and the data were saved
on a laptop computer. The ECGI procedure is summarized in Figure 4-1.
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Figure 19 (Figure 4-1): Study procedure
Panel A: The ECGI Procedure. 256 carbon electrodes are applied to the subject's torso to measure 256

ECGs. The subject then undergoes a thoracic CT scan, which provides epicardial surface geometry
and torso-electrode positions in the same reference frame. The potential and geometry data are
processed mathematically to obtain noninvasive ECGI epicardial images that include EPM, EGM,
activation and repolarization sequences. From these data, EMM, EDM and ESM are constructed.
Panel B: Comparing the EP scar to the anatomical scar. To image the anatomical scar, contrast

enhanced MRI images are obtained from six patients without implanted devices, and SPECT images
are obtained from the other two. CT and MRI images are co-registered to construct the ASM, which is
compared to the ESM. EDM = EGM Deflection Maps (number of deflections per EGM during SR);
EPM = Epicardial Potential Maps; EMM = EGM Magnitude Maps (peak-to-peak EGM QRS
magnitude during SR); ESM= EP Scar Map (based on EMM and/or EDM); AI = Activation
Isochrones; ASM = Anatomical Scar Map (from contrast-enhanced MRI).
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The BSP and torso-heart geometrical relationship were combined by ECGI algorithms to
noninvasively construct epicardial potential maps, electrograms (EGM), activation
sequences (isochrones) and repolarization patterns1. ECGI is constructed on a
beat-by-beat basis and does not require accumulating data from many identical beats (as
required with the “roving-probe” approach of catheter mapping). Activation times were
determined by the maximal negative slope of the epicardial electrograms and used to
construct isochrone maps. Lines of block (LOB) were determined if local activation times
differed by more than 50ms. Slow conduction is represented by crowded isochrones.
Activation movies for consecutive beats were also constructed by animating the
activation wavefront on the epicardial surface. For each frame of ECGI data, a
corresponding frame depicting the three dimensional spatial locations of activation sites
was generated. The activation wavefront connecting these sites was displayed as a red
line on a blue epicardial surface. Once all time frames were processed in this fashion, an
activation movie was generated to display propagation of the wavefront. Repolarization
data (T wave) was excluded between consecutive beats of VT.

Gadolinium-enhanced cardiac magnetic resonance (MR) scans were conducted on 6 of
the patients to obtain images of the infarct anatomical substrate. MRI was performed on a
1.5T MR system (Sonata: Siemens Medical Solutions, Malvern, PA) with maximum
gradient capabilities (40 mT/meter gradient strength: 200 mT/meter/sec slew rate). The
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study was ECG-gated. After obtaining scout true Fast Imaging with Steady Precession
(FISP) images to determine the short and long axis views of the heart, 0.2 mmol/Kg
gadolinium-based MR contrast agent (Optimark; TycoHealthcare, Mallinckrodt, St. Louis,
MO) was injected at 1 cc/sec via a compatible power injector. After a 10-minute delay,
two-dimensional T1-weighted inversion recovery segmented fast gradient recalled echo
images (repetition time 8 ms, echo time 4 ms, flip angle 30 degrees, segments 13,
field-of-view 300-380 mm, matrix 256 x 172, triggered every 2 heartbeats) were obtained.
Images were obtained in the short axis plane of the heart from the base of the left
ventricle to the apex. Images were obtained contiguously every 8 mm. To determine the
appropriate inversion recovery time, a scout sequence was run after the gadolinium
injection and just prior to the 10-minute delayed acquisition, allowing the operator to
select inversion recovery time to best null the myocardium. The infarct regions were
labeled and digitized as anatomical scar substrate. Registration between the MR and CT
images was established based on the normalized mutual information. For two patients,
nuclear single photon emission computed tomography (SPECT) data were collected
retrospectively for qualitative comparison and analysis. The anatomic scar imaging and
the ECGI scar imaging were performed independently to eliminate bias.

4.3 Results
4.3.1 Patient #1,#2, and #3: Characteristics of Post-MI Electrical Substrate

ECGI-imaged electrical characteristics of the epicardial substrate and MR-imaged
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anatomical scar for Patient 1 are shown in Figure 4-2. In Panel A, isochrone map shows
earliest activation at the superior RV (white asterisk), propagating towards inferior RV
and LV (white arrows). One wavefront encounters a long LOB along the septum, as
shown by left anterior descending coronary artery (LAD). The other wavefront
propagates slowly and counterclockwise around the LOB, activating the LV in a typical
left bundle branch block (LBBB) pattern. Magnitude map shows the epicardial
distribution of EGM magnitude (“voltage map”). The lowest magnitude region (blue) is
located at the apical LV, near the distal LAD. The boundaries of the low magnitude region
coincide with the LOB in the isochrone map. Deflection map shows the epicardial
distribution of EGM fractionation. The most fragmented EGMs are located at the apical
LV region. EP scar map labels the electrical scar in red by thresholding magnitude map
(smaller than 30% of maximum EGM). Four selected EGMs (a-d) from a non-scar region
and four selected EGMs (e-h) from the scar region are shown (note different voltage
scale), demonstrating much smaller magnitudes and high degree of fragmentation. In
Panel B, the anatomical scar is labeled from registered MR-CT images using yellow
markers. The anatomical scar map correlates well with the EP scar map of panel A in
terms of location, size and morphology of the scar.
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Figure 20 (Figure 4-2): ECGI images for patient 1
Panel A: ECGI AI map, EMM, EDM and ESM in three views. White asterisk in AI map shows the

RV breakthrough site and white arrows show direction of wavefront propagation. Eight selected
EGMs from non-scar region of ESM (blue) and from scar region (red) are shown on the right. Panel B:
ASM in the same three views based on MRI-CT registered images. MRI image and CT-MRI
registration results are shown on the right.

ECGI data for Patient 2 are shown in Figure 4-3. In Panel A, the isochrone map shows a
normal sinus rhythm (SR) epicardial activation sequence. A region in the inferior view of
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isochrone map demonstrates earlier activation than the normal RV breakthrough, (pink)
which suggests diastolic activities within an inferior scar. Magnitude map shows low
magnitude regions (blue) over inferior, superior, and apical regions of the heart. The low
amplitude region at the inferior base coincides with the LOB in the inferior isochrone
map. Deflection map shows regions of highly fragmented EGMs on the inferior surface
of the heart. EP scar map labels the electrical scar (red). Six selected EGMs (a-f) from the
scar region are depicted, showing low magnitudes and fractionation. Two selected EGMs
(g-h) from the non-scar region are also shown, with much larger magnitude without
fragmentation. In Panel B, the anatomical scar is labeled using yellow markers. Because
the slice thickness (8mm) of the MR scan is larger than that of the CT (1mm), the
superior basal scar is not captured by MRI. The location of the electrical scar (EP scar
map) and anatomical scar (anatomical scar map) are well correlated, but the electrical
scar is somewhat larger than the anatomical scar, suggesting the presence of an
electrophysiological border zone.
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Figure 21 (Figure 4-3): ECGI images for patient 2

Panel A: ECGI AI map, EMM, EDM and ESM in three views. White asterisk in the AI map shows the

RV breakthrough site. Eight selected EGMs from non-scar region of ESM (blue) and from scar region
(red) are shown on the right. Panel B: ASM in the same three views based on CT-MRI images. MRI
image and CT-MRI registration results are shown on the right.

ECGI data for Patient 3 are shown in Panel A and B of Figure 4-4. In Panel A, the
isochrone map shows a normal sinus rhythm epicardial activation sequence. The RV

- 85 -

breakthrough site is labeled by a white asterisk and lateral LV is activated last (light blue).
Similar to the patient 2, the scar region in the inferior view of isochrone map shows
earlier activation than the normal RV breakthrough, suggesting the diastolic activities
within the scar. Magnitude map shows low potential regions (blue) over inferior, right
lateral, and mid-LV part of the heart. Similar to patient 2, the low potential region at the
inferior base (site d, e and f) coincides with the LOB in the inferior isochrone map. EP
scar map labels the electrical scar (red). Four selected EGMs (c-f) from the scar region
are depicted in red, showing low magnitudes and fractionation. Two selected EGMs (a-b)
from the non-scar region are depicted in blue, showing much larger magnitude without
fragmentation. In Panel B, parts of the anatomical scar are labeled using yellow markers
from MR images, after they are registered to CT images.
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Figure 22 (Figure 4-4): ECGI images for patient 3

ECGI AI map during SR, EMM and ESM are shown in three partially overlapping views. In the SR AI
map, the RV breakthrough site is labeled by white asterisk. Six selected EGMs from non-scar region
of ESM (blue) and from scar region (red) are shown on the right. Panel B shows the ASM in the same
three views based on CT-MRI images. A typical contrast-enhanced MR image and CT-MRI
registration result are shown on the right.

4.2.2 Patient #4, #5 and #6: Diastolic Late Potentials Post-MI

Diastolic late potentials were observed in three of the patients (patient #4, #5 and #6).
ECGI images for Patient 4 are shown in Figure 4-5. The EP scar map and magnitude map
show a large scar along the LAD anteriorly and the posterior descending artery (PDA)
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inferiorly (in red). Deflection map shows fragmented EGMs in the inferior basal region,
where diastolic late potentials are also imaged (black boxes on EGMs). In order to
exclude baseline fluctuations, which may appear as late potentials, non-scar EGMs a and
b are plotted together with scar EGM e for magnitude comparison. Although the QRS
peak-to-peak magnitude of the non-scar EGM is 4.5 times larger than that of the scar
EGM, the late potentials in the scar EGM are 3.5 times larger than the baseline
fluctuations in the non-scar EGM, which confirms their physiological origin. In all three
patients, late potentials occurred in the area of greatest fractionation.

Figure 23 (Figure 4-5): ECGI images for patient 4

ECGI EMM, EDM and ESM are shown in three views. Six selected EGMs from the non-scar region
(blue, top) and from the scar region (red, bottom) are shown on the right. Scar EGM e (red) is also
shown in the top panel together with non-scar EGMs a and b for magnitude comparison.
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ECGI images for Patient 5 are shown in Figure 4-6. Similar with Patient 4, EP scar map
and magnitude map show a large scar along the LAD anteriorly and the PDA inferiorly
(in red). Deflection map shows fragmented EGMs in the right inferior and apical region,
where diastolic late potentials are also imaged (black box on EGMs). The non-scar EGMs
a, b, and c are plotted together with scar EGM i for magnitude and morphology
comparison. Note absence of diastolic deflections (“late potentials”) in the non-scar
EGMs.

Movies of ECGI-imaged epicardial activation during systole and diastole

(Movie 1) are available in the attached CD.

Figure 24 (Figure 4-6): ECGI images for patient 5

ECGI EMM, EDM and ESM are shown in anterior and inferior views. Nine selected EGMs from the
non-scar region (blue, top) and from the scar region (red, bottom) are shown on the right. Scar EGM i
(red) is also shown in the top panels together with non-scar EGMs a, b, and c for magnitude and
morphology comparison. Movies of the ECGI-imaged epicardial activation during systole and diastole
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are available in the attached CD.

ECGI images for Patient 6 are shown in Figure 4-7. The isochrone map shows a normal
RV breakthrough (white asterisk). EP scar map and magnitude map show a large
apical/LV scar; another smaller scar is located at the superior region (site c) close to the
aorta (AO) (labeled red in EP scar map). The borders of the scars correspond to lines of
block and slow conduction in isochrone map. Diastolic late potentials are imaged in the
region close to sites c and e (black box on EGMs). The non-scar EGMs a, and b are
plotted together with scar EGM c for magnitude comparison. Minimal baseline
fluctuations are observed in the non-scar EGMs (a, b), supporting physiological origin of
diastolic late deflections in scar EGMs (c and e).

Figure 25 (Figure 4-7): ECGI images for patient 6

ECGI AI map, EMM and ESM are shown in three partially overlapping views. The normal RV
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breakthrough during SR is labeled by a white asterisk. Six selected EGMs from the non-scar region
(blue) and from the scar region (red) are shown on the right. Scar EGM c is also shown together with
non-scar EGMs a and b for magnitude and morphology comparison.

4.2.3 Patient #7 and #8: VT associated with Post-MI Scar

VT was recorded in patients #7 and #8. ECGI images for Patient 7 are shown in Figure
4-8. Isochrone map during SR shows a slow conduction line along the LAD, which
coincides with the boundary of the low potential region in anterior RV. The LV activates
before the RV, generating an RBBB pattern. EP scar map and magnitude map show a
large anterior RV scar, labeled as S2 in EP scar map. Another smaller scar is located at the
LV basal region (S1). Two scar-related reentry circuits are present in the VT isochrone
map; one is formed around the S1 scar (white arrows), and the second (black arrows)
around the S2 scar. By sharing a common central pathway (blue arrows), the two
pathways form a double-loop activation pattern during VT.
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Figure 26 (Figure 4-8): ECGI images for patient 7

ECGI AI map during SR (top row) and VT (bottom row), EMM and ESM are shown in three views. In
the SR AI map, direction of epicardial wavefront propagation is labeled by white arrows. White
dashed arrows indicate slow conduction. In the VT AI map, two reentry circuits are shown. The white
arrows show a reentry pathway around scar S1, and the black arrows show a second reentry pathway
around scar S2. Blue arrows show the common central pathway shared by the two reentry circuits.
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The origin of each ECGI-imaged VT beat was the inferior base of the heart. Propagation
pattern of the VT consisted of two wavefronts, one (white arrows) propagates clockwise,
with a high degree of curvature, to the base of lateral LV and encounters an inferior line
of block at the edge of the S1 scar. The other (black arrows) propagates superiorly toward
the base and makes a slow counter-clockwise turn around a line of block near the septum
to RV, around the S2 scar. The latest activation during VT is at the lateral base of the RV.
This second loop connects with the first wavefront at the inferior base, where the next
wavefront begins. Movies of the epicardial activation are available in the attached CD
(Movie 2), showing a short period of earliest activation near the borderzone of the scar S1.
The subsequent VT beat begins near this borderzone site.

ECGI images for Patient 8 are shown in Figure 4-9. The isochrone map during SR shows
a normal RV breakthrough site (white asterisk) and a normal epicardial activation pattern.
EP scar map and magnitude map show a left inferior scar in the left lateral view. The
boundary of the scar coincides with slow conduction lines in both the SR isochrone map
and the VT isochrone map. During VT, the LV epicardial activation front begins at the
lateral apex (white circle), and moves around the scar (curved black arrows). Ventricular
activation occurs in a right bundle branch block (RBBB) pattern, which is typical for LV
tachycardia.
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Figure 27 (Figure 4-9): ECGI images for patient 8

ECGI AI map during SR (top) and VT (bottom), EMM and ESM are shown in three views. In the SR
AI map, the RV breakthrough site is labeled by a white asterisk and the direction of epicardial
activation is shown by white arrows. In the VT AI map and ESM, the earliest epicardial breakthrough
site is labeled by a white circle, and the following epicardial activation direction is shown by black
arrows.
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4.4 Discussion
In this study, we report eight cases of post-MI patients imaged noninvasively with ECGI.
We demonstrate that ECGI can noninvasively image the electrophysiological properties
of MI epicardial substrate during sinus rhythm. From these data, quantitative measures
can be derived, including voltage magnitudes and number of deflections of epicardial
electrograms. All ECGI data are generated within a single sinus beat, an advantage over
catheter mapping which requires assembling data from many identical beats.

Contrast-enhanced magnetic resonance imaging (ceMRI) with a gadolinium-based
contrast agent has been used for anatomical imaging of MI. In one study, infarct surface
area and mass, measured by ceMRI, were better than LV ejection fraction at identifying
of patients who are prone to VT after a myocardial infarct.114 Here, we show that ECGI
can noninvasively image a post-MI “electrophysiological scar” (ESM) that corresponds
very closely to the epicardial aspect of the anatomical scar in terms of location and size.
This finding suggests that ECGI could be employed as a low-cost, noninvasive imaging
modality to image the epicardial morphology of MI scars without using a contrast agent.
The information on the epicardial extent of the electrophysiological scar could be
incorporated as one parameter in a method of risk stratification for VT. In patients with
implanted devices, in which MRI can not be employed, ECGI could constitute an
alternative noninvasive modality for imaging the scar substrate.
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Previous studies have shown that fractionated, low-magnitude electrograms are
commonly found in the post-MI region.130 It is well-accepted that fractionated
electrograms in healed infarct reflect slow, non-uniform and discontinuous conduction.130,
135

The anatomical substrate of a patchy scar contains islands of surviving myocardial

fibers separated by inexcitable scar tissue. This provides an electrophysiological substrate
that supports asymmetrical electrical loading on a propagating action potential, a property
that favors formation of unidirectional block.108 The combination of unidirectional block
and slow conduction is highly arrhythmogenic, providing conditions for reentrant VT.108
Consistent with previous invasive studies

130 135

, the ECGI noninvasive epicardial

electrograms from the scar are fragmentated (deflection map), of small magnitude
(magnitude map) and prolonged duration, reflecting the substrate properties described
above. These electrogram properties (low magnitude, long duration, fractionation) could
be considered, together with the extent of the abnormal electrophysiological region, in
risk-stratification for VT. 136

Catheter ablation of VT is associated with a limited success rate, and is generally limited
to patients with hemodynamically stable VT. Catheter-based substrate mapping during
sinus rhythm based on electrogram properties (magnitude and morphology) has been
used to characterize the substrate for VT and guide a substrate-based ablation procedure.
ECGI could provide similar information noninvasively.
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Signal-averaged electrocardiograms of low amplitude and high frequency have been
recorded from the body surface in post-MI patients at the end of the QRS complex.137,138
These late potentials are thought to originate from the infarct border zone and correspond
to fragmented electrograms recorded directly from the heart.139,140 In three of our patients
(#4, #5, and #6), late diastolic potentials were imaged on the epicardial surface of the
heart during sinus rhythm. This activity usually starts around 160ms after the QRS onset
on the reconstructed epicardial electrogram, consistent with invasive mapping.140 The late
potentials are located in a region of the epicardial border zone with higher degree of
electrogram fragmentation, consistent with previous direct recordings139,140; they likely
reflect slow conduction along viable myocardial fibers in the border zone.

In this study, hemodynamically stable VT was captured in two patients (#7 and #8). In
both

patients,

ECGI-imaged

reentry

circuits

were

closely

related

to

the

electrophysiological scar. These data are consistent with a recently published animal
study,116

in which epicardial reentrant VTs were induced in a post-MI swine model. In

this model, the isthmus of the reentrant circuit was confined to a region of viable
myocardium surrounded by the scar tissue. From our study, ECGI-imaged activation
sequence during the VT, together with the imaged electrophysiological substrate during
SR, could provide useful information for guiding catheter ablation of these VTs. For
example, patient #7 had a corridor of viable tissue between two scar regions, and the VT
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beats originated in this channel. Ciaccio et al 141,142 showed in infarcted canine (invasive
direct epicardial mapping) and human hearts (endocardial mapping) that the scar-related
reentry isthmus (common central pathway) could be localized from the SR activation
map. They defined the longest-duration activation pathway by tracing the activation
sequence from the latest to the earliest activation region. This “primary path” was in
accord with propagation within the isthmus during VT, and our ECGI-derived common
central pathway during sinus rhythm and VT in Figure 4-8 agrees with those findings.
Similar results were found for patient #8, where the scar-dependent reentry pathway
during VT corresponds to the pathway of the longest conduction during SR. The VT’s
imaged here were well-tolerated and stable, which comprise a small fraction of all VT
patients. However, the consistency between the ECGI results (in patients #7 and #8) and
Ciaccio’s findings suggest that ECGI could be employed to locate noninvasively the VT
isthmus by analyzing the epicardial activation map during SR, thereby guiding and
facilitating VT ablation without the need to induce a stable arrhythmia.

As discussed in previous publications 1, isochrone maps are useful in displaying the
activation sequence as color-coded images for periodic and stable rhythms. For
complicated and dynamic changing rhythms, such as atrial fibrillation or polymorphic VT,
analysis of several sequential isochrone maps is required to describe the activation pattern.
In this study, we constructed dynamic continuous activation movies that helped greatly in
this regard. The activation movie captured the origin and entire activation pattern of a
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long, dynamically changing rhythm. This is particularly useful during a clinical on-site
application. With recent developments, ECGI can be generated in real-time during the
clinical intervention.

Several limitations of the study should be recognized. At this stage of development,
ECGI images are limited to the epicardium. Intraoperative epicardial mapping and
endocardial mapping suggest epicardial location of the arrhythmia substrate in up to 33%
of patients124,143. Epicardial location has been suggested as one reason for failure of
endocardial catheter ablation.144-146. This realization of epicardial involvement and the
need to differentiate between endocardial and epicardial circuits, has led to development
of a technique for epicardial mapping and ablation through subxyphoid approach.125,147.
However, if needed, ECGI could be combined with catheter endocardial mapping to
provide information on both surfaces of the heart.

The extent of the ECGI-determined electrophysiological scar depended on the threshold
chosen for scar EGM magnitude (30% or smaller than the maximum EGM magnitude in
non-scar regions). With this choice, the electrophysiological scars and ceMRI-imaged
anatomical scars were highly correlated in our patient population. It will require a much
larger-scale study to establish a magnitude criterion with high level of statistical
significance, possibly with different magnitudes in different regions of the heart. As
shown here, using multiple criteria (EGMs magnitude, duration, and fractionation)
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increases the accuracy of scar determination (in patient #1 and #2 adding fractionation as
a criterion prevented over-estimation of the scar size). It should be added that slice
thickness of the MRI images was relatively coarse compared to the CT images (1mm)
and did not always capture the anatomical scar with the same resolution, especially in
very inferior and very superior regions.

Finally, the number of the patients included in the study is relatively small. At this stage,
ECGI is still a novel research tool, which precludes its application in large-scale
multicenter clinical studies. In particular, our results suggest that ECGI could be used for
arrhythmia risk stratification based on electrophysiological properties of the scar (low
potentials, degree of EGMs fractionation) that reflect “patchiness” and heterogeneity of
the infarct substrate. This observation needs to be validated in a large study, where
quantitative statistical correlation between risk and these properties can be established.

4.5 Legends for the Video files
Movie 1 (Patient #5): Epicardial activation during systole and diastole. Blue area denotes

low voltage region (scar). Top left: two electrograms from normal myocardium (blue,
yellow) and from scar (red, cyan). Top right shows the scar electrogram on an expanded
scale. LP = late potentials. Note that diastolic activity is in the scar region.
Movie 2 (Patient #7): Epicardial activation during stable slow VT. Blue area denotes low

voltage region (scar). See text in paper for detailed description.
- 100 -

Chapter 5 Insights from Noninvasive Electrocardiographic
Imaging (ECGI) of Ventricular Arrhythmias in Patients
Undergoing Catheter Ablation

Abstract
Ventricular tachycardia (VT) is a common cause of sudden cardiac death. Advances in
knowledge of VT mechanisms and invasive mapping techniques have facilitated the
ability to treat VT with radiofrequency catheter ablation, but significant limitations
persist. We report our experience with a noninvasive electroanatomic mapping system
(Electrocardiographic Imaging, ECGI) before and during VT ablation procedures. Eleven
consecutive patients referred for VT catheter ablation procedure were included. ECGI
was performed either before (8 patients) or during (3 patients) the ablation procedure.
Blinded ECGI and invasive electrophysiology (EP) study results were compared. All
ECGI procedures yielded high-resolution images of epicardial activity. Over a wide range
of VT types and locations, ECGI results were consistent with EP data regarding
localization of the arrhythmia origin (including myocardial depth) and mechanism (focal,
reentrant, fascicular). ECGI also provided mechanistic electrophysiological insights,
relating arrhythmia patterns to the myocardial substrate. ECGI is feasible and reliable to
perform in the study of ventricular arrhythmias both before and during an ablation
procedure.

ECGI

has

unique

potential

clinical

advantages,

especially

for

hemodynamically intolerant VT or VT that is difficult to induce. Because it provides
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local cardiac information, ECGI may aid in better understanding of mechanisms of
ventricular arrhythmia. Further prospective trials of ECGI with clinical endpoints are
warranted.

5.1 Introduction
Ventricular tachycardia (VT) is a common cause of sudden cardiac death(SCD)148-150.
While implantable cardiac defibrillators are used to abort SCD151, they do not treat the
underlying disease. Understanding mechanisms of VT has led to their treatment with
radiofrequency catheter ablation152-155. Innovative imaging modalities have facilitated
ablation procedures, improving success and safety. Nevertheless, success rates are
variable, and morbidity and mortality related to these lengthy procedures are significant.

There are limitations to current VT ablation procedures. First, the point-by-point
roving-probe method for electrical mapping is time-consuming and requires a sustained,
hemodynamically-tolerated monomorphic VT. Conversely, hemodynamically intolerant
VT does not allow for detailed mapping. Third, particularly for VT arising from the RV
outflow tract, sedation for the ablation procedure often renders the VT noninducible156.
Fourth, there are limitations in identifying and ablating atypical endocardial sites, such as
the coronary cusps of the aorta157. Finally, there are specific challenges in identifying and
ablating nonendocardial reentry circuits or focal sources, frequently seen in patients with
nonischemic cardiomyopathies147,158
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Thus, the ability to noninvasively image the initiation, propagation and other
characteristics of VT during a single beat has potential clinical benefit. Here, we present
observations

from

using

a

noninvasive

electroanatomic

mapping

method,

Electrocardiographic Imaging (ECGI), in a series of patients undergoing catheter ablation
for various forms of VT.

5.2 Methods
Eleven consecutive patients referred for catheter ablation for sustained symptomatic VT
were included in this study. All protocols were approved by the Human Research
Protection Office (HRPO) at Washington University in St. Louis, and informed consent
was obtained.

ECGI methodology was described in detail

1,2

. 256 carbon electrodes on strips were

applied to patient’s torso surface. Small CT markers were attached to each electrode. All
strips were connected to a portable mapping system (BioSemi, Netherlands). After
electrodes application, patients underwent thoracic noncontrast gated CT with axial
resolution of 3mm. Scans were gated at 70% of the R-R interval (ventricular diastole).
For patients who had continued ECGI mapping during a subsequent EP study, the 256
carbon electrodes were kept in the same position. Patient-specific ventricular epicardial
surface geometry and body surface electrode positions were labeled and digitized from
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CT images.

The 256 channels of body surface potentials (BSP) were sampled at 1-ms intervals during
the cardiac cycle, and the data were saved on a laptop computer.

BSP were acquired

during sinus rhythm, VT, and programmed electrical stimulation, when available.

The BSP and geometrical information (torso-heart geometrical relationship) were
combined by ECGI algorithms to noninvasively construct epicardial electrograms,
activation sequences (isochrones), potential maps, and repolarization patterns 1,2. ECGI is
constructed on a beat-by-beat basis and does not require accumulating data from many
identical beats. Activation times were determined by the maximal negative slope of the
epicardial electrograms. Activation movies for several consecutive beats were also
constructed by animating the activation wave front on the patient-specific CT-derived
epicardial surface. Based on the isochrone map, lines or regions of block were inferred if
activation times in adjacent area differed by more than 50ms. Slow conduction is
represented by crowded isochrones.

ECGI was performed prior to the ablation procedure (8 patients) when the patients
demonstrated spontaneous ventricular rhythms. Otherwise, ECGI was used during the
ablation procedure (3 patients). The results of ECGI were processed independently from
the results of the EP study. Additionally, EP operators did not have access to ECGI results
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prior to the procedure. Additional cardiac images, such as three-dimensional
electroanatomic maps, gadolinium-enhanced cardiac MRI and single-photon emission
computed tomography (SPECT), were obtained retrospectively, when available, for each
patient. Pertinent medical records for patients in this study are summarized in Table 5-1.
Table 4 (Table 5-1) Clinical background
Age
Gender

RV
1

RV
2

RV
3

RV
4

RV
5

LV
1

LV
2
LV
3
LV
6

LV
Clincial Presentation

Fraction

48

Symptomatic

years

nonsustained VT at rest

Female

and after exertion.

42
years
Male
58
years
Female
21
years
Male
76
years
Male

63
years
Female
59
years
Male
45
years
Male

Ejection

Symptomatic
nonsustained VT at rest.

Symptomatic sustained
VT at rest.

Symptomatic
nonsustained VT at rest.

42%

recovery portion of

VT

Antiarrhythmic

Substrate

Morphology

Medication

Nonischemic
cardiomyopathy

70%

Normal

LBBB pattern
Right Inferior

65%

Normal

(V3)
LBBB pattern
Inferior

Right Inferior

58%

Normal

Right Inferior

sustained slow VT

Recurring syncope and
sustained VT at rest.

Beta-blocker

(V3)
Previous anterior

RBBB pattern

myocardial

Left Inferior

infarction

(V2)

Nonischemic

RBBB pattern,

cardiomyopathy

Right Superior

35%

10%

antiarrhythmic drugs
Minimally symptomatic

Beta-blocker

LBBB pattern

Symptomatic sustained

tolerating multiple

Beta-blocker

(V3-V4)

exercise stress test.

slow VT at rest, poorly

None

LBBB pattern

Recurrent admissions
for sustained VT during

Ventricular

Previous inferior
40%

myocardial
infarction

55%

Cardiac sarcoid
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RBBB pattern,
Left Superior

Beta-blocker

Amiodarone,
Mexiletine,
Beta-blocker

Beta-blocker

RBBB pattern,

Amiodarone,

Right Superior

Beta-blocker

LV
4

35
years
Male

LV

53

5

years

Symptomatic sustained
VT who had undergone
prior EPS with slow

70%

Normal

65%

Normal

RBBB pattern,

Calcium-channel

Left Superior

blocker

pathway modification.
Symptomatic sustained

Female

VT at rest.

RBBB pattern,
Left Superior

Amiodarone

5.3 Results
Eleven ECGI procedures were performed on 10 patients (mean age 50 years, range 21 –
76 years). One patient required a second (epicardial) ablation procedure eight months
later and underwent ECGI before both procedures. All ECGI procedures were completed
successfully and yielded high-resolution images. There were no major equipment failures
or adverse patient events related to ECGI image acquisition.

Tachycardia characteristics obtained during the EP study, including conventional 12-lead
ECG morphology, cycle length, and information regarding induction, testing and ablation
of the tachycardia are detailed in Table 5-2. In total, 4 patients had a focal source in the
right ventricular outflow tract (RVOT), 1 patient had a focal source in the left coronary
cusp of the aorta, 1 patient had a focal nonendocardial source in the apical lateral left
ventricle, 2 patients had reentry around myocardial scars, 2 patients had intrafascicular
reentry (fascicular VT), and 1 patient had focal epicardial VT related to advanced cardiac
sarcoid disease.
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Table 5 (Table 5-2) Tachycardia characteristics
Primary
Timing
VT
of

VT

Diagnostic

Procedural

Conclusion of

Cycle

Maneuvers

Endpoint

EPS

VT Induction
Morphology

Follow Up

ECGI
Length
RF application
LBBB

•

Spontaneous

eliminated
Activation Map:
ventricular

Before

pattern

and

left coronary

EPS

Right Inferior

isoproterenol

(V3)

induced VPD’s

Left coronary

No

cusp origin

recurrance

Mid-septal

No

RVOT

recurrance

Mid-septal

No

RVOT

recurrance

Posterior right

No

RVOT

recurrance

ectopy.

N/A

RV1

cusp, 15 ms
preQRS.
Noninducible at
conclusion.
•

Pace Map: 12/12
RF application
match,
eliminated

Spontaneous

mid-septal
ventricular

LBBB
and

Before

N/A

pattern

RV2

RVOT.

isoproterenol

EPS

•

ectopy.
Activation Map:

Inferior (V3)
induced VPD’s

mid-septal
Noninducible at
RVOT, 19 ms
conclusion.
preQRS.
•

Before

LBBB

Spontaneous

pattern

and
N/A

RV3
EPS

Right Inferior
(V3-V4)

isoproterenol

Activation Map:
midseptal

eliminated

RVOT, 30 ms

ventricular

preQRS.
•

RF application

ectopy.

Pace Map: 12/12

induced VPD’s
match, midseptal
RVOT

Noninducible at
conclusion.
RF application
eliminated

Before

LBBB

Spontaneous

pattern

and

•
N/A

RV4
EPS

Inferior (V3,

isoproterenol

V4)

induced VPD’s

Pace Map: 12/12

ventricular

match posterior

ectopy.

right RVOT
Noninducible at
conclusion.
LBBB
pattern

No inducible

Left Inferior

arrhythmia

(V2)

during EPS.

Received

Before
RV5

N/A

N/A

N/A

N/A
ICD

EPS
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•

Activation Map:
Earliest
activation
Underwent
anterolateral

Double
apex, local

VT1 & 2:
ventricular

390 ms
electrogram,

RBBB

heart

reentrant.

transplant for

endocardial RF
refractory

extrastimuli

During
pattern,

LV1

Not likely to be
Multiple

EPS

yielded

(VT2 at

sustained,

490 ms)

Right

•

21ms preQRS.

applications

Pace Map: 12/12

failed to alter

match

Superior

Epicardial or

heart failure

midmyocardial

and

origin.

intractable

the tachycardia.

tolerated VT
anterolateral

VT.
apex
•

Entrainment:
PPI-TCL = 74ms

•

Voltage Map:
inferobasal
septal scar

•

Activation Map:
earliest
RF applications
activation

Spontaneous,

altered, then
VT1 & 2:

sustained

Reentrant.
ICD implant

inferobasal

627ms

terminated the
Before

RBBB

tolerated

EPS

pattern,

accelerated

septum, border
tachycardia.

LV2
(VT2 at

Inferobasal
No

zone, 67ms
septal scar

Left Superior

idioventricular

recurrance

preQRS. Highly

641ms)

Noninducible at

border azone.

fractionated

rhtyhm

conclusion.
signal.
•

Entrainment:
concealed,
PPI-TCL = 13
ms

•

Activation Map:
earliest

VT1: RBBB
activation

RF applications

pattern,

Before

Right

Spontaneous,

Superior

tolerated
nonsustained

eliminated the

apical. Two

nonsustained

distinct exit sites

tachycardia.

Likely reentrant

ICD implant.

Two exit sites

8 months

from an

later, VT

inferolateral

recurred (see

apical scar.

LV6)

Left posterior

No

463 ms

LV3
EPS

inferolateral

(VT2 at
corresponding to

VT2: RBBB

VT

500ms)
two VT

Noninducible at

pattern, Right
morphologies.

conclusion.

Inferior
0-10ms pre
QRS.
LV4

During

RBBB

Single LV

317 ms

•

Activation Map:
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RF applications

EPS

pattern,

ventricular

earliest

Left Superior

extrastimuli

midinferior

eliminated the

fascicular VT

recurrance

sustained
tachycardia.

induced

septum, 30ms

sustained

pre-QRS

tolerated VT

fascicular

Noninducible at

potential.

conclusion.
No ablation

During

RBBB

With

pattern,

isoproterenol,

•

performed due
Pace Map:

344 ms

LV5
EPS

Left Superior
(V3)

to patient

Likely left

anxiety and

posterior

adverse reaction

fascicular VT

Treated with

10-11/12 match

nonsustained

CCB

mid-apical

VT

septum
to
isoproterenol.
•

Epicardial access

•

Activation Map:

Spontaneous,
tolerated,

heart

insufflation

Focal or

transplant for

eliminated the

microreentrant

refractory
heart failure.

nonsustained
anterolateral

nonsustained

EPS

after pericardial

activation
1177ms

pattern, Right

LV6

Underwent

Earliest

RBBB
Before

RF applications

tachycardia.

Inferior
VT

Epicardial

Explant

origin

confirmed

basal. 0-10 ms
preQRS
•

Noninducible at

cardiac

conclusion.

sarcoid.

Pace Map: 12/12

Based on the results of prior studies, we used ECGI to identify characteristics of each
tachycardia based on single-beat analysis of isochrone, potential, local electrogram, and
wavefront propagation information. A three-step process was used to determine each
patient’s unique tachycardia properties:

•

Step 1: Localize the origin with isochrone and potential maps

•

Step 2: Determine mechanism by observing three-dimensional propagation
pattern

- 109 -

•

Step 3: Determine myocardial depth by using local electrograms (pure Q wave for
epicardial sources, rS complex for intramural or endocardial sources)

Detailed results of ECGI are presented below, organized by location and mechanism of
the clinical VT. A summary schematic of the locations of the various VT’s and a
comparison of ECGI observations and EP study results are shown in Figure 5-1 and Table
5-3.

Figure 28 (Figure 5-1): Sites of origin of the ventricular tachycardias included in this study.

ECGI characteristics of VT localization, propagation and local electrogram compared with the
conclusion of the EP study are shown in Table 5-3. LA= Left Atrium, RVOT = Right Ventricle
Outflow Tract, PA= Pulmonary Artery, L=Left, R=Right, NC=Noncoronary Cusps of the Aorta;
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Table 6 (Table 5-3) ECGI observations and tachycardia characteristics
Patient

ECGI
Localization

ECGI
Propagation

RV1

Left coronary
cusp

Radial

Focal, left coronary cusp
origin

RV2

Mid-septal
RVOT

Radial

Focal, mid-septal RVOT

RV3

Mid-septal
RVOT

Radial

Focal, mid-septal RVOT

RV4

Posterior right
RVOT

Radial

Focal, posterior right RVOT

RV5

Anterior left
RVOT

Radial

N/A

LV1

Apical lateral
LV

Radial

Focal, apical lateral LV
Epicardial or midmyocardial
origin

Inferior basal
LV

Spiral wavefront
High degree of
curvature
Anatomic line of
block
Presystolic
activation

LV3

Two sites:
1) Inferior
lateral LV
2) Apical lateral
LV

Spiral wavefront
High degree of
curvature
Anatomic line of
block
Presystolic
activation

Q wave and rS
complex
Low amplitude,
fractionated

Likely reentrant
Two exit sites from inferior
lateral apical scar

LV4

Large area
apical LV

Radial

rS complex

Left posterior fascicular

LV5

Large area
apical LV

Radial

Q wave

Likely left posterior
fascicular

LV6

Anterior basal
LV

Radial

Q wave

Focal, anterior basal LV
Epicardial origin

LV2

ECGI Local
Electrogram

Q wave

Low amplitude,
fractionated
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Conclusion of EP Study

Reentrant.
Inferior basal LV septal scar

5.3.1 Left Bundle Branch Block (LBBB) pattern VT (RVOT tachycardia)

Five patients (RV1 to RV5, mean age 49 years, range 21-76 years) underwent EP study
with the presumptive diagnosis of symptomatic RVOT tachycardia based on conventional
12-lead ECG analysis and normal cardiac function from prior imaging. None of the
patients met diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy. Of
four catheter-mapped tachycardias (RV1 to RV4), two had mid-septal RVOT origins, one
had posterior right origin and one had a left coronary aortic cusp origin (Figure 5-1). The
four ablations were deemed successful based on the absence of the PVC morphology
after ablation and the absence of symptoms in follow-up clinic visits.

The three-step process of ECGI analysis is demonstrated using Figure 5-2A, which
displays ECGI isochrone and potential maps of a premature ventricular beat from a
patient with a mid-septal RVOT source (RV2).

•

Step 1: Localization—Isochrone map identifies an area in the septal RVOT as the
earliest activation (white asterisk). Consistently, the potential map shows an
intense local minimum; (dark blue, indicating initiation of wave front) at the same
location.

•

Step 2: Propagation—Propagation pattern is away from this location in a radial
fashion, consistent with a focal mechanism.
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•

Step 3: Myocardial Depth—Local electrogram at this location shows a small r
wave followed by a deep S wave, consistent with an endocardial origin (not
shown).

Figure 29 (Figure 5-2): ECGI of a mid-septal RVOT tachycardia, (RV2)

Panel A: isochrone map (upper row) and potential map (lower row, 43 ms from the onset of QRS)
during a spontaneous PVC beat in three views (AP=Anteroposterior). White asterisk indicates the
ECGI determined mid-septal RVOT VT origin. White arrows indicate the direction of activation
wavefront propagation. The conventional 12-lead ECG for the PVC is shown on the right. Panel B
shows isochrone map (upper row) and potential map (lower row, 45 ms from the onset of QRS) for a
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sinus beat in three views. White asterisk indicates the RV epicardial breakthrough site. AO = Aorta,
LAD = Left Anterior Descending Coronary Artery, LA = Left Atrium, TV = Tricuspid Valve, MV =
Mitral Valve, RA = Right Atrium.

The noninvasive ECGI images were confirmed during the ablation procedure, where
invasive activation mapping of the PVCs identified earliest activation in the mid-septal
RVOT with a perfect pace map match. Radiofrequency ablation at this location
eliminated the ventricular ectopy.

For comparison, ECGI images are shown during sinus rhythm in Figure 5-2B. The
earliest epicardial breakthrough in the anterior RV is marked by the white asterisk. The
wavefront propagates from RV to LV with some slowing of conduction (crowded
isochrones) across the anterior septum. The latest activation region is the lateral LV. The
epicardial potential map for the same sinus beat shows an intense negative potential
minimum around the breakthrough site, typical of sinus rhythm pattern.2

Similar data are presented for other patients with LBBB-VT. All five LBBB-VTs
originated in the outflow tracts, as shown in Figure 5-1.

Several similarities exist among this group of LBBB-VT patients, namely the propagation
pattern and presumed mechanism. Uniformly, the ECGI-derived activation sequence for
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the VT (during a PVC) begins in the right ventricle and proceeds along the anterior RV
from base to apex. Using Figure 5-2A as an example, the wavefront encounters a line of
slow conduction at the ventricular septum, as shown by the crowded isochrones near the
labeled left anterior descending artery (LAD). Activation of the left ventricle proceeds
apex to base, with the basal lateral LV the last area to activate. This pattern of activation
can be considered a “signature” of LBBB-VT ventricular activation.

The second similarity of these LBBB outflow tract tachycardias is the observed
mechanism. These tachycardias generally have a focal, rather than reentrant, mechanism.
With the ECGI map, a focal mechanism can be inferred by an area of early intense
negative potential at the same site as isochronal initiation with a radial activation
wavefront. All five ECGI images of outflow tract tachycardia suggested focal
mechanisms.

The largest variations among the group were in the exact locations of the tachycardia
initiation sites. Importantly, the exact location and orientation of VT activation could not
be determined from the conventional 12-lead ECG. For example, two patients with
mid-septal RVOT origins (RV2 and RV3) had very similar ECGI images (Figure 5-2 and
Figure 5-4), but significant differences on the conventional 12-lead ECG. The ECG in
Figure 5-2 shows a pure inferior activation pattern with an isoelectric signal in lead I.
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Figure 30 (Figure 5-3): ECGI of tachycardia originating in the left coronary aortic cusp, (RV1)

Panel A: Isochrone map (upper row) and potential map, (lower row, 34 ms from the onset of QRS)
for a PVC beat in three views. White asterisk indicates the ECGI determined RVOT VT origin.
Arrows indicate the activation wavefront propagation direction. The conventional 12-lead ECG from a
PVC is shown on the right. Panel B shows the isochrone map (upper row) and potential map (lower
row, 45 ms from the onset of QRS) for a sinus beat. White asterisk indicates RV epicardial
breakthrough. Arrows show the sinus activation propagation sequence. Panel C shows a CT cross
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section image; yellow dot indicates the ECGI determined VT origin. Panel D shows the surface ECG
of a PVC during the EP study and (bottom) the electrogram recorded with ablation catheter at the site
of the left coronary aortic cusp.

Spontaneous PVCs from Patient RV1 had the most leftward origin of early isochrone and
negative potential. Figure 5-3 shows the corresponding ECGI results to highlight the area
of focal initiation (white asterisks in panel A) that begins at the base of the left side of the
aorta, near the left coronary cusp. The propagation pattern continues superiorly and
rightward towards the anterior RV (white arrows) and then across the septum in a typical
LBBB pattern. When superimposed onto the CT scan obtained during ECGI, the origin of
the VT is found to be in the left coronary cusp of the aorta, which concurs with the
findings of the EP study. Of note, despite published data for interpreting the ECG for
left-sided outflow VT
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, the conventional 12-lead ECG in this case does not readily

identify the correct location of the VT.

Figure 5-4 (RV3) has a markedly positive signal in lead I, suggesting a more leftward
activation pattern. The difference in surface ECG morphology can be accounted for by
different cardiac geometries relative to the body-surface leads. In this case, the surface
ECG suggests different locations for the arrhythmias foci, but ECGI, which takes into
account the specific patient anatomy, shows otherwise. This ECGI finding was supported
by catheter mapping.
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Figure 31 (Figure 5-4): ECGI of a mid-septal RVOT tachycardia, (RV3)

Panel A: isochrone map (upper row) and potential map (lower row, 43 ms from the onset of QRS) for
a PVC beat in three views. Black asterisk indicates the ECGI determined RVOT VT origin. Arrows
indicate the activation wavefront propagation direction. The conventional 12-lead ECG during PVC is
shown on the right. Panel B shows the isochrone map (upper row) and potential map (lower row, 66
ms from the onset of QRS) for a sinus beat. White asterisk indicates RV epicardial breakthrough;
arrows show direction of wave front propagation.

Two additional patients had sites of origin in the anterior left and posterior right RVOT,
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respectively (Figures 5-5 and 5-6). The overall activation pattern for both patients was
consistent with the “signature” LBBB pattern. The area of earliest activation on these
isochrone maps varied when compared to the mid-septal RVOT location. For Figure 5-5
(RV4), with a posterior right origin, the earliest isochrone and negative potential were in
the most posterior portion of the RVOT. Interestingly, the earliest propagation pattern
included a portion of the anterior LV as well as the RV. The area of slowed conduction in
this patient was displaced apically and laterally from the septum, but the overall LBBB
signature pattern was preserved. The early anterior LV activation may account for the
decreased terminal leftward forces on the conventional 12-lead ECG.
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Figure 32 (Figure 5-5): ECGI of a posterior right RVOT tachycardia, (RV4)

Panel A: Isochrone map (upper row) and potential map (lower row, 31 ms from the onset of QRS) for
a PVC beat in two views. White asterisk indicates the ECGI determined RVOT VT origin. Arrows
show the activation wavefront propagation direction. The conventional 12-lead ECG during the PVC
is shown on the right. Panel B shows the isochrone map (upper row) and potential map (lower row, 50
ms from the onset of QRS) for a sinus beat in two views. White asterisk indicates RV epicardial
breakthrough. The arrows show direction of wave front propagation.
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For Figure 5-6 (RV5), demonstrates an anterior left origin with the earliest isochrone and
negative potential occurring more anteriorly in the RVOT. The activation pattern
advanced quickly and preferentially down the anterior right ventricle, without early LV
activation.

Figure 33 (Figure 5-6): ECGI of an anterior left RVOT tachycardia, (RV5)

The isochrone map (upper row) and potential map (lower row, 35 ms from the onset of QRS) for a
PVC beat in three views. White asterisk indicates the ECGI determined RVOT VT origin. The white
arrows show the direction of the activation wavefront propagation. The conventional 12-lead ECG
during the PVC is shown on the right.

5.3.2 Right Bundle Branch Block (RBBB) pattern VT (LV tachycardia)

Five patients underwent six ablation procedures with a presumptive diagnosis of VT
originating in the LV based on conventional 12-lead ECG analysis and cardiac imaging
(LV1-LV6, mean age 51 years, range 35-63). ECGI was performed before the EP
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procedure for three patients and during the EP procedure for the other three patients.

In total, two patients had reentry around a myocardial scar, two patients had
intrafascicular reentry (fascicular VT), one patient had a focal VT of intramural origin,
and one patient had a focal epicardial VT related to advanced cardiac sarcoid disease.

In all six patients, ECGI accurately localized the VT (Figure 5-1). Unlike RVOT
tachycardia with a “signature” LBBB pattern and a consistent focal propagation pattern,
tachycardias from the LV had different activation patterns, reflecting the variety of
origins and mechanisms of LV-VT (Table 5-3). Pertinent illustrative examples are
described below, using the three-step process of localization, propagation and myocardial
depth to characterize each tachycardia.

Patient LV1 had a nonischemic cardiomyopathy and at the end of her EP study, she was
deemed to have a nonendocardial focal VT at the apical-lateral LV. ECGI results during
the EP study are shown in Figure 5-7. Double ventricular extrastimuli induced
hemodynamically tolerated VT at a cycle length of 390ms. Isochrone maps of the RV
pacing train, premature ventricular stimuli, and first beat of induced VT are shown in
Figures 5-7A, 5-7B, and 5-7C, respectively.
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Figure 34 (Figure 5-7): ECGI of a focal ventricular tachycardia induced by programmed
electrical stimulation, (LV1)

Panel A: Epicardial activation sequence during drivetrain (S1) pacing at cycle length of 600ms.(RAO
= right anterior oblique, LAO=left anterior oblique). White arrows show direction of wavefront
propagation. Thick black line indicates conduction block. Earliest epicardial activation site is marked
by + and corresponds to the underlying endocardial pacing site. ECGI epicardial electrogram from this
site is shown (blue arrow) with rS complex consistent with endocardial activation. The conventional
12-lead ECG during VT is shown on the right. Panel B: Premature (S2) pacing at 280ms coupling
interval from the same pacing site. The major wave front is forced to pivot around the extended line of
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block. There is some fusion with an intramural trans-septal front (small white arrow). Panel C: VT;
earliest epicardial activation site is marked by asterisk. ECGI electrogram from the VT origin site is
shown (blue arrow), with a pure Q wave, suggestive of an epicardial origin. A body surface ECG is
shown on the right of Panel B. All S1 beats (blue) are similar, as are the two S2 beats (black) and all
VT beats (red). Invasive LV endocardial activation map of the VT in LAO projection is in Panel C,
right (red is early). ECGI epicardial activation movies are in the attached CD (LV1).

With drive train pacing (S1, Figure 5-7A), the earliest epicardial activation starts from the
pacing site (white +) near the RV apex and propagates both superiorly and inferiorly
towards the left ventricle. ECGI epicardial electrogram from the site of earliest epicardial
activation shows rS morphology, consistent with endocardial initiation of the paced beats.

The epicardial activation sequence during premature ventricular extrastimuli (S2) from
the same site is shown in Figure 5-7B. The premature beat retains a similar overall
activation pattern to drive train pacing, with two distinct differences. First, the line of
block is elongated over the anterior septum towards the base of the heart (LAO view),
demonstrating its functional nature. Second, in the LV the line of block shifts inferiorly
and the latest activation region (white -) is delayed and shifted apically (left lateral view).

Figure 5-7C shows epicardial activation during the first beat of induced VT. The earliest
epicardial activation (black star in left lateral view) occurs at the latest activation region
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of the previous S2 paced beat, suggesting triggered activity as the mechanism. The
activation wavefronts propagate towards both the apex and the base (white arrows). The
activation wavefront that propagates towards the apex encounters a line of block. The
activation wavefront that propagates towards the base turns around the line of block and
propagates toward the RV. The electrogram from the earliest epicardial site is a pure Q
wave, indicating an epicardial origin of the VT 34. ECGI epicardial activation movies are
in the attached CD (LV1).

A three-dimensional endocardial map was created during the procedure, showing the
earliest activation in a large area in the anterolateral apex (Figure 5-7D). At the
conclusion of the procedure, it was deemed that the likely mechanism was focal, and that
the endocardium was not the site of origin. These conclusions are consistent with the
ECGI images and electrograms.

Patients LV2 and LV3 were found to have reentrant VT around areas of myocardial scar
during EP study. ECGI results for patient LV2 are shown in Figure 5-8. This patient had
an extensive inferoseptal scar from a prior inferior wall myocardial infarction (SPECT
image in Figure 5-8C) and presented with slow hemodynamically tolerated VT. As shown
by ECG lead V2 (inset), sinus capture (SC) beats occasionally interrupted the VT rhythm.
ECGI images of an SC beat and a VT beat are shown in panels A and B, respectively.
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Figure 35 (Figure 5-8): ECGI of reentrant VT from inferobasal scar, (LV2)

Panel A: Four views of activation sequence during a sinus capture (SC) beat (labeled A, blue on the
V2 ECG).

Arrows indicate direction of the activation wavefronts.

Panel B: Activation sequence

during VT beats (labeled B, red on the V2 ECG). White arrows indicate a clockwise lateral loop (left
lateral and LAO inferior views); Pink arrows show propagation into the RV in a counter-clockwise
fashion. Panel C: Left: SPECT images showing a scar at the inferobasal LV region (blue). Right:
NavX invasive endocardial map of VT activation (red early, blue late). ECGI epicardial activation
movies, including early activation of a region near the inferior scar border, are in the attached CD
(LV2). The conventional 12-lead ECG during VT and the ablation-catheter signals are shown on the
right side of the figure.
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The origin of each ECGI-imaged VT beat was the inferior base of the heart (red, LAO
and left lateral views). The propagation pattern of the VT consisted of two wave fronts.
One (white arrows) propagated clockwise, with a high degree of curvature, toward the
base of lateral LV, where it encountered an inferior line of block. The other (pink arrows)
propagated superiorly toward the base where it made a slow counter-clockwise turn
around a line of block near the septum to RV. The latest activation during VT was at the
lateral base of the RV. This second wavefront connected with the first wavefront at the
inferior base, where the next wavefront begins. In this region of the inferobasal septum,
ECGI reconstructs low-amplitude, highly fractionated electrograms, consistent with a
scar (data not shown). Movies of the epicardial activation are available in the attached
CD (LV2), showing a short period of earliest activation near the border zone of the scar.
The subsequent VT beat begins near this border zone site. During the ablation procedure,
a voltage map confirmed the inferobasal septal scar (Figure 5-8C). A limited invasive
activation map during the slow VT showed the earliest activation in the scar border zone
in the inferobasal septum, with the earliest electrogram signal >50 ms before the surface
QRS (Right side of Figure 5-8).

A second scar-based reentrant VT is shown in Figure 5-9. This patient presented with
syncope and sustained VT on ambulatory monitoring. A gadolinium-enhanced MRI
revealed patchy myocardial and subepicardial enhancement in the lateral LV, consistent
with a focal myocarditis or cardiac sarcoid. ECGI during VT identified two distinct areas
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of early epicardial activation (white asterisks, Figure 5-9A), which differed slightly from
beat to beat (T1, T2, T3). The propagation pattern varied somewhat based on the relative
contribution of the two sources, but the images in Figure 5-9 show that for all beats the
wavefront turns clockwise and propagates to the LV lateral base with a high degree of
curvature, where it reaches a line of block in the inferolateral base. A fusion beat is also
shown (SF) with a combination of normal anterior RV activation and abnormal
inferolateral VT activation. Movies of the epicardial activation are available in the
attached CD (LV3).
Electrogram analysis showed both pure Q wave and rS pattern during VT, consistent with
both epicardial and endocardial involvement. Figure 5-9B shows a peak-to-peak
amplitude “substrate map” of ECGI epicardial electrograms obtained during the SF beat.
The mid-lateral LV has a region of low amplitude (blue), which corresponds closely to
the MRI scar images. The activation sequence is superimposed on the substrate map,
demonstrating its relationship to the scar substrate (blue). During the ablation procedure,
pre-ablation activation mapping detected an earliest endocardial activation site in the
inferolateral LV, which corresponds to the earliest region of epicardial activation mapped
by ECGI.
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Figure 36 (Figure 5-9): ECGI of a reentrant VT in lateral VT (lateral wall infiltrative
cardiomyopathy), (LV3)

Panel A. Activation patterns for three consecutive VT beats (T1, T2, T3) and one fusion beat of sinus
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and VT activation (SF) in three views. The displayed beats are marked by T1, T2, T3 and SF on one
surface ECG. Asterisks mark earliest epicardial activation sites and arrows the propagation direction of
the activation wave front. For the VT beats, white arrows show the clockwise rotating wave fronts and
pink arrows show a second wavefront that activates the RV. The black asterisk and yellow arrows in
SF1 map show normal RV breakthrough site and activation, which fuses with VT activation (white
asterisk and arrows). ECGI epicardial activation movies are available in the attached CD. Panel B.
Substrate map during a sinus beat, created using peak-to-peak magnitude of ECGI epicardial
electrograms (low potentials are blue; scale in mV). Arrows indicating the activation pattern are
superimposed, demonstrating how the wavefront relates to the underlying scar substrate. Panel C.
Contrast-enhanced (gadolinium) MRI images in two views. The LV mid-lateral scar appears bright
(arrows). Panel D. NavX map of endocardial activation during VT; regions of earliest activation are
red. The conventional 12-lead ECG of the VT is shown on the right.

Two patients in the study had fascicular VT (LV4 and LV5), thought to be a
microreentrant circuit involving the distal Purkinje network. ECGI activation sequences
for these patients are shown in Figure 5-10 and Figure 5-11. In Figure 5-10A, the VT
earliest epicardial activation is over a large area at the apex. A broad wavefront
propagates towards the LV base. One segment rotates clockwise to the lateral base. A
second segment propagates inferiorly toward the posterior base (inferior view) and after a
long conduction delay activates the RV and propagates superiorly towards the base of the
heart. This is consistent with the RBBB pattern seen on the conventional 12-lead ECG.
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The ECGI local electrogram at the apex (blue arrow) clearly shows rS morphology,
identifying an endocardial or intramural origin of VT. Movies of ECGI-imaged epicardial
activation are available in the attached CD (LV4).

Figure 37 (Figure 5-10): ECGI of left posterior fascicular VT, (LV4).

Panel A: Four views of the activation sequence during VT. White arrows indicate the activation
pathways during the first 120 ms. Yellow arrows indicate the activation sequence of anterior-lateral
RV after a long conduction delay. Epicardial electrogram with rS morphology at apex (blue arrow)
indicates endocardial or deep intramural origin of the VT. ECGI epicardial activation movies are in the
attached CD.

Panel B: Endocardial CARTO activation maps in AP and left-lateral views demonstrate

successful ablation at an endocardial site (red sphere) that corresponds to the ECGI-imaged site of
earliest epicardial activation. The conventional 12-lead ECG and catheter recordings during the
induced VT are shown on the right.
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During the EP study, activation mapping revealed the earliest activation at the
mid-to-apical inferior septum, where a fascicular potential was recorded (Figure 5-10B).
This apical septal site is consistent with the ECGI epicardial activation maps.

Results from the second fascicular VT (LV5) can be found in Figure 5-11. The
conventional 12-lead ECG showed monomorphic VT and clinically, despite extensive
mapping, the procedure was ultimately abandoned due to the inability to obtain a perfect
pacemap match. Interestingly, ECGI demonstrated both morphology and magnitude
differences between beats of VT. This is highlighted in the isochrone maps. Between VT
morphologies, there are similar slow conduction lines, lines of block, and general patterns
of propagation. However, the most distinct difference between different beats is the
location of the earliest activation site (asterisk). Movies of ECGI-imaged epicardial
activation are available in the attached CD (LV5). ECGI of the pacemap “target” VT
was considerably different than the other imaged VT beats, which helps explain the
inability to successfully ablate the VT.
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Figure 38 (Figure 5-11): Patient LV5.

Panel A: Three morphologies of VT within five consecutive beats. Each row shows the ECGI
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activation map for one VT morphology. The five consecutive VT beats in lead V4 are color coded
based on the morphology. White arrows indicate the direction of the activation wavefronts. Yellow
arrows indicate slow conduction and late RV activation. Asterisk marks the earliest activation site for
the beat. ECGI epicardial activation movies are in the attached CD. Panel B: ECGI maps of epicardial
activation during the “target” pacemap VT beat (top row) and two unsuccessful pacemap locations
near the left posterior fascicle in the middle and bottom rows.

Finally, patient LV3 presented eight months after his first endocardial ablation with
frequent nonsustained VT and worsening heart failure symptoms. His cardiac function
had deteriorated over time. On conventional 12-lead ECG, he had three distinct
morphologies of VT. His predominant arrhythmia had characteristics consistent with an
epicardial location, and an epicardial ablation was performed. ECGI images are shown in
Figure 5-12.

Isochrone map and potential map show earliest activation during VT in the anterolateral
base (Figure 5-12A). The propagation pattern is radial from a central focus, and the local
electrogram is pure Q wave, consistent with an epicardial source. Electroanatomic
mapping of the epicardial surface during VT (Figure 5-12B) was entirely consistent with
the noninvasive ECGI findings.
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Figure 39 (Figure 5-12): ECGI of anterior basal focal VT, (LV6)

Panel A. Isochrone map (upper row) and potential map (lower row, 88 ms from the onset of QRS)
during VT beat in three views. Asterisk indicates the ECGI determined VT origin. White arrows
indicate the direction of activation wavefront propagation. Epicardial electrogram with Q wave at the
earliest activation region is shown in blue. Panel B. Epicardial electroanatomical map (CARTO) is
shown in LAO projection, with early activation at the anterolateral base (red). The conventional
12-lead ECG during a VT beat is shown on the right.
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5.4 Discussion
This paper reports the first findings from a noninvasive three-dimensional
electroanatomic mapping system, ECGI, in a series of patients undergoing catheter
ablation for a broad range of ventricular tachycardia types. A number of general
conclusions regarding ECGI performance in this study should be mentioned. First, ECGI
proved to be a reliable and versatile system, with 100% imaging success rate when
performed either before or during an EP study. Second, despite a wide range of VT
locations and mechanisms included in this study, ECGI results were consistent with the
conclusions of the ablation procedures in all cases. Third, based on comparison with
three-dimensional catheter mapping, when available, ECGI provided high local spatial
resolution. This property overcomes a limitation of the body surface ECG, which
provides only global information. For example, despite a monomorphic appearance of the
conventional 12-lead ECG during VT in patient LV3, there are differences in local
activation between beats, with a shift of initial activation sites (Figure 5-9).

The combination of three aspects of ECGI results could accurately characterize each
tachycardia: localization, propagation and electrogram characteristics. With these three
data elements, one can construct ECGI criteria to differentiate between focal mechanisms
(local initiation; radial propagation pattern) and reentrant mechanisms (spiral wavefront
with high degree of curvature; usually associated with an anatomic or functional line of
block and / or an underlying scar; early activation in the scar region).
- 136 -

The ability of ECGI to obtain information on local epicardial activation and its
progression on a beat-by-beat basis can provide important insights into VT mechanisms.
An interesting example of focal tachycardia is the VT induced by programmed
stimulation (LV1, nonischemic cardiomyopathy; Figure 4). At baseline pacing
(CL=600ms), an inferior (anatomical) line of block was present on lateral LV. During
premature pacing (S1-S2=280ms), this line of block was functionally extended, forcing
the activation front to pivot around it with high curvature, thereby prolonging activation
time (relative to the time of pacing stimulus) and shifting latest activation to a location
near the center of the anatomical block. The next beat is the first VT beat. It is coupled to
the S2 premature beat and starts from the location of its latest activation. The delayed late
activation by S2 promotes recovery and capture of adjacent ventricular regions by the VT
excitation. Taken together, these properties are consistent with triggered activity as the
mechanism of VT initiation.

Physiological insights can also be obtained for reentrant VTs. The examples in this study
include the relationship and anchoring to a myocardial scar, early activation in the scar,
and exit sites at the scar border form which the rotating wave front emerges. From the
clinical perspective, this information can assist in guiding ablation. It should be
mentioned that frequently the ECGI-imaged activation wave front sequence did not cover
the entire tachycardia cycle length. This can be accounted for by intramural activation
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(ECGI is limited to the epicardium) and/or slow discontinuous conduction inside the scar
(reflected in early activation detected by ECGI at the scar border zone).

The results of this study suggest possible clinical usefulness for ECGI. Potential clinical
advantages include: 1) the ability to map the entire heart in a single beat, including areas
of presystolic activation and areas of scar; 2) the ability to map prior to an ablation
procedure (catheter or surgical), without the antiarrhythmic effects of sedation; 3)
identification of alternate non-RVOT sites of VT in patients with outflow tract
tachycardias, such as the example above from the left coronary cusp; 4) identification of
epicardial origin of VT based on electrogram morphology (Q wave vs. rS pattern), which
allows for a more appropriate individualized ablation strategy, such as early epicardial
access; 5) ability to image noninvasively the electrical substrate over time, which can be
applied in follow up evaluations of therapy or progression of disease. A randomized trial
would be needed, however, before one can conclude that the use of ECGI translates into
faster, safer and more successful procedures.

An obvious limitation of all ECGI studies at this translational stage is a limit on the
number of subjects. This is dictated by the unavailability of ECGI systems for multi-site
studies, by the need for careful processing and detailed analysis of data on a case by case
basis, and by the still experimental stage of this new approach. In this pilot VT study, we
present examples of different types of tachycardia and examine the ability of ECGI to
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provide mechanistic insights. A detailed description of mechanisms and further
evaluation of the clinical application of ECGI in VT patients will require a multi-center
study in much larger groups of subjects in each VT category.

5.5 Legends for the Video files
LV1.wmv:

Patient (LV1), Epicardial Focal VT; The first two beats are S1 paced beats,

followed by two S2 paced beats and two VT beats.

LV2.wmv:

Patient (LV2), Scar-related Reentry VT; The first two beats and last beat are

VTs, the third beat is sinus capture (SC) beat.

LV3.wmv:

Patient (LV3), Scar-related Reentry VT; The first three beats are VT beats,

the last beat is the sinus fusion beat.

LV4.wmv:

Patient (LV4), Fascicular VT; Two beats of epicardial activation during VT

are shown.

LV5.wmv: Patient (LV5), Fascicular VT; Eight beats of epicardial activation during VT

are shown.
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Chapter 6 Characterization of Epicardial Activation in Humans
with Diverse AF Patterns using Noninvasive ECG imaging (ECGI)

Abstract
Many mechanisms for the initiation and perpetuation of atrial fibrillation (AF) have been
demonstrated over the last several decades. The tools to study these mechanisms in
humans have limitations, the most common being invasiveness of a mapping procedure.
In this paper, we present simultaneous noninvasive biatrial epicardial activation
sequences of AF in humans, obtained using the Electrocardiographic Imaging (ECGI)
system, and analyzed in terms of mechanisms and complexity of activation patterns.
We performed ECGI in 36 patients with a diagnosis of AF. To determine ECGI atrial
accuracy, atrial pacing from different sites was performed in six patients (37 pacing
events), and ECGI was compared to registered CARTO images. Then, ECGI was
performed on all 36 patients during AF and ECGI epicardial maps were analyzed for
mechanisms and complexity. ECGI noninvasively imaged the low-amplitude signals of
AF in a wide range of patients (97% procedural success). The spatial accuracy in
determining initiation sites as simulated by atrial pacing was ~ 6mm. ECGI imaged many
activation patterns of AF, most commonly multiple wavelets (92%), with pulmonary vein
(69%) and non-pulmonary vein (62%) focal source sites. Rotor activity was seen rarely
(15%). AF complexity increased with longer clinical history of AF, though the degree of
complexity of nonparoxysmal AF varied and overlapped. ECGI offers a way to identify
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unique epicardial activation patterns of AF in a patient-specific manner. The results are
consistent with contemporary animal models of AF mechanisms and highlight the
coexistence of a variety of mechanisms among patients.

6.1 Introduction

Atrial fibrillation (AF) is the most common cardiac arrhythmia, accountable for increased
risks of stroke, heart failure, and all-cause mortality160,161. It is responsible for nearly
one-third of all hospital admissions with a cardiac rhythm abnormality162. Published
guidelines have provided a standardized approach toward treating AF163. In general,
patients are clustered into groups based on the clinical duration and frequency of
recurrence of AF (paroxysmal, persistent, longstanding persistent, permanent). While this
approach has served clinicians well, it does not take into account the various mechanisms
of the arrhythmia.

Lessons from numerous models of AF have brought about conflicting results regarding a
single unifying mechanism. Common theories include the “multiple wavelet”
hypothesis164, the “mother rotor/fibrillatory conduction” hypothesis165, and the
“pulmonary vein/focal source” hypothesis166. Additional contributions from the
autonomic nervous system likely play a key role in AF as well167. Mechanisms of
initiation and perpetuation of AF continue to be the subject of on-going intense
investigation.168-175
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Toward improving the treatment of AF, it is incumbant to understand the underlying
mechanism in each individual patient. Indeed, the HRS/EHRA/ECAS 2007 Expert
Consensus Statement on the Surgical and Catheter Treatment of Atrial Fibrillation
summarizes the state of our knowledge by stating, “Although much has been learned
about the mechanisms of AF, they remain incompletely understood. Because of this, it is
not possible to precisely tailor an ablation strategy to a particular AF mechanism.”176

Currently, there is a paucity of simultaneous atrial mapping data during AF in patients. In
this paper, we present simulatneous noninvasive biatrial epicardial activation sequences
of AF for a wide range of AF phenotypes. The maps were obtained using the noninvasive
Electrocardiographic Imaging (ECGI)1 system and analyzed in terms of mechanisms and
complexity of activation patterns.

6.2 Methods
Thirty-six subjects included in this study had histories of atrial arrhythmias and were
referred from the electrophysiology and cardiothoracic surgery services. Subjects were
identified in both the inpatient and outpatient settings. All protocols were approved by the
Institutional Review Board at Washington University in St. Louis, and informed consent
was obtained from all patients.
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ECGI System
ECGI methodology was described previously in detail1,2. 256 carbon electrodes organized
on strips were applied to patient’s torso surface. Small CT markers were attached to the
back side of each carbon electrode. All carbon electrode strips were connected to a
portable mapping system (Active 2 system, BioSemi, Netherlands). After the electrodes
were applied, the patients underwent thoracic noncontrast gated CT imaging with an axial
resolution of 3mm. Scans were gated at 20% of the R-R interval (atrial diastole) if in
sinus rhythm. When the ECGI was performed during an EP study or pulmonary vein
isolation procedure, the carbon electrodes were kept in the same position as during the
preprocedural CT. Atrial epicardial surface geometry and body surface electrode positions
were labeled and digitized from CT images.

The 256 channels of body surface potentials (BSP) were sampled at 1-ms intervals during
the cardiac cycle, and the data were saved on a laptop computer.

BSP were acquired

during sinus rhythm or atrial arrhythmias. During the EP study, BSP were acquired during
atrial pacing from various locations and during atrial tachycardias. Several minutes of
data were recorded from each patient. The QRST complex was excluded from the
reconstruction and analysis of atrial arrhythmias.

The BSP and geometrical information (torso-heart geometrical relationship) were
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combined by ECGI algorithms to noninvasively construct epicardial potential maps,
electrograms, activation sequences (isochrones) and repolarization patterns. ECGI has
been

extensively

validated

in

animal

models3-9,91,177

and

human

studies.1,2,10,12-18,33,34,102,178,179 ECGI is constructed on a beat-by-beat basis and does not
require accumulating data from many identical beats. Activation times were determined
by the maximal negative slope of the epicardial electrograms. Activation movies for
several consecutive beats were also constructed by animating the activation wave front on
the patient-specific CT-derived epicardial surface. Activation movies are created from
several recordings for each patient. All the activation movies from different recordings
are analyzed. Lines or regions of block were determined if activation times across local
areas differed by more than 50ms. Slow conduction is represented by crowded
isochrones.

Clinical Classification of AF
AF was classified based on standard criteria of AF duration. Paroxysmal AF is defined as
recurrent AF lasting less than 7 days and terminating spontaneously. Persistent AF is
defined by episodes longer than 7 days in duration or that requirement for electrical or
pharmacologic cardioversion. Long-standing persistent AF is defined as longer than one
year in duration.

Simulation of Focal Atrial Activation with Pacing during Biatrial ECGI Mapping
- 144 -

ECGI was performed on six patients in sinus rhythm undergoing pulmonary vein
isolation procedures. ECGI was obtained during pacing from various sites in the left and
right atria to simulate focal initiation sites. Anatomic locations of the pacing sites were
recorded onto an endocardial electroanatomic map (CARTO, Biosense-Webster) or
regionalized to the specific structure being paced. ECGI reconstructions of the paced P
waves were analyzed to determine the location of pacing site based on earliest isochronal
activation, location of a local potential minimum during depolarization and
corresponding potential maximum during repolarization. Examples are shown in Figure 1.
When possible, the three-dimensional distance from the ECGI-imaged site to the
recorded anatomic site from a registered electroanatomic map was measured (Amira 4.1,
Visage Imaging).

Analysis of Atrial Arrhythmias
Static isochrone maps of the atrial activation sequence were constructed for patients in
sinus rhythm and organized atrial arrhythmias. For patients in AF, activation movies of
AF were constructed during long RR intervals (500 to 1000ms) by animating the
activation wavefront on the CT epicardial surface using one millisecond incremental time
intervals. Detailed visual analysis of at least five atrial fibrillation movies for each
patient (500-1000 ms per movie) was performed. The number of observed simultaneous
wavelets participating in AF (“number of wavelets”), the locations of spontaneous atrial
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depolarization sites, and number of such sites that initiated new wavefronts (“number of
focal sources”) were recorded. To minimize nonphysiologic error, the definition of a
“focal source” required a local cycle length of at least 100ms and had to be observed at
least twice in a movie segment. To quantify the complexity of an individual’s AF, a
“complexity index” was calculated as the arithmetic sum of the mean number of wavelets
and the mean number of focal sources. A complexity index of 1 represents the simplest
AF, with higher numbers representing more complex AF.

Continuous variables, such as number of wavelets or focal sources, were analyzed using a
Student’s t-test. When patients were grouped according to their clinical history
(paroxysmal, persistent, long-standing persisitent), an analysis of variance (ANOVA) test
was used to determine differences between the three groups.

Patient Selection
The pertinent clinical characteristics of the thirty-six patients are summarized in Table
6-1 and Table 6-2. Twenty of the thirty-six patients were ECGI-imaged during atrial
fibrillation. Six patients referred for AF were found by ECGI to have other atrial
arrhythmias (atypical atrial flutter (4), atrial tachycardia (2)). Fifteen patients were
imaged during sinus rhythm. Using clinical criteria, eleven of the thirty-six patients were
classified as paroxysmal (31%), nineteen as persistent (53%), and six (16%) as
long-standing persistent. This was a heterogeneous group with respect to age (31 to 76
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years), duration of AF (1 month to 30 years), and left atrial size (3.5 to 5.7 cm).

Overall, ECGI yielded interpretable images in 35 of 36 patients (97%). One patient
without interpretable ECGI was diagnosed with atrial flutter from a pacemaker
interrogation and did not have any discernable atrial activity on her standard 12-lead ECG.
She had undergone a prior Cox-maze procedure and mitral valve replacement. In all
patients, ECGI was well-tolerated without any adverse events related to the imaging.
Table 7 (Table 6-1) Clinical Characteristics
Number (%)

Mean (Range)

55.4 years

Age

(31-76 years)

Gender
Male

24 (67%)

Female

12 (33%)

Caucasian

33 (91%)

Race
Black

2 (6%)

Other

1 (3%)
8.3 years (0.2 to 30 years)

Years since diagnosis of AF
Clinical classification of AF
Paroxysmal

11 (31%)

Persistent

19 (53%)

Longstanding Persistent

6 (17%)

Left atrial dimension

4.4 cm (3.5 to 5.7 cm)

Mitral regurgitation

0.86 (0[none] to 3[severe])

Clinical History
CHF

2 (6%)

HTN

14 (39%)

DM

2 (6%)

CVA/TIA

4 (11%)

Antiarrhythmic medication
Immediate family history of AF

36 (100%)
6 (17%)
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Seven patients had a prior pulmonary vein isolation procedure (2 persistent, 5
long-standing persistent). At the time of ECGI, five of the seven were in AF, one was in
atrial tachycardia and one was in atypical atrial flutter. Two patients had a prior
Cox-Maze procedure; one was imaged in atypical atrial flutter while the other was
imaged during AF. One patient had a suspected atrial tachycardia based on ambulatory
monitoring but had only isolated premature atrial beats during EP study. One patient with
a prior Fontan corrective surgery had an atypical atrial flutter and had undergone two
prior right atrial radiofrequency ablation procedures. One patient was imaged during an
ablation procedure for idiopathic VT and developed AF during induced VT.
Table 8 (Table 6-2) Detailed Patient AF characteristics
Patient #

Clinical Group

Mapped

# Wavelets

Rhythm

#
sources

Focal

Complexity

Prior

Index

Procedures

11

Paroxysmal

Sinus

NA

NA

15

Paroxysmal

Sinus

NA

NA

16

Paroxysmal

Sinus

NA

NA

20

Paroxysmal

Sinus

NA

NA

22

Paroxysmal

Sinus, PAC

NA

NA

26

Paroxysmal

Sinus

NA

NA

23

Paroxysmal

AF

1

0

1

19

Paroxysmal

Sinus, AF

1

1

2

27

Paroxysmal

Sinus, AF

1.5

2

3.5

33

Paroxysmal

Sinus, AT, AF

1

1

2

35

Paroxysmal

Sinus, AT, AF

1

1

2

8

Persistent

Sinus

NA

NA

24

Persistent

Sinus

NA

NA

25

Persistent

Sinus

NA

NA

6

Persistent

Sinus

NA

NA

1

Persistent

AF

2

4

6

3

Persistent

AF

1

1

2
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4

Persistent

AF

1.5

3

4.5

10

Persistent

AF

1.5

1

2.5

13

Persistent

AF

2.5

4

6.5

14

Persistent

AF

1.5

2

3.5

17

Persistent

AF

2.5

3

5.5

18

Persistent

AF

1.5

2

3.5

7

Persistent

AF

2.5

3

5.5

34

Persistent

AF

2.5

2

4.5

32

Persistent

AF

4

3

7

Prior Maze

29

Persistent

AF

2

2

4

Prior PVI

30

Persistent

AF/AFL

2

2

4

Prior PVI

28

Persistent

AF/AFL

2

1

3

Fontan

21

Longstanding

AFL

NA

NA

AF

2

3

5

Prior PVI

AF

3

6

9

Prior PVI

AF

2

3

5

Prior PVI

AF

3

3

6

Prior PVI

AT

3

1

4

Prior PVI

Prior Maze

Persistent
2

Longstanding
Persistent

5

Longstanding
Persistent

12

Longstanding
Persistent

31

Longstanding
Persistent

9

Longstanding
Persistent

6.3 Results
Simulation of Focal Atrial Activation with Pacing
In six patients, ECGI was performed during pulmonary vein isolation procedures with
atrial pacing from various atrial locations. A total of thirty-seven paced events were
recorded in all four pulmonary veins (PV), posterior left atrium, mitral valve isthmus,
coronary sinus, atrial septum, sinus node and atrial appendages. The cardiac structure
being paced was correctly identified by ECGI in all 37 pacing events (100% accuracy).
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Twelve pacing events were recorded on endocardial electroanatomic maps and merged
with the epicardial atrial shell derived from the ECGI-CT image. ECGI-determined
pacing locations were accurate within a mean 6.3 ± 3.9 mm (Figure 6-1).

Figure 40 (Figure 6-1) Evaluation of ECGI Accuracy in Locating Atrial Initiation Sites

Simulated by Pacing. TOP LEFT: Isochronal map of the left atrium in Anteroposterior (AP) view with
white star indicating the earliest activation as imaged by ECGI. BOTTOM LEFT: Potential map of the
left atrium (AP view) locating the local minimum (blue region, white star). TOP RIGHT: Merged 3-D
CARTO left atrial image with ECGI image, in the AP view. Pacing sites marked from CARTO in the
RSPV and various points on the intraatrial septum are recorded in red, with ECGI-predicted sites
marked in yellow. BOTTOM RIGHT: Detailed information regarding the specific sites included in the
atrial pacing simulation and the distance between CARTO and ECGI-imaged points.
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RSPV = Right

Superior Pulmonary Vein; RIPV = Right Inferior Pulmonary Vein; LAA = Left Atrial Appendage; MV
= Mitral Valve.

Analysis of Atrial Arrhythmias
When atrial arrhythmias were imaged, many activation patterns were observed. For most
patients (24/26, 92%), multiple simultaneous wavelets were visible on the atrial
epicardium. Rarely (2/26, 8%), the predominant mechanism was one single wave
macroreentry, involving both atria. Rotor activity was less common (4/26, 15%) than
multiple wavelets and was observed in the posterior left atrium, posterolateral and
anterolateral right atrium. Rotors rarely sustained more than one full rotation before
breaking into several less organized wavelets. In six patients with a clinical diagnosis of
AF, ECGI determined the actual mechanism to be occult atypical atrial flutter (4/26, 15%)
and atrial tachycardia (2/26, 8%) based on the regularity and reproducibility of the atrial
activation pattern.

Spontaneous, focal, radial epicardial activation occuring near the pulmonary veins (PV)
(18/26, 69%) or from non-PV sites (16/26, 62%) were commonly seen in addition to the
multiple wavelets. Non-PV spontaneous activation sites were predominately left atrial
posterior wall, coronary sinus, lateral right atrium, or vena cava. By convention, we refer
to these location as “focal source sites,” though their role in intiating AF was not studied.
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Examples of several of the observed activation patterns are shown in Figures 2-7 and In
the attached CD Movies 1-6. With simpler forms of AF, an isochrone map can represent
the pattern of AF. However, for most patients, the patterns of atrial activation involve
several wavelets with frequent wavebreaks and shifting pivots, making isochrones less
robust. We refer the reader to the movies in the attached CD for dynamic activation
movies of AF. Figures 2 and 3 (and corresponding Movies 1 and 2 in the attached CD)
show examples of PV focal source sites in the left inferior and left superior PV (LIPV and
LSPV, respectively) during AF. Movie 3 in the attached CD demonstrates a PV focal
source site in the right inferior PV (RIPV) during AF. Figure 4 (and Movie 4 in the
attached CD) shows one example of a focal source site and rotor activity at the
anterolateral right atrium during AF. Figure 5 (and Movie 5 in the attached CD)
demonstrates the less common phenomenon of single wave macroreentry underlying
paroxymal nonsustained AF in a young patient with a structurally normal heart. Figures 6
and 7 (and Movie 6 in the attached CD) is a representative example of a more complex
AF pattern with several simultaneous wavelets and partial rotor activity in the left atrial
posterior wall and right atrium. PV-focal source activities are also observed. Figure 6
demonstrates the combination of PV-focal source activity and wavelet pattern. Figure 7
shows a complex multiple wavelet pattern during the same AF.
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LSPV

RSPV

*

LIPV

RIPV

Figure 41 (Figure 6-2) Example of LIPV focal source.

ECGI isochrone map of both atria in the PA view during ~100 ms of AF demonstrates the initiation of
atrial depolarization from the LIPV (white) with radial spread. Slow conduction (crowded isochrones)
is seen near the right pulmonary veins, and a line of block is seen inferiorly beneath the LIPV (red to
blue). A corresponding activation movie is in the attached CD (Movie 1).
Pulmonary Vein; LIPV = Left Inferior Pulmonary Vein.
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LSPV = Left Superior

LSPV

*

LIPV

RSPV
RIPV

Figure 42 (Figure 6-3) Example of a LSPV focal source

ECGI isochrone map of both atria in the PA view during ~70 ms of AF demonstrates the initiation of
atrial depolarization from the superior aspect of the LSPV (light pink). Slow conduction (crowded
isochrones) is seen across the left atrial posterior wall. A corresponding movie is in the attached CD
(Movie 2).
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Figure 43 (Figure 6-4) Example of a right atrial focal source

Isochrone map of both atria in a right lateral view during atrial fibrillation demonstrates a pattern of
local spontaneous depolarization in the anterolateral right atrium with a counterclockwise rotor-like
pattern of activation. A corresponding movie is in the attached CD, demonstrating this pattern
repeating three times (Movie 4).
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RSPV

LAA

LIPV

RAA
RIPV

RA
MV
TV

Posterior

Anterior

Figure 44 (Figure 6-5) Example of single wave biatrial reentry

ECGI isochrone map of both atria in the right posterior view (left) and anterior view (right) during
~100 ms of atrial fibrillation demonstrates a single spiral wave. The broad, sweeping activation
wavefront involves both atria and propagates in a counterclockwise fashion (seen best in anterior view,
right panel ). Black line marks the inter-atrial septum. An activation movie of four continuous beats
can be found in the attached CD (Movie 5).

- 156 -

Figure 45(Figure 6-6) Example of combination pattern with PV focal source and single wavelet

Activation (from 46 ms to 73 ms) of both atria in the PA view is shown. Atria surface is shown in blue.
Activation wavelets are shown in red (boundaries highlighted green). White arrows indicate the
propagation direction of the wavelet. The white star denotes a pivot point of wavelet rotation. At 46ms,
a focal source emerges from LSPV and focal sources a wave of radial activation (51ms). The
emerging wavelet pivots around an area in the LA posterior wall (59-63ms) (star) and then propagates
towards the right PVs (63-73ms). (from Movie 6 in attached CD)
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Figure 46 (Figure 6-7) Example of multiple wavelets pattern

Activation (from 503 ms to 533 ms) of both atria in the PA view is shown. Atria surface is shown in
blue. Activation wavelets are shown in red (boundaries highlighted green). White arrows indicate the
propagation direction of wavelets. The white stars denote the pivot points around which the wavelets
turn. Single wavelet at 503ms breaks into two wavelets on the posterior LA wall (508-525ms) and
propagates around two pivot points (stars). At 533ms, the two wavelets coalesce and terminate. (from
Movie 6 in attached CD).

Analysis of AF Complexity
Of the twenty-six patients who were imaged during an atrial arrhythmia, there were
significant differences in the complexity of the arrhythmia based on the standard clinical
grouping (paroxysmal, persistent, long-standing persistent). AF complexity was
determined by the mean number of simultaneous wavelets and focal source sites.

Patients classified as having paroxysmal AF had fewer wavelets (mean 1.1) during AF
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than patients with persistent AF (2.2 wavelets, p = 0.017) or long-standing persistent (2.6
wavelets, p < 0.005) AF. In aggregate, the three groups were significantly different with
regard to number of wavelets (ANOVA p = 0.011, see Figure 8 Panel A).

Similarly, patients with paroxysmal AF had fewer focal source sites (mean 1.0 focal
sources) than patients with persistent (2.3 focal sources, p = 0.034) or long-standing
persistent (3.2 focal sources, p = 0.034) AF. Compared among the three groups, each
group was significantly different (ANOVA p = 0.031, Figure 8 Panel A).
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Figure 47(Figure 6-8) Complexity Analysis
Panel A: Increasing complexity of atrial fibrillation stratified by clinical classification of paroxysmal,

perisistent and long-standing persistent AF. (ANOVA for wavelet, p = 0.011; focal focal sources, p =
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0.031) Panel B. Complexity Index for paroxysmal, persistent and longstanding persistent AF groups.
Complexity Index is the sum of the mean number of wavelets and number of focal source sites for
each patient. A Complexity Index of 1 is the minimum, and represents the “simplest” AF. The
Complexity Index increases with the duration of AF. There is overlap between the persistent and
longstanding persistent groups.

Within the group of patients with paroxysmal AF, there was considerable homogeneity
and simplicity with regards to the number of wavelets and focal sources. Using the sum
of the mean number of wavelets and focal sources as a “complexity index,” patients with
paroxysmal AF had values that ranged from 1 to 3.5, with a mean of 1.9 (see Figure 8
Panel B). In general, paroxysmal AF patients had fewer than 3 wavelets with 0-2 focal
focal sources.

In contrast, patients with persistent AF demonstrated heterogeneity with regards to these
parameters. Patients in this group had one to four simultaneous wavelets and one to four
focal focal sources visible during AF. The complexity index ranged from 2 to 7, with a
mean of 4.4. At the extremes, the “simplest” AF pattern among the patients with
persistent AF (Patient 3) had a single wavelet from a single driver in the right atrium
(complexity index of 2). The most complex AF pattern in this group (Patient 13) had an
average of four wavelets and at least three identifiable focal source sites contributing to
AF.
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The patients with long-standing persistent AF had the most complex AF patterns. One
patient in this group (Patient 5) who had undergone several prior catheter ablations,
exhibited the most complex AF pattern of the entire cohort, with a mean of three wavelets
arising from a total of six identifiable focal source sites (two pulmonary veins, coronary
sinus, right atrium, and two sites in the posterior left atrial wall). Graphically (Figure 8
Panel B), the persistent and long-standing persistent groups demonstrated overlap with
regards to the complexity index, while the paroxysmal group did not.

6.4 Discussion
AF is characterized by a dynamically changing activation sequence.180,181 This hallmark
of AF poses a severe limitation on point-by-point catheter mapping of AF, which requires
a stable, monomorphic arrhythmia. Simultaneous recording from many electrodes over a
relatively long duration is required to accurately map AF. Invasive multi-channel
mapping studies were conducted on both epicardial and endocardial atrial surfaces in
animals182-190. These studies have been invaluable and provided the basis for much of our
understanding of AF mechanisms. However, many aspects of animal models of AF are
different from properties of human AF, including the ion-channel profiles of atrial cells,
the atrial anatomical substrates, and the modification of these properties by remodeling
processes over time.

Because of these differences and to characterize human AF,

intra-operative multi-channel epicardial mapping studies were performed in patients.
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Observations from direct epicardial recordings34,191-193have been instrumental to the
characterization of AF in humans. These landmark observations were limited, however,
by access to only certain parts of the atria, relatively short time periods for recording data
in a patient with an open chest, and the influence of general anesthesia on autonomic tone.
Also, in most studies, mapping was confined to regions of the atrial epicardium with
limited spatial resolution. In other studies, invasive endocardial mapping of AF was
performed using multi-channel catheter (basket or balloon) arrays in the left and right
atria194-198, as well as the pulmonary veins199. The catheter approach limited mapping to
the endocardial surfaces of the atria. Although this approach is less invasive than surgical
mapping, it still involves effects of sedation, and the intra-atrial presence of the array
greatly limits mapping time. The mapping resolution is also compromised by the limited
number of recording electrodes. Due to its invasive nature, this approach is not suitable
for conducting repeated mapping protocols in longitudinal studies of atrial
electrophysiology over time. Several AF mechanisms have been proposed based on the
animal studies and limited number of human studies mentioned above. They include the
mother rotor/fibrillatory conduction

168,200-202

, the pulmonary vein/focal mechanism166,

and the multiple wavelet mechanism164. Studies have also suggested involvement of the
autonomic nervous system in human AF167.

The present study applies ECGI as a noninvasive mapping tool for studying mechanisms
of human AF. ECGI can map the epicardial activation pattern of AF on both atria with
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relatively high spatial resolution. There is no surgery, sedation or invasive intervention
involved in ECGI mapping, therefore the AF pattern can be observed in “real-world”
conditions, over long periods of time (minutes to hours). Due to its noninvasive nature,
ECGI can be repeatedly conducted on the same patient to provide longitudinal
information on the evolution of the atrial electrophysiological substrate over time. ECGI
has been validated extensively in animal and human studies in normal hearts and a
variety of pathological conditions1-10,12-18,33,34,91,102,177-179The pacing data presented here
determine ECGI’s atrial accuracy at 6mm and is comparable to previously published data
from ventricular reconstructions3,10,91. This study is the first to report detailed,
three-dimensional noninvasive imaging of bi-atrial epicardial activation patterns during
AF in humans. Major findings include: 1) ECGI is feasible with low amplitude
fibrillatory atrial signals; 2) many various epicardial activation patterns are observed over
a population, but specific, and often reproducible, activation patterns can be identified in
individual patients; 3) the most common activation pattern was multiple concurrent
wavelets with simultaneous spontaneously depolarizing (focal source) sites from areas
near the pulmonary veins and other sites within both atria; 4) complexity of AF increased
with longer clinical duration of AF, though; 5) among non-paroxysmal AF, the clinical
distinction of “long-standing” did not seem to differentiate complexity.

The data presented here are consistent in many ways with the contemporary animal
models of AF mechanisms182-190 and highlight the coexistence of a variety of mechanisms
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as previously reported in animals and humans34,191-193. ECGI offers a way to identify
unique atrial activation patterns in a patient-specific manner. Observed epicardial
activation patterns were often, though not always, repeated in each patient, which
suggests a possible clinical application for patient-specific therapy.

Because it is

noninvasive, ECGI can be applied to large populations. Considering that ECGI is a new
method, still in its translational phase and requiring careful analysis of extremely large
amount of data for each recorded AF, the study population of 36 patients is rather large. It
is an appropriately heterogeneous cohort for characterizing the wide spectrum of AF
patterns, which was the aim of the study. Prospectively-designed studies using ECGI in
specific subgroups of patients may better characterize the most common underlying
mechanisms of AF.

Clinically, ECGI provides a noninvasive way to define a patient’s individual electrical
phenotype, which could lead to a tailored treatment plan. For example, if we can
visualize electrically important areas before an ablation procedure, such as a right atrial
focal source site, it may guide the procedure. Our observation that patients with
paroxysmal AF have “simpler” forms of AF is likely an important reason for the greater
success rates of catheter ablation in this patient group. More interesting, however, is the
range of complexity in patients with nonparoxysmal AF, with some patients having a
simpler pattern, like paroxysmal AF, and others a much more complex pattern. This may
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help explain the wide range of reported success with catheter ablation in patients with
nonparoxysmal AF. Additionally, our data showed overlap in AF complexity between
persistent and longstanding persistent groups. ECGI may have a role in identifying the
longstanding persistent AF patients who would be more likely to benefit from an ablation
procedure. Conversely, ECGI may identify patients who are unlikely to benefit from a
catheter or surgical ablation due to extensive scarring17 and complex atrial activation
patterns that may be difficult to treat with current strategies. Finally, ECGI offers
potential to noninvasively follow therapy (electrical or pharmacological) outcome over
time, and better understand why AF recurs in some patients.

Several key limitations are worth noting. First, ECGI reconstructs potentials on the
epicardial surface of the atria. While the atria are generally thin, evolving evidence
suggests at least a modest difference between local endocardial and epicardial
activation191.The observation that we describe as a “focal source” may well be the
epicardial breakthrough of intramural activation. In the future, simultaneous endocardial
and ECGI epicardial mapping may further elucidate the role of intramural activity and
effects of fiber orientation and tissue anisotropy in AF. Second, the ill-posed nature of the
mathematical formulation of ECGI limits its spatial resolution. Therefore, ECGI images
cannot differentiate micro-reentry from focal source activity. Third, this first ECGI AF
study was aimed at obtaining comparative data from a wide range of phenotypes, with
patients form all clinical classification groups of AF. Future studies will focus on each
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subgroup with greater detail. Moreover, the study included patients who had prior
catheter or surgical procedures. While this type of AF may not be naturally occurring, it is
certainly of clinical relevance. Finally, a limitation for ECGI is the inherent AF signal
quality, which is often of low amplitude on the body surface. By considering at least five
AF activation movies (ranging from 500-1000 ms each) for each patient and limiting the
definition of “focal source” to a cycle length of at least 100ms, nonphysiologic artifacts
were minimized.

6.5 Conclusions
ECGI can noninvasively image the low-amplitude signals of AF in a wide range of
patients. The spatial accuracy of determining initiation sites (as simulated by atrial
pacing) is ~ 6mm. In our patient population, ECGI imaged many mechanisms of atrial
fibrillation, most commonly multiple wavelets (92%), with pulmonary vein (69%) and
non-pulmonary vein (62%) focal source sites. Rotor activity was seen rarely (15%). Not
surprisingly, AF complexity increased with longer clinical history of AF, though the
degree of complexity of nonparoxysmal AF varied and overlapped. Looking forward,
ECGI may be used scientifically as an additional tool to study the various mechanisms of
AF in subgroups of patients and clinically to provide mechanistic-based diagnosis and
individualized treatment plans.
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6.6 Legends for the Video files
With simpler forms of AF, an isochrone map can represent the overall pattern of AF.
However, for most patients, the patterns of atrial activation involve several wavelets with
frequent wavebreaks and shifting pivots, making isochrones less robust. The following
movies in the attached CD highlight various epicardial activation patterns observed
during AF.

Movie 1 (with Figure 6-2 in text). Example of a left inferior pulmonary vein (LIPV) focal

source. Activation movie in the PA view during ~100 ms of atrial fibrillation
demonstrates the initiation of a focal atrial depolarization from the LIPV with radial
spread. Slow conduction is seen near the right pulmonary veins, and a line of block is
seen inferiorly beneath the RIPV.

Movie 2 (with Figure 6-3 in text). Example of a left superior pulmonary vein (LSPV)

focal source. Activation movie in the PA view during ~70 ms of atrial fibrillation
demonstrates the initiation of a focal atrial depolarization from the LSPV with radial
spread. Slow conduction is seen across the left atrial posterior wall.

Movie 3. Example of a right inferior pulmonary vein (RIPV) focal source. Activation
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movie in the PA view during ~30 ms of atrial fibrillation demonstrates the initiation of
focal atrial depolarization from the RIPV with radial spread.

Movie 4 (with Figure 6-4 in text). Example of a non-PV right atrial focal source,

triggering rotor activity in a patient with persistent AF. Activation movie of both atria in a
right lateral view during AF demonstrates a repeating pattern of local spontaneous
depolarization (focal source) in the anterolateral right atrium.

Movie 5 (with Figure 6-5 in text). Example of single wave biatrial reentry pattern in a

patient with paroxysmal AF. Activation movie of both atria in the right posterior view
during ~600 ms of AF demonstrates a single wave without an obvious focal source. This
movie is presented in a translucent view, allowing the reader to visualize the wavefront
on the posterior wall (brighter color) as well as the distant anterior structures (faded
color). The broad, sweeping activation wavefront propagates in both atria in a
counter-clockwise fashion.

Movie 6 (with Figures 6-6 and 6-7 in text). Example of complex patterns in a patient with

persistent AF with rotor activity. Activation movie of both atria in the PA view shows ~
1000 ms of AF. Multiple simultaneous mechanisms are seen, including multiple wavelets
and partial rotors with distinct locations of wave break on the posterior left atrium and
right atrium.
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Chapter 7 Noninvasive Electrocardiographic Imaging of
Normal Human Atrial Repolarization, Ventricular Bigeminy,
Focal Atrial Tachycardia after Pulmonary Vein Isolation, and
Scar-Related Atypical Atrial Flutter

7.1 Noninvasive Electrocardiographic Imaging of Normal Human Atrial
Repolarization
Knowledge of normal atrial activation and repolarization patterns provides an important
baseline for understanding atrial arrhythmias. We recently published images of normal
atrial activation under complete physiological conditions, using a novel noninvasive
imaging modality developed in our laboratory, called Electrocardiographic Imaging
(ECGI).1 256 carbon electrodes organized in strips are applied to the patient’s torso
surface to obtain body surface potentials (BSP) and the patient undergoes thoracic
noncontrast gated CT with the electrodes in place. The BSP and anatomical information
from the CT scan (torso-heart geometrical relationship) are combined mathematically by
ECGI algorithms to noninvasively construct epicardial potential maps, electrograms and
activation sequences (isochrones) and repolarization patterns.2 Here we provide images
of normal atrial repolarization obtained from a 49-year-old male with normal atrial
activity. The figure shows ECGI images of atrial surface potentials at two instances
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during depolarization (left panel, 18ms and 36ms from onset of P wave) and
repolarization (right panel, 105ms and 123ms from onset of P wave); arrows show
propagation of zero potential lines, ＋ is potential maximum, － is potential minimum.
The sequence of repolarization (white arrows) is determined by and follows the sequence
of depolarization (black arrows), unlike the ventricles where the repolarization sequence
is determined by local repolarization properties.2 A close similarity between potential
patterns during depolarization and repolarization is evident in the image and is consistent
with previous invasive mapping in canine experiments.203 The patterns are almost
identical, except that the polarity is reversed. This indicates that the repolarization
sequence follows the depolarization sequence, because differences in action potential
durations across the atria are much smaller than differences in atrial activation times, as
expected in the absence of a specialized conduction system involvement. LA: left atria;
RA: right atria; SVC: superior vena cava; IVC: inferior vena cava; PV: pulmonary veins
(denoted by the four black circles).
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Figure 48 (Figure 7-1): Normal human atrial repolarization (see text for details)

7.2

Noninvasive

Electrocardiographic

Imaging

of Focal

Atrial

Tachycardia after Pulmonary Vein Isolation
Electrocardiographic imaging (ECGI) is a novel, noninvasive tool for imaging cardiac
arrhythmia and defining electrophysiologic properties.1,35 ECGI combines multi-electrode
body surface ECG recordings with three-dimensional anatomical heart-torso imaging to
reconstruct an epicardial electroanatomical map. ECGI-reconstructed data can be
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presented as epicardial potential maps, electrograms, or isochrones during activation and
repolarization. The ECGI procedure has been extensively tested and validated in
experimental preparations with normal and abnormal canine hearts4,5,8,9,21,23,24,204.
Recently, ECGI has been validated in humans1,10,33-35. To date, we have presented human
ECGI studies of normal activation and repolarization
block

1,10

, various pacing protocols

1,10,33

1,35

, right and left bundle branch

, atrial flutter 1, native sinus rhythm and

bi-ventricular pacing for cardiac resynchronization (CRT) in heart failure patients 10, and
focal ventricular tachycardia 34.

This report describes the first case in which ECGI was applied in a patient with a focal
atrial tachycardia. In particular, ECGI accurately located the earliest site of activation in
an atrium which had previously undergone two percutaneous pulmonary vein isolation
procedures. The tachyarrhythmia was successfully terminated with RF ablation in the
ECGI-determined location.

7.2.1 Case Report

A fifty-five year old caucasian female with a history of two prior pulmonary vein
isolation procedures for long standing atrial fibrillation was evaluated for increasing
palpitations and an episode of near syncope. She had a history of rheumatic mitral valve
disease and had undergone a percutaneous valvuloplasty nine years prior. Since her
valvuloplasty, she had an average of two admissions each year for symptomatic atrial
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fibrillation. She was cardioverted each time and, in addition to her oral anticoagulation,
she was tried on a number of antiarrhythmic medications without sustained success. She
underwent percutaneous pulmonary vein isolation procedures fourteen and six months
prior to this admission. Low voltage electrograms were recorded throughout the left
atrium during the first and second procedures. Transthoracic and transesophageal
echocardiography demonstrated marked left atrial enlargement (~5.6 cm), mild mitral
stenosis (mean gradient = 6-8 mmHg) and mild-to-moderate mitral regurgitation.

When she presented with recurring palpitations after the 2nd pulmonary vein isolation
procedure, an ECG revealed an ectopic atrial tachycardia with a rate of 136bpm. Neither
sotalol nor dofetilide suppressed the arrhythmia. The decision was made to attempt an
ablation procedure. Prior to the procedure, ECGI was performed to noninvasively
localize the source of tachycardia.
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Figure 49 (Figure 7-2): ECGI three-dimensional voltage and electrogram maps

Panel A and B show atrial epicardial potential maps at 10 ms and 112 ms after the onset of the surface
P wave. Panel A captures the epicardial breakthrough pattern during activation, and Panel B shows the
repolarization pattern with reverse polarity. The white asterisk indicates the site of earliest activation
as predicted by ECGI. Panel C shows the ECGI-determined earliest activation site (white asterisk) on
a CT image of the atria. Panel D is an electrogram magnitude map (peak-to-peak) reconstructed by
ECGI (posterior view). The dark blue represents a region of low magnitude electrograms, indicating a
scar region. Three electrograms selected from a non-scar region (a) and from the scar region (b, c) are
shown. Location of low magnitude electrograms is consistent with prior pulmonary vein isolations and
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left atrial substrate modification. RIPV = right inferior pulmonary vein; LIPV = left inferior
pulmonary vein; RSPV = right superior pulmonary vein; LSPV = left superior pulmonary vein; LAA =
left atrial appendage; RAA = right atrial appendage;

ECGI-reconstructed atrial epicardial surface voltage maps were produced for a single
P-wave extracted during the tachycardia (Figure 7-2). At the onset of the surface P wave,
an epicardial breakthrough (local potential minimum) was imaged on the left atrium, near
the atrial septum (Figure 7-2A). During the end of the surface P wave, a repolarization
pattern with reverse polarity (local potential maximum) appeared at the same site (Figure
7-2B). These observations strongly suggested the existence of an activation source at the
breakthrough site. These findings were consistent for several ECGI imaged P waves
during the tachycardia. Panel C superimposes the site of the breakthrough on a CT image.
As shown, the earliest site of activation determined by ECGI was located on the roof of
the left atrium, between the right superior pulmonary vein and the atrial septum (Figure
7-2C).

Additionally, ECGI-reconstructed atrial epicardial potential maps were organized by
location to provide temporal electrograms for any given site on the atrial epicardium. A
three-dimensional map encoding electrogram magnitudes is shown in Figure 7-2D. Very
low magnitude electrograms were reconstructed on the posterior left atrium, especially
around the pulmonary veins, consistent with scar from the patient’s previous pulmonary
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vein isolation procedures. For reference, ECGI-imaged atrial electrogram magnitudes in
normal subjects range from 0.6mV to 1mV. Low voltages were also observed on the
posterior wall of the left atrium. This probably reflects the patient’s underlying disease
and the effects of the two prior ablation procedures. Diffuse low voltage was observed
during the initial study prior to the pulmonary vein isolation. The prior procedures
induced wide circumferential ablation that contained much of the posterior wall, linear
lesions connecting the superior veins and inferior veins, and ablation of residual
potentials recorded on the posterior wall by a lasso catheter. During the ECGI study,
potentials neither could be identified within the pulmonary veins nor the antra around the
orifices, suggesting successful prior pulmonary vein isolation procedures. This was
consistent with recordings made by a lasso catheter during the study.
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Figure 50 (Figure 7-3) Electroanatomic isochrone map and multichannel intracardiac
electrograms.

Panel A is the left atrial electroanatomic isochrone map. The white marker (arrow) identifies the
ablation site that successfully terminated the atrial tachycardia. The red markers are sites where RF
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energy was applied circumferentially around the site of earliest activation. Panel B is the multichannel
endocardial electrogram recording prior to successful ablation, with the ablation catheter at the
superior left atrium, near the activation site predicted by ECGI. Surface leads I, aVF, and V1 are
followed by intracardiac recordings from the ablation catheter, a decapolar catheter located on the
lateral wall of the right atrium, and a decapolar catheter positioned in the coronary sinus (proximal to
distal).The ablation catheter measured spontaneous diastolic potentials 58 msec prior to the onset of
the surface P wave.

At the onset of the EP study that followed the ECGI procedure, the patient was in an
atrial tachycardia with a cycle length of 540ms. Using a lasso catheter, all four pulmonary
veins were determined to be electrically isolated. Right and left atrial electroanatomic
catheter mapping identified a focal tachycardia originating from the superior left atrium,
between the right superior pulmonary vein and the atrial septum (Figure 7-3). Figure
7-3A is a catheter electroanatomic isochrone map (CARTO) constructed in the
electrophysiology laboratory during mapping and ablation of the tachycardia. The site of
earliest activation is indicated by the white dot. RF energy was applied at this site and
circumferentially around this site as indicated by the red markers. Diastolic potentials
were recorded 58ms before the onset of the surface P-wave near the ECGI-predicted site
(Figure 7-3B). The tachycardia was terminated with application of RF energy to this
location, and the tachycardia did not recur with administration of isoproterenol. The
patient concluded the study in sinus rhythm.
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7.2.2 Conclusion

This report describes a clinical application of the ECGI noninvasive electrical imaging
system as an adjunctive technology to accurately identify the specific origin of a focal left
atrial tachycardia and atrial electrophysiological substrate prior to catheter ablation. This
case has several points of interest. Atrial tachycardias are relatively common in patients
with atrial fibrillation who have undergone isolation of the pulmonary veins and often
require additional mapping and ablation. Localization of an atrial tachycardia by analysis
of the standard 12 lead ECG is difficult because the P-wave morphology can be affected
by the T-wave. Moreover, the criteria for interpretation of P-wave morphology recorded
on a standard lead ECG205 may not be valid in patients with diseased atria who have
undergone circumferential pulmonary vein isolation combined with ablation of
fragmented potentials. In the case under discussion, ECGI correctly located the
arrhythmic focus to the roof of the left atrium, between the right superior pulmonary vein
and atrial septum. Because the CT scan was not registered to the CARTO electroanatomic
image, a precise quantitative measure of localization accuracy could not be obtained.
ECGI also identified areas of low voltage on the posterior wall of the left atrium that
were attributable to the patient’s prior ablation procedures and underlying atrial myopathy.
The feasibility of assessing PV isolation noninvasively using ECGI will be further tested
in a larger study. Despite an abnormal left atrial substrate with extensive scar tissue,
ECGI was accurate in its localization of the focus of the tachycardia. Although further
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work remains to prove its clinical utility in large groups of patients, ECGI offers promise
for improved noninvasive analysis of the origin and mechanisms of atrial arrhythmias.

7.3 Noninvasive Electrocardiographic Imaging of Scar-Related Atypical
Atrial Flutter
7.3.1 Introduction

Atrial arrhythmias, including atrial fibrillation, atrial flutter and other types of atrial
tachycardia are common in humans. For instance, atrial fibrillation affects 0.5-1% of the
general population, and more than 6% of people over 80 years old.206 Knowledge of
electrophysiological properties of the underlying atrial substrate can improve diagnosis
and treatment of these arrhythmias. However, until recently a noninvasive method for
imaging cardiac electrophysiology and arrhythmias has not been available.
Electrocardiographic Imaging (ECGI) was developed for this purpose.1,35 ECGI
reconstructs an epicardial electro-anatomical map noninvasively by combining a
250-electrode body surface ECG with CT scan of the heart-torso geometry. The ECGI
images can be presented as epicardial potential maps, electrograms, isochrones or
repolarization maps during activation and repolarization.1,35 ECGI was systematically
tested and validated experimentally in normal and abnormal canine hearts.5,8,9,23,24 In
these experimental settings, torso potentials (the ECGI input) and epicardial potentials
(the ECGI output) were measured simultaneously and at high spatial and temporal
resolution. The directly measured epicardial potentials provided the ideal “gold standard”
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for validation of the noninvasive ECGI reconstructions; We evaluated and validated the
performance of ECGI under many different conditions, including ECGI of myocardial
scars23,24

and reentry circuits8,24, the electrophysiological elements imaged in this report.

Recently, ECGI has also been successfully applied and validated in human subjects,
including comparison to intra-operative multi-electrode mapping during surgery33,
determination of ECGI accuracy in locating focal sites of initial activation in humans by
comparison to known locations of pacing electrodes in various RV and LV positions1,10,
comparison to catheter-based localization of focal VT34 and determination of the origin of
human atrial tachycardia 207 In this case report, we describe the atrial substrate and
arrhythmia mechanism of atypical atrial flutter in a patient who previously underwent
catheter ablations for atrial fibrillation.

7.3.2 Patient History

The patient is a 48-year-old male with a two-year history of paroxysmal atrial fibrillation,
unresponsive to multiple drug therapy. When not in atrial fibrillation, the patient had
marked bradycardia, suggestive of sinus node dysfunction. He underwent catheter-based
pulmonary vein (PV) isolation. After his first catheter ablation, the patient developed
atypical atrial flutter. During this tachycardia, he had ventricular rates of 130 to 140 beats
per minute. The patient’s negative F-waves on Lead I were consistent with a left atrial
(LA) origin of this tachycardia. Four months after the first ablation, he underwent a
second procedure which revealed an inducible tricuspid isthmus-dependent atrial flutter
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and inducible LA reentry. The PVs were re-isolated and complete electrical isolation was
documented. Additional ablations were made in the left side of the mitral isthmus, on the
LA roof, and on the right side of the tricuspid IVC isthmus. Atrial flutter was not
inducible following these ablations. Three months after the second ablation, the patient
redeveloped persistent atypical atrial flutter. He was referred for a surgical COX-MAZE
procedure after unsuccessful cardioversion.

7.3.3 Methods

Body-surface ECG data were recorded for 5 minutes from 250 carbon electrodes
mounted in strips. ECGI reconstructions were performed during beats with relatively long
RR interval for which the atrial F wave was not masked by the QRS, and also for a 10
seconds ECG segment from which the QRST was removed. 208 Following the QRST
removal, the ECG had a typical sawtooth morphology, and the ECGI-reconstructed atrial
activation sequence was repetitious and consistent with only minor variations between
cycles.

7.3.4 Results

One day before the COX-MAZE procedure, ECGI was performed. Based on the
magnitudes of the ECGI reconstructed epicardial electrograms, the atrial tissue was
classified in terms of its electrophysiological properties. ECGI images showed low
potential regions (electrogram magnitude <0.5mV peak to peak; Figure 7-4A) around

- 183 -

each of the PVs and in the left atrial appendage (LAA) region. At surgery, scar tissue was
observed around the PVs and on the LAA (Figure 7-4B), which corresponded well with
the low voltage regions imaged by ECGI. Figure 7-4C shows two selected ECGI
electrograms, one from the scar region (b) and one from a region remote to the scar (a).

Figure 51 (Figure 7-4): ECGI magnitude map

Panel A: ECGI epicardial electrogram magnitude map (posterior view). Small magnitude regions
(<0.5mV; shown in blue) indicate scar. Panel B: photograph extracted from the video recorded during
the Cox-Maze procedure; Tissue appearing white is the scar. Panel C: Two selected
ECGI-reconstructed epicardial electrograms from different sites on the epicardial surface: (a) remote
to the scar; (b) within the scar （locations are marked in panel A） LIPV = Left Inferior Pulmonary
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Vein, LSPV = Left Superior Pulmonary Vein, RIPV = Right Inferior Pulmonary Vein, RSPV = Right
Superior Pulmonary Vein, LAA = Left Atrial Appendage, RAA = Right Atrial Appendage

ECGI-imaged activation sequence for one flutter cycle is shown in Figure 7-5. The
reentry circuit driving the atypical flutter was mainly confined to the left atrium (LA).
The circuit is depicted by the solid black and white arrows in the four panels of Figure
7-5. Earliest activation occurred at the LA inferior region below the left inferior PV
(LIPV) (site 1). The activation front propagated posteriorly towards the right atrium (site
2) as indicated by the solid white arrows in Panel A and B. It could not propagate
superiorly due to a line of block connecting the two inferior PVs (thick black line),
associated with the posterior scar from the previous catheter ablations. This line of block
extended to the anterior LA (Panel C). After about 50ms delay due to slow conduction at
the border of the low potential region near the two right PVs (white arrow, Panel B), the
activation wavefront turned around the line of block into the previously unexcited
superior region (site 3). The reentrant wavefront continued to propagate towards the roof
of the LA (site 4). From the LA roof, the wavefront propagated to anterior site 7, both
directly and via the left atrial appendage (LAA) (site 6) (Panels C and D), and continued
to the inferior mitral valve region (MV; site 8). It passed the MV isthmus, completing the
reentry circuit (Panels C and D). The next flutter cycle started again from site 1. A
secondary wavefront emerged from the reentry circuit and propagated mainly in the right
atrium (RA) (dashed black arrows in Panels B, C and D). It descended from the roof of
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the LA (site 4) to the inferior portion of RA free wall (site 5). There was a long line of
functional block between site 2 and site 5 (thick black line in Panel B) due to
refractoriness.

Figure 52 (Figure 7-5): ECGI reconstructed isochrone map of the flutter cycle.

Solid arrows show the reentry circuit. Dashed arrows show a secondary front emanated from the main
reentry circuit. The sequence of reentry is 1Æ2Æ3Æ4Æ(6)Æ7Æ8Æ1. Black circles show locations
of the four pulmonary veins. RA = Right Atrium, LA = Left Atrium, MV = Mitral Valve, TV =
Tricuspid Valve. LIPV = Left Inferior Pulmonary Vein, LSPV = Left Superior Pulmonary Vein, RIPV
= Right Inferior Pulmonary Vein, RSPV = Right Superior Pulmonary Vein, LAA = Left Atrial
Appendage.
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7.3.5 Summary

We report the first application of ECGI in a patient with atypical atrial flutter that
developed after catheter ablation for PV isolation. ECGI detected and mapped regions of
low voltages that coincided with scar tissue around the pulmonary veins from the
previous catheter ablation procedures, as verified during a COX-MAZE surgical
procedure. The flutter reentry circuit was constrained by the scar and mainly confined to
the LA. The mitral isthmus between the coronary sinus and the PVs participated in the
reentry circuit. ECGI also imaged a region of low potentials on the let atrial appendage
(LAA), which is uncommon. Typically, the left atrial appendage (LAA) is a region of
highest voltage, as measured by endocardial mapping. During the COX-MAZE procedure
it was observed that the LAA is extensively scarred (due to the underlying disease, not
prior ablation), consistent with the ECGI reconstruction of low voltages in this region.
The case reported in this manuscript was unique from the ECGI perspective, because
prior to the COX-MAZE procedure the diagnosis was atrial fibrillation. ECGI
constructed a monomorphic stable reentrant activation pattern that was repeated for many
beats, indicating anatomical rather than functional reentry. Both ECGI reconstruction of
low potentials and direct observation during surgery consistently identified an extensive
scar around which the ECGI reconstructed isochrones formed the reentry circuit; the scar
provided the anatomical substrate that stabilized the reentry. The repeatability of the
reentry pattern over many beats demonstrates the consistency of ECGI methodology. It
should be recognized that ECGI generates the entire activation map during a single beat
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and is therefore well suited to detect beat-to-beat changes during an arrhythmia. In
contrast, catheter mapping (e.g. CARTO) is conducted point-by-point in a roving-prove
fashion and requires data from many beats to construct an activation map. As such, it
cannot provide data for comparison to ECGI in most cases. Following the COX-MAZE
procedure, the patient returned to normal sinus rhythm.

7.4 Noninvasive Electrocardiographic Imaging of Ventricular Bigeminy
in a Human Subject
Ventricular bigeminy refers to the appearance of paired different ventricular complexes in
the body surface ECG (Figure 7-6, lead V2, inset in Panel A). From this ECG
morphology it is inferred that bigeminy is generated by interaction between an
extrasystolic beat and a regular periodic ventricular beat.209 The regular beat is typically
generated by sinus rhythm, but could also be a paced rhythm. The mechanism of
ventricular bigeminy was mainly inferred based on analysis of body surface ECG
signals.209,210 However, the ECG measures the reflection of cardiac electrical activation at
a limited number of points, on the body surface, remote from the heart. It does not
provide detailed information about cardiac activation patterns, data that are necessary for
understanding the mechanism of ventricular bigeminy. Here we apply noninvasive
Electrocardiographic Imaging (ECGI)1 to image ventricular epicardial activation during
bigeminy in a patient with atrial fibrillation, who underwent AV node ablation and an
implanted pacemaker in the right ventricular (RV) apex (asterisk in anterior view). ECGI
is a functional imaging modality that combines 250 body-surface ECGs with thoracic CT.
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1,35

Using inverse reconstruction algorithms, ECGI generates electroanatomical maps on

the epicardial surface of the heart noninvasively. Following extensive validation, it has
been

applied

in

human

subjects

with

various

cardiac

electrophysiological

conditions.10,33,34,207 Panel A of Figure 7-6 shows the sequence of ventricular activation
during bigeminy. The top row demonstrates the regular paced beat with wavefront
propagation from the pacing site to the rest of the heart over 160 ms duration due to slow
activation in the absence of conduction system participation. The bottom row shows
activation during the following beat, with wavefront propagating from an LV ectopic
initiation site (triangle in posterior view) to complete ventricular activation in 130 ms.
The interaction between the extrasystolic beat and the paced beat generates the bigeminy.
Occasionally, we captured and imaged fusion between the paced rhythm and the
extrasystole. Such fusion beats are shown in Panel B of Figure 7-6. In the top row, the
initiation of paced activation precedes that of extrasystolic activation by 15 ms. This
closely coupled biventricular activation increases electrical synchronization and reduces
the QRS duration to 100ms. In the bottom row, the sequence is reversed and the
extrasystole initiation precedes the paced beat by 10 ms with fusion beats of similar
duration but different morphology. These first ECGI images of bigeminy in a human
subject provide detailed epicardial activation sequences, confirming its origin in the
interaction between an extrasystolic beat and a regular periodic beat.

- 189 -

Figure 53 (Figure 7-6) ECGI reconstructed isochrone map
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Panel A: The ventricular activation sequence during bigeminy. Top row shows activation sequence for
a paced beat from a pacemaker lead located at right ventricular (RV) apex (black asterisk) in the
anterior and posterior views (with atria removed). Bottom row shows activation during an
extrasystolic beat from a left ventricular (LV) ectopic site (triangle). Panel B: Ventricular activation
sequence during two different fusion beats between the paced beat and extrasystolic beat. In the top
row, the onset of paced activation precedes that of extrasystolic activation by 15 ms. In the bottom row,
the extrasystole onset precedes the paced beat by 10 ms. RA = Right Atrium; SVC=Superior Vena
Cava; IVC = Inferior Vena Cava; MV = Mitral Valve; TV = Tricuspid Valve; The solid black line in
the posterior view indicates septum location.
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Chapter 8 Conclusions and Future Work

8.1 Conclusions

Cardiac arrhythmias continue to be a leading cause of death and disability. Despite this
alarming fact, a noninvasive imaging modality (analogous to CT or MRI) for cardiac
electrophysiology and arrhythmia has not been available for clinical diagnosis and
guidance of therapy. Importantly, such an imaging modality is also greatly needed for the
study of arrhythmia mechanisms in humans, where the arrhythmic substrate and disease
processes differ considerably from those in experimental animal models. In Dr. Yoram
Rudy’s Laboratory, we have developed, implemented, and validated a novel noninvasive
imaging modality (Electrocardiographic Imaging, ECGI) and demonstrated its successful
application in humans. ECGI reconstructs epicardial potentials, electrograms and
isochrones from body-surface electrocardiograms combined with heart-torso geometry
from computed tomography (CT). The studies presented in this dissertation focused on
the continued development of ECGI methodology and clinical applications in different
group of adult patients.

By introducing the application of a meshless method, the Method of Fundamental
Solutions (MFS), to ECGI, the time-consuming meshing operation involved in the
boundary element method (BEM) is eliminated, and the mesh-related artifacts in the
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BEM reconstructed epicardial images are avoided. Our studies demonstrate that the MFS
method has similar accuracy but simpler implementation due to the elimination of
complex singular integrals involved in BEM. These properties of MFS can enhance the
practical application of ECGI as a clinical diagnostic tool. We have also proposed a Real
Time ECGI procedure, in which ECGI inverse computation could be executed as fast as
the BSP data acquisition speed. In Real Time ECGI mode, the epicardial potential
information could be obtained during the BSPM recording, without any delay or data
accumulation. Real Time ECGI can provide epicardial electrophysiological data during
the clinical procedure, thus enabling interactive guidance of intervention.

ECGI has been successfully applied in patients with post-myocardial infarction,
ventricular arrhythmias, and atrial arrhythmias. In these human studies, ECGI has
demonstrated its ability to (1) noninvasively characterize the electrophysiological
substrate within one recorded beat; (2) noninvasively image the complicated ventricular
and atrial arrhythmias in a beat to beat fashion and provide insight to explain underlying
mechanisms, especially for patients who have dynamically changing conditions and can
not be easily mapped using currently available mapping tools; (3) noninvasively provide
location information about the origin of focal arrhythmias and facilitate ablations; (4)
provide noninvasive electrophysiology information for patient-specific treatment plans.
Our studies demonstrate that ECGI has great potential to be applied in both clinical
practice to facilitate the treatment of cardiac arrhythmias and scientific research to better
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understand the underlying mechanism of disease.

8.2 Future Work

Although ECGI has been improved dramatically and been successfully applied in many
different clinical settings over years, there is still room to enhance the ECGI system in the
following aspects: (1) a better and more automatic segmentation algorithm can enhance
the clinical application of ECGI; (2) a better user-interface, providing multiple choices
for inverse computation including regularization method and inverse parameters, can
make ECGI system easier to use; (3) better integration with other imaging modalities
such as MRI will enhance ECGI’s visualization capability and provide fused
anatomical-electrophysiological information; (4) integration with invasive mapping
systems such as CARTO, Navx etc. will provide comprehensive electrophysiological
information (both epicardial and endocardial mapping data); (5) better consideration of
inhomogeneous volume conductor will improve the accuracy of ECGI. With the
development of computational power and signal processing techniques, all these
technique improvement will be achieved.

ECGI has been extensively tested and validated over the last decades. Our studies with
relatively small numbers of subjects have clearly demonstrated ECGI’s capabilities and
potentials to provide important information and play unique roles in both clinical practice
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and basic electrophysiological research. In the next phase of ECGI application, better
designed prospective studies should be conducted to evaluate ECGI’s performance in
guiding clinical practice in a more direct way. In these studies, ECGI results will not only
be used to confirm data obtained from other imaging or mapping tools, but also be
considered as important independent information to influence clinical interactions and
decisions. Clinical trials with large numbers of subjects should also be conducted to
evaluate ECGI’s clinical usefulness.
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